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ABSTRACT	
	 Traumatic	brain	injury	(TBI)	is	a	major	source	of	disability	in	modern	
societies.	However,	there	are	no	good	pharmacological	strategies	for	treating	
long-term	TBI	complications	because	we	do	not	fully	understand	the	injury	
processes	that	occur	afterward.	Moreover,	a	significant	percent	of	patients	
entering	the	emergency	room	with	TBI	have	a	blood	alcohol	level	above	the	legal	
limit.	Alcohol	use	and	intoxication	is	a	widespread	issue	in	our	society.	Binge	
drinking	is	the	most	common	way	in	which	alcohol	is	consumed,	and	alarmingly,	
Americans	of	all	age	groups	binge	drink	on	a	frequent	basis.	Despite	the	
prevalence	of	alcohol	intoxication	seen	together	with	TBI,	how	it	affects	the	brain	
injury	and	recovery	process	is	not	well	understood.	Our	laboratory	has	previously	
found	that	a	repeated	dose	of	binge	alcohol	prior	to	TBI	impairs	functional	
sensorimotor	recovery.	One	means	by	which	the	brain	responds	to	injury	is	the	
mobilization	of	neural	precursor	cells	produced	by	neurogenesis.	However,	the	
effect	of	pre-injury	binge	alcohol	exposure	on	the	reactive	neurogenesis	that	
occurs	after	TBI	is	not	known.	Adult	neurogenesis	is	an	alternative	form	of	
plasticity,	which	involves	the	production	of	new	neurons	and	may	contribute	to	
functional	recovery	after	TBI.	The	subventricular	zone	(SVZ)	is	one	of	the	brain’s	
main	neurogenic	niches.	The	experiments	in	this	dissertation	therefore	sought	to	
	xiv	
determine	the	short	and	long	term	effects	of	pre-TBI	binge	alcohol	on	the	neural	
stem	cell	responses	in	the	SVZ	following	brain	injury.	We	assessed	the	SVZ	neural	
stem	cell	response	after	binge	alcohol	and	TBI	by	utilizing	the	proliferation	marker	
5-bromo-2’-deoxyuridine	(BrdU)	along	with	other	markers	for	neurogenesis	such	
as	Doublecortin.	We	found	that	binge	alcohol	did	not	affect	short	and	long	term	
lesion	size	(as	measured	at	24	hours,	7	days	and	6	weeks	post	TBI).	As	expected,	
TBI	alone	significantly	increased	SVZ	proliferation	bilaterally	24	hours	post	injury.	
Surprisingly,	binge	alcohol	alone	also	significantly	increased	proliferation	
bilaterally	in	the	SVZ	at	the	24	hour	time	point.	A	combined	binge	alcohol	and	TBI	
regimen	resulted	in	decreased	SVZ	proliferation	bilaterally	at	24	hours	and	7	days	
post-TBI.	Furthermore,	when	assessed	at	6	weeks	after	TBI,	binge	alcohol	
significantly	decreased	SVZ	neuronal	differentiation.	While	we	observed	that	TBI	
alone	increased	migration	toward	the	rostral	migratory	stream	(RMS),	binge	
alcohol	did	not	affect	either	RMS	or	perilesional	migration	post-TBI.	Taken	
together,	the	results	from	this	dissertation	suggest	that	pre-TBI	binge	alcohol	
negatively	impacts	functional	recovery	by	decreasing	short-term	neural	stem	cell	
proliferative	responses	as	well	as	long-term	neuronal	differentiation	of	these	
proliferative	cells	in	the	SVZ.		
	1	
CHAPTER	ONE	
OVERVIEW	AND	HYPOTHESIS	
	 The	prevalence	of	traumatic	brain	injury	(TBI)	in	our	society	is	striking	with	
1.7	million	occurrences	annually	(CDC	2010).	Many	survivors	are	faced	with	
debilitating	outcomes	such	as	deficits	in	sensory	or	motor	function	and	increased	
risk	for	mood	and	dementia	disorders	(Langlois	et	al	2006).	Yet,	no	
pharmacological	treatments	have	been	found	to	be	effective	at	treating	long-term	
TBI	effects.	Important	to	this	study,	up	to	43%	of	TBI	patients	entering	the	
emergency	department	have	blood	alcohol	levels	above	the	legal	limit	of	0.08%	
(Talving	et	al	2010).	Clinical	studies	indicate	that	being	intoxicated	at	the	time	of	
head	injury	leads	to	delayed	recovery	(Schutte	&	Hanks	2010).	Binge	drinking	has	
become	one	of	the	most	common	ways	in	which	alcohol	is	abused	according	to	a	
2012	CDC	report.	A	recent	finding	from	our	group	has	shown	that	using	a	rat	
model	of	TBI	and	binge	alcohol,	the	recovery	in	skilled	sensorimotor	task	
performance	is	slower	in	alcohol-exposed	animals	(Vaagenes	et	al	2015).	The	
cellular	and	molecular	underpinnings	of	the	impact	of	this	binge	pattern	of	
alcohol	consumption	on	TBI	recovery	has	yet	to	be	elucidated,	and	we	believe	
that	a	more	fundamental	understanding	of	TBI	and	binge	alcohol	will	help	in	
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designing	better	therapeutic	interventions	for	patients.	One	way	in	which	the	
brain	compensates	after	an	injury	such	as	TBI	is	to	increase	neurogenesis	in	
various	regions	such	as	the	subventricular	zone	(SVZ).	Neurogenesis	is	thought	to	
improve	functional	recovery	by	incorporation	of	new	neurons	that	take	on	the	
previous	functions	of	the	damaged	neurons.	The	goal	of	this	dissertation	was	to	
determine	how	TBI	affects	neurogenesis	in	the	SVZ	and	if	alcohol	binge	prior	to	
TBI	leads	to	a	reduction	in	neurogenesis.	The	results	from	this	dissertation	will	
show	directly	how	TBI	affects	the	three	most	important	parameters	of	
neurogenesis:	proliferation,	differentiation	and	migration.	
We	therefore	hypothesize	that:	A	binge	pattern	of	alcohol	consumption	prior	to	
traumatic	brain	injury	results	in	a	decrease	in	the	neural	stem	cell	(NSC)	
response	from	the	SVZ.		
This	hypothesis	will	be	tested	by	the	following	specific	aims:	
Aim	1:	Determine	the	effect	of	binge	alcohol	and	TBI	on	SVZ	proliferation:	
Proliferation	will	be	measured	by	BrdU	staining	using	unbiased	stereology	at	
early	time	points	of	24	hours	and	7	days	after	TBI.		
	 There	will	be	4	experimental	groups:	one	group	will	receive	binge	alcohol	
(3g/kg/day,	3	days,	by	oral	gavage)	and	TBI	(controlled	cortical	impact	to	
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sensorimotor	cortex);	the	next	group	will	receive	vehicle	gavage	(isovolumic	
water)	and	TBI;	another	group	will	receive	binge	alcohol	and	sham	TBI	
(craniotomy	without	cortical	damage)	and	the	final	group	will	receive	vehicle	
gavage	and	sham	TBI.	Immediately	after	surgery,	all	rats	will	receive	
bromodeoxyuridine	(BrdU)	(100mg/kg/day	ip	for	up	to	7	days)	and	survive	for	1	
day	after	TBI	or	7	days	after	TBI.	At	1	day	or	7	days	after	TBI,	rats	will	be	
euthanized	and	transcardially	perfused.	Brains	will	be	cryosectioned	and	
immunostained	for	BrdU	and	visualized	by	Diaminobenzidene	(DAB)	labeling.	We	
will	be	using	stereology	to	assess	the	number	of	BrdU	positive	cells,	which	is	a	
measure	for	cellular	proliferation.	
Aim2:	At	6	weeks	after	TBI,	determine	the	effect	of	binge	alcohol	and	TBI	on	
neuronal	differentiation	in	the	SVZ	and	the	migration	of	new	neurons	to	the	
perilesion	area	and	olfactory	bulb.	Differentiation	will	be	determined	by	
measuring	BrdU	and	Doublecortin	(DCX)	staining.	Migration	will	be	measured	by	
examining	BrdU	and	DCX	staining	at	target	migrating	sites	(perilesional	area	and	
rostral	migratory	stream).		
	 Animals	will	undergo	the	same	basic	experimental	conditions	as	outlined	in	
aim	1.	They	will	receive	BrdU	(100mg/kg/day,	ip)	for	7	days	following	TBI	to	label	
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all	proliferation	and	will	survive	for	6	weeks.	At	6	weeks	after	TBI,	rats	will	be	
euthanized	and	brain	tissues	processed.	We	will	use	stereology	to	assess	the	
number	of	NSC	with	a	combination	of	markers	including	BrdU	for	proliferation	
and	DCX	for	differentiation	and	migration.	
	
	
	5	
CHAPTER	TWO	
	REVIEW	OF	RELATED	LITERATURE	
Traumatic	Brain	Injury	
	 Traumatic	Brain	Injury	(TBI)	is	one	of	the	major	sources	of	disability	in	our	
modern	society	(Diaz-Arrastia	et	al	2014).	In	the	United	States,	about	1.7	million	
people	suffer	from	TBI	every	year	(Coronado	et	al	2012)	About	3%	of	these	people	
die	due	to	the	severity	of	the	injury	or	the	complication	that	follows	TBI	(Corrigan	
et	al	2010).	Of	the	97%	of	the	people	who	survive,	many	face	the	difficult	
prospect	of	living	with	long-term	disability.	Additionally,	the	military	faces	
challenges	dealing	with	TBI,	as	it	had	been	called	the	“signature	wound	of	the	war	
in	Iraq	and	Afghanistan”(Lawhorne	2010).		
	 TBI	is	divided	into	two	distinct	phases,	the	primary	and	secondary	injury	
processes.		Primary	injury	is	the	immediate,	direct	biomechanical	insult	causing	
rapid	brain	tissue	deformation	and	cortical,	sub-cortical	or	axonal	tissue	damage	
and	death.		The	results	of	primary	injury	are	either	focal	or	diffuse	lesions.	
Primary	injury	often	involves	vasculature	damage	leading	to	bleeding;	this	type	of	
bleeding	can	occur	anywhere	within	the	head	such	as	epidural,	subdural,	
intracerebral	hematoma,	contusion	and	laceration.	Epidural	hematoma	is	when	a	
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blood	vessel	is	torn	and	blood	pools	between	the	skull	and	the	meninges	(also	
known	as	extradural	hematoma).		When	the	blood	pools	between	the	dura	and	
the	arachnoid,	it	is	called	subdural	hematoma.	Subarachnoid	hematoma	is	when	
blood	collects	in	the	space	between	the	arachnoid	membrane	and	the	pial	mater	
covering	the	brain	(this	space	is	also	known	as	the	subarachnoid	space).	Usually,	
subarachnoid	hematoma	poses	poor	prognosis	for	TBI	patients	especially	if	co-
occurring	with	loss	of	consciousness	(Servadei	et	al	2002).	Intracerebral	
hematoma	is	when	blood	bleeds	into	the	brain	parenchymal	space.	Hematoma	is	
diagnosed	by	CT	and	MRI	scans	and	in	certain	cases,	needs	to	be	evacuated.		
	 Clinical	presentation	in	the	emergency	room	is	an	important	first	step	
toward	the	treatment	of	TBI.	The	presence	of	symptoms	such	as	loss	of	or	altered	
consciousness,	headaches,	nausea,	vomiting	or	dizziness	in	trauma	patients	
warrants	that	CT	scan	should	be	performed	immediately.	CT	is	the	procedure	of	
choice	to	initially	assess	patients	with	cranial	trauma	as	it	is	able	to	detect	skull	
fractures	and	hematomas.	Patients	who	present	without	obvious	signs	of	external	
trauma	still	need	to	be	closely	evaluated	especially	if	they	are	intoxicated.	Alcohol	
intoxication	can	lead	to	difficulty	in	diagnosing	subdural	hemorrhages.		
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Glasgow	Coma	Scale	(GSC)	
Eye	Opening	 Best	Motor	Response	 Best	Verbal	Response	
Spontaneous:E4	 Obeys	commands:M6	 Oriented:V5	
To	voice:E3	 Localizes:M5	 Confused	conversation:V4	
To	pain:E2	 Withdrawal:M4	 Inappropriate	words:V3	
None:E1	 Abnormal	flexion:M3	 Incomprehensible	sounds:V2	
	 Extensor	posture:M2	 None:	V3	
	 None:M1	 	
Score=(E+M+V)=3	to	15	
Table	1:	The	GCS	is	widely	used	by	clinicians	to	diagnose	the	extent	of	functional	
deficits	after	TBI.	Adapted	from	(Teasdale	&	Jennett	1976).		
	 Once	head	injury	is	ascertained	in	patients,	the	extent	of	injury	can	be	
further	categorized	into	mild,	moderate	and	severe	using	the	Glasgow	Coma	Scale	
(GSC),	(see	Table	1).	The	GSC	is	used	by	clinicians	to	communicate	the	assessment	
of	trauma	patients	and	the	GSC	score	is	an	important	prognosticator	of	clinical	
outcome.	Mild	TBI	is	classified	as	GCS	14-15,	moderate	TBI	is	9-13	and	severe	TBI	
as	3-8	(Narayan	1997).	The	GSC	relies	on	the	examination	of	eye,	verbal	and	
motor	function	to	evaluate	the	patients.	For	instance,	a	patient	with	mild	TBI	
would	be	conscious	and	responsive	to	verbal	communication;	however,	this	
patient	might	be	disoriented	and	have	difficulty	sensing	painful	stimuli.	Mild	TBI	
presents	a	problem	in	diagnosis,	as	the	patients	might	not	come	into	the	clinic	to	
report	it.	Additionally,	patients	with	mild	TBI	might	not	have	any	indication	of	
trauma	on	CT	scans	and	the	clinical	symptoms	might	show	up	over	the	course	of	
several	weeks	(Zollman	2011).	In	contrast,	a	moderate	TBI	patient	would	be	
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conscious	but	could	be	much	more	disoriented	and	would	have	impaired	ability	to	
communicate.	Finally,	severe	TBI	patients	would	be	unconscious	and	would	not	
be	able	to	communicate	or	open	their	eyes	(Zollman	2011).		
	 Depending	on	the	severity	of	TBI,	hypotension	and	hypoxia	might	be	an	
issue	for	the	patient;	therefore	endotracheal	intubation	might	need	to	be	
performed.	Overall,	not	much	can	be	done	regarding	primary	TBI	injury.	Head	
injuries	are	stabilized	in	the	emergency	room	and	the	hematomas	are	removed	or	
cerebral	spinal	fluid	evacuated	in	the	case	of	elevated	intracranial	pressure	(ICP).	
	 The	secondary	TBI	injury	process	is	the	main	target	for	therapeutic	
intervention.	Over	hours	to	months	and	years	after	the	initial	primary	trauma,	
additional	complications	such	as	intracranial	hemorrhage,	brain	tissue	swelling,	
elevated	ICP,	hypoxic	and	ischemic	conditions	can	occur	(Morales	et	al	2005).	
Various	molecular	changes	occur	that	characterize	the	secondary	injury	process:	
elevation	of	pro-inflammatory	cytokines,	increase	in	oxidative	stress	and	
excitotoxicity.	All	of	these	process	might	culminate	in	prolonged	neuronal	
inflammation	and	degeneration.		
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Elevated	Intracranial	Pressure	and	Cerebral	Perfusion	Pressure	
	 	In	a	normal	adult,	ICP	is	around	15mmHg.	A	sustained	increase	of	over	
20mmHg	is	not	well	tolerated	in	the	case	of	injury	and	is	associated	with	
increased	mortality	(Eisenberg	1988,	Narayan	1982).	Sustained	elevation	in	ICP	
after	brain	injury	can	lead	to	cerebral	ischemia	or	even	more	severely,	brain	
herniation.	Ventriculostomy	is	a	procedure	in	which	a	silicon	catheter	is	used	to	
measure	ICP	and	to	drain	the	CSF	if	needed.	Additionally,	mannitol	can	be	given	
intravenously	to	effectively	lower	ICP.		
	 Cerebral	perfusion	pressure	(CPP)	is	a	measure	of	how	well	blood	flows	in	
the	brain	after	an	injury.	CPP	is	defined	as	CPP=MAP-ICP;	where	CPP	is	MAP	
(mean	arterial	pressure)	minus	ICP	(intracranial	pressure).	CPP	below	50mmHg	for	
an	extended	amount	of	time	is	dangerous	for	the	brain	because	the	perfusion	
cannot	match	the	brain	metabolic	needs	and	can	lead	to	cerebral	ischemia	(Katz	
et	al	2006).		
	 Secondary	injury	processes	start	as	a	consequence	of	the	trauma	forces	
involved	in	the	primary	injury	process.	Calcium	homeostasis	is	first	disrupted	
(Bains	&	Hall	2012).	During	normal	conditions,	calcium	is	tightly	regulated	such	
that	its	concentration	in	the	cells	of	the	CNS	is	very	low	and	the	extracellular	
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concentration	is	much	higher.	Primary	injury	leads	to	cells	unable	to	maintain	this	
gradient	and	more	calcium	enters	the	cell	cytosol.	This	leads	to	depolarization	and	
release	of	glutamate	which	is	an	excitatory	neurotransmitter.	An	excess	of	
extracellular	glutamate	leads	to	a	process	called	excitotoxicity.	Excitotoxicity	
happens	when	excess	extracellular	glutamate	binds	to	NMDA	and	AMPA	
receptors.	These	receptors	are	ligand-gated	ion	channels	which	allow	even	more	
extracellular	calcium	to	enter	the	cell	leading	to	more	glutamate	release.	This	
becomes	a	self-perpetuating	mechanism	leading	to	cell	death	through	the	
mechanism	of	apoptosis.	The	disruption	of	chemical	gradients	of	different	ions	in	
the	brain	combined	with	decreased	oxygen	due	to	hemorrhage	leads	to	reduced	
ATP	production	which	can	lead	to	issues	like	disrupted	protein	synthesis	and	
disruption	of	antioxidant	systems	such	as	the	glutathione	peroxidase	system.	
Collectively,	the	brain	experiences	oxidative	stress	because	free	radicals	such	as	
superoxide	and	peroxinitrite	are	elevated.	These	free	radicals	are	extremely	
harmful	to	the	cell	because	carbon	in	lipids,	nucleic	acids	and	proteins	can	react	
with	these	reactive	oxygen	species	(ROS)	(Hall	et	al	2010).	Oxidative	stress,	
besides	affecting	neurons	and	glia,	can	be	detrimental	to	the	blood	brain	barrier	
(BBB).	The	BBB	serves	as	the	vascular	filtering	of	the	brain;	it	allows	necessary	
nutrients	to	enter	the	CNS	and	waste	products	to	exit	while	blocking	undesirable	
11	
	
compounds	access	to	the	brain	(Smith	et	al	1994).	The	cellular	composition	of	the	
BBB	is	made	up	of	endothelial	cells	that	form	tight	junctions	with	each	other.	
Surrounding	these	endothelial	cells	are	pericytes,	smooth	muscle	cells	and	
astrocytes	which	form	a	structure	called	end	feet	(Chodobski	et	al	2011).	
Following	TBI,	the	BBB	breaks	down	and	becomes	more	leaky.	This	might	be	due	
to	an	increase	in	lipid	peroxidation,	which	is	a	consequence	of	elevated	ROS.	
Blocking	lipid	peroxidation	was	showed	to	reduce	BBB	permeability	after	TBI	
(Smith	et	al	1994).		
	 Reduced	ATP	synthesis	after	TBI	also	impairs	the	active	transport	of	
pyruvate	into	the	mitochondria	leading	to	a	decrease	in	the	Krebs	cycle.	As	a	
result,	cells	enter	a	Pasteur	shift,	a	process	in	which	normal	aerobic	respiration	is	
shifted	to	anaerobic	respiration.	Glucose	is	broken	down	incompletely	leading	to	
excess	lactic	acid	accumulation	which	results	in	a	condition	called	lactic	acidosis	
(Hall	2012).			
	 Brain	edema	is	a	characteristic	physiological	response	of	the	brain	to	injury	
and	is	thought	to	have	two	distinctive	components,	vasogenic	and	cytotoxic.	
Vasogenic	edema	is	a	result	of	increased	blood	brain	barrier	(BBB)	leakage	after	
TBI.	Tight	junctions	that	make	up	the	BBB	are	broken	down	after	brain	injury	and	
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allow	extravasations	of	fluid	and	proteins	into	the	interstitial	space	of	the	brain	
parenchyma.	Cytotoxic	edema,	also	known	as	cellular	edema,	happens	at	the	
individual	cell	level,	which	is	due	to	altered	cellular	ion	homeostasis	and	cell	
membrane	dysfunction.	The	time	course	of	vasogenic	and	cytotoxic	edema	is	
different,	with	vasogenic	edema	happening	early	on	right	after	primary	TBI	injury	
while	cytotoxic	edema	happens	in	a	much	more	delayed	manner.	Brain	edema	
generally	is	maximal	around	24	to	48	hours	(Marmarou	1994).		
	 Brain	inflammation	is	an	important	component	of	TBI	secondary	injury	and	
has	both	acute	and	chronic	aspects.	Inflammation	is	thought	to	be	both	beneficial	
and	detrimental	and	is	composed	of	both	released	factors	(IL-1b,	eicosanoids)	and	
cellular	factors	(neutrophils	and	macrophages)	(Popovich	et	al	1999,	Schoettle	
1990,	Shapira	1992,	Toulmond	&	Rothwell	1995).	IL-1b	is	an	important	
inflammatory	mediator	and	is	found	to	be	elevated	in	CSF	(Marion	et	al	1997)	and	
contused	brain	tissue	of	TBI	patients	(Clark	et	al	1999).	Additionally,	other	
cytokines	have	subsequently	been	found	to	be	playing	roles	in	post-TBI	
inflammation	including	IL-6	(Kossmanna	1996),	and	IL-8	(Kossmann	1997).	
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Different	Types	of	TBI	
	 	There	are	two	main	types	of	TBI,	closed,	and	penetrating	brain	injury.	In	
closed	TBI,	the	injury	can	occur	due	to	two	primary	general	means,	static	and	
dynamic	loading	(Graham	2002).	Static	loading	is	when	a	slow	moving	force	is	
applied	to	the	head;	an	example	of	this	would	be	the	head	being	crushed	by	a	
heavy	object	such	as	a	car.		In	dynamic	loading	causing	TBI,	which	occurs	more	
frequently,	the	head	is	subjected	to	sudden	acceleration	and	deceleration	forces	
(Stålhammar	1986).		Dynamic	loading	can	further	be	divided	into	two	types,	
impulsive	or	impact	loading.	In	the	impulsive	dynamic	loading	scenario,	the	head	
is	set	into	motion	suddenly	or	brought	to	a	stop	suddenly.	This	is	most	commonly	
seen	in	whiplash	type	of	injury.		An	example	of	an	impact	dynamic	loading	
situation	would	be	a	blunt	object	such	as	a	baseball	bat	striking	the	head.	Both	
impulsive	and	impact	loading	types	of	TBI	produce	tissue	deformation	due	to	the	
mechanical	forces	involved.		
	 The	other	major	type	of	TBI	is	penetrating	brain	injury.	This	type	of	injury	is	
associated	with	armed	combat,	such	as	gunshot	and	missile	wounds.	The	severity	
of	penetrating	TBI	is	determined	by	the	size	of	the	projectile,	shape,	mass,	
velocity	and	location	of	impact	(Morales	et	al	2005).		
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Blast	Injury	
	 	TBI	resulting	from	blasts	from	explosive	devices	(i.e	Improvised	explosive	
devices	or	IED’s)	is	increasingly	recognized	as	being	mechanistically	and	
physiologically	distinct	compared	to	traditional	penetrating	and	closed	head	TBI	
(Ling	et	al	2009).	It	is	thought	that	up	to	60%	of	deployed	military	personnel	are	
potentially	exposed	to	blast	TBI.	Furthermore,	there	are	some	important	links	
between	blast	TBI	and	post	traumatic	stress	disorder	(PTSD).	Primary	blast	results	
in	forces	emanating	from	the	explosion	in	the	form	of	pressure	wave	transients	
causing	injuries	to	the	brain	much	like	closed	TBI	would.	Interestingly,	common	
diagnoses	among	blast	TBI	patients	are	diffuse	brain	edema,	hyperemia,	and	
vasospasm.			
Concussive	Sport	Head	Injury	
	 It	had	been	recognized	that	repetitive	exposure	to	mild	TBI	that	is	
experienced	by	certain	athletes	such	as	boxers	and	football	players	could	result	in	
a	condition	called	chronic	traumatic	encephalopathy	(CTE).	Signs	and	symptoms	
of	this	condition	are	somewhat	similar	to	Parkinson’s	disease	in	which	the	
patients	have	gait	disorder,	slurred	speech,	neuropsychiatric	and	behavioral	
symptoms	(Gardner	et	al	2013).		
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Animal	TBI	Models	
	 Modeling	of	human	TBI	in	laboratory	animals	requires	that	the	clinical	
symptoms	seen	in	human	patients	be	replicated	in	the	model.	For	instance,	
primary	injury	to	the	cortex	must	be	the	same	as	seen	in	humans	and	secondary	
injury	processes	should	closely	mimic	that	of	the	human	condition.	Additionally,	a	
good	model	needs	to	have	parameters	of	the	injury	adjusted	so	that	it	can	
produce	graded	severity	of	TBI	injury	(mild,	moderate	and	severe).	Furthermore,	a	
good	model	needs	to	be	reproducible	between	different	laboratories.		To	this	
end,	models	that	had	been	shown	to	produce	focal	brain	injury	are	midline	fluid	
percussion	(MFP),	controlled	cortical	impact	(CCI)	and	weight	drop	(Figure	1).	
However,	in	addition	to	the	focal	nature	of	the	injuries	that	these	models	
produce,	there	is	an	additional	axonal	injury	when	the	injury	severity	reaches	a	
threshold.		
	 The	weight	drop	model	relies	on	gravitational	force	of	a	free	falling	object	
to	produce	a	focal	TBI	(Feeney	et	al	1981).	In	this	model,	rat	or	mice	are	
anesthetized	and	restrained	to	stabilize	the	head	during	impact	as	to	ensure	
reproducibility	(Figure	1A).	The	skull	of	the	animal	is	exposed	and	craniotomy	to	
expose	the	brain	can	be	performed;	however,	another	variation	on	this	model	is	
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without	craniotomy.	The	severity	of	TBI	can	be	adjusted	by	changing	the	mass	of	
the	weight	or	its	height	in	which	it	is	dropped	from.	A	strong	advantage	of	the	
weight	drop	model	is	its	convenience;	it	is	very	easy	and	quick	to	set	up	for	the	
investigator.	The	weight	drop	model	is	able	to	reproduce	clinical	symptoms	of	
concussive	TBI	such	as	cortical	cell	loss,	axonal	injury	and	in	more	severe	TBI	
parameters,	contusions	and	hemorrhages.	Additionally,	behavioral	dysfunctions	
are	reproduced	in	animals	with	the	weight	drop	models	such	as	impairments	in	
motor	function	as	well	as	cognitive	deficits	and	these	behavioral	deficits	do	
correlate	to	injury	severity	(Chen	et	al	1996,	Tang	et	al	1997).	However,	there	are	
also	some	strong	drawbacks	of	the	weight	drop	model:	the	lesion	produced	can	
be	inaccurate	(especially	when	no	craniotomy	is	performed)	and	there	are	
chances	the	animals	might	get	a	secondary	“rebound”	injury.	Furthermore,	this	
model	had	not	been	evaluated	in	rodents	for	long-term	effects	or	recovery	
making	it	less	applicable	to	human	TBI.	
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Three	Widely	Used	Animal	Models	of	TBI	
	
Figure	1:	Three	well	characterized	models	of	TBI.	A.	The	weight	drop	model;	
adapted	from	(Michael	2016).	B.	The	controlled	cortical	impact	model;	adapted	
from	(Michael	2016).	C.	The	lateral	fluid	percussion	model;	adapted	from	(Kabadi	
et	al	2010).		
A	 B	
C	
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	 The	midline	fluid	percussion	(MFP)	TBI	model	was	first	demonstrated	in	cat	
and	rabbit	(Härtl	et	al	1997,	Hayes	et	al	1987);	however,	it	was	later	adapted	for	
use	in	rat	(Dixon	et	al	1987,	McIntosh	et	al	1987).	In	the	MFP	model,	the	skull	is	
exposed	and	a	craniotomy	performed	(at	the	midline)	to	expose	the	brain.	A	
pendulum	is	the	source	of	kinetic	energy	that	causes	a	fluid	bolus	to	strike	the	
dural	surface	of	the	brain	(Figure	1C).	The	fluid	force	extends	into	the	epidural	
space	causing	diffuse	loading	of	the	brain	(Sullivan	et	al	1976).		The	severity	of	
MFP	TBI	can	be	varied	by	the	height	at	which	the	pendulum	is	released.	The	MFP	
model	leads	to	focal	injury	in	the	gray	matter	of	areas	directly	in	and	around	the	
site	of	contact	and	can	lead	to	intraparenchymal	and	subarachnoid	hemorrhage	
(Graham	et	al	2000).	Additionally,	depressed	cerebral	blood	flow	is	observed	for	
around	24	hours	post	TBI	(Ozawa	et	al	1991).	Animal	models	of	MFP	TBI	have	
deficits	in	cognition	and	motor	functions	(Dixon	et	al	1987).	A	major	disadvantage	
of	MFP	is	the	high	mortality	rate	because	the	percussive	force	acting	on	the	brain	
often	leads	to	herniation	and	brainstem	damage.		
	 The	controlled	cortical	impact	(CCI)	TBI	model	relies	on	a	rigid	impactor	that	
is	either	pneumatic	or	electromagnetically	powered	(Figure	1B).	The	CCI	was	first	
demonstrated	in	ferret	(Lighthall	1988)	and	subsequently	adapted	for	use	in	rat	
(Dixon	et	al	1991)	and	mouse	(Smith	et	al	1995).	The	cortical	locations	of	the	CCI	
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model	can	be	varied;	for	instance,	midline	CCI	has	been	performed	(Lighthall	
1988)	and	lateral	cortices	(Chen	et	al	2003).	Importantly,	CCI	TBI	produces	less	
mortality	due	to	minimal	brain	stem	damage.	The	severity	of	TBI	can	be	greatly	
varied	by	changing	the	parameter	of	the	impactor	such	as	time,	velocity	and	
depth.	There	is	also	no	chance	of	secondary	damage	due	to	“rebound”	injury.	The	
CCI	TBI	model	can	recreate	a	variety	of	clinical	signs	observed	in	human	TBI	
patients	such	as	contusion,	intraparenchymal,	epidural	and	subdural	hematomas	
(Dixon	et	al	1991,	Lighthall	1988),	gray	and	white	matter	damage,	ventricular	
enlargement	(Dixon	et	al	1999),	and	hippocampal	and	thalamic	degeneration	(Hall	
et	al	2005).	These	widespread	effects	due	to	CCI	TBI	correlate	to	behavioral	
deficits,	as	impairments	in	sensorimotor	(Fox	et	al	1998)	and	cognitive	functions	
(Scheff	et	al	1997)	are	observed	for	extended	periods	of	time	after	TBI	for	up	to	
one	year.	An	additional	and	important	benefit	of	the	CCI	TBI	model	is	its	
reproducibility	among	different	laboratories.	Due	to	these	reasons,	the	CCI	model	
was	used	in	the	experiments	in	this	dissertation.	
	 More	recently,	the	military	conflicts	in	the	Middle	East	have	demonstrated	
the	need	for	developing	an	animal	model	for	blast	injury	to	study	the	effect	
produced	by	improvised	explosive	devices	(IED).	The	injury	characteristic	of	blasts	
is	rapid	pressure	waves	moving	through	the	brain	tissue	(Risling	&	Davidsson	
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2012).	This	could	also	be	accompanied	by	further	non-blast	injuries	from	blunt	
trauma	either	from	shrapnel	or	environmental	objects	(Sundaramurthy	et	al	
2012).	Rodents	have	been	used	to	model	this	blast	injury,	which	utilize	a	unique	
shock	wave	generator.	In	this	model,	anesthetized	mice	are	placed	in	a	metallic	
tube	and	subjected	to	pressure	waves,	which	closely	resemble	the	force	produced	
by	an	IED.	Diffuse	cortical	damage,	edema	and	intracranial	hematoma	are	
commonly	seen	in	this	model	(Svetlov	et	al	2010).	
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Current	and	Potential	Treatments	for	TBI	
	 The	Neurotrauma	Pharmacology	Workgroup	in	2012	(Diaz-Arrastia	et	al	
2014),	reviewed	the	current	possible	treatments	for	TBI	to	identify	strengths	and	
limitations	in	these	drugs.	Their	findings	are	summarized	below:	
	 Acetylcholinesterase	inhibitors	(AchEI)	increase	the	concentration	of	
acetylcholine	at	the	synapse	by	inhibiting	its	breakdown.	Studies	using	various	
AchEI	such	as	physostigmine	(Cardenas	et	al	1994,	McLean	et	al	1987),	donepezil	
(Ballesteros	et	al	2008),	and	rivastigmine	(Blount	et	al	2002),	have	shown	some	
potential	benefits	for	chronic	TBI	patients	with	cognitive	deficits.	Additionally,	
pre-clinical	trials	have	shown	beneficial	effects	of	AchEI	including	decreased	
neuronal	cell	death,	decreasing	hippocampal	neural	degeneration,	reduced	BBB	
breakdown,	decreased	vasogenic	brain	edema	and	preservation	of	neurological	
functions	(Ballesteros	et	al	2008,	Chen	et	al	1998).	However,	the	majority	of	
clinical	studies	on	the	efficacy	of	AchEI	for	TBI	were	not	randomized	controlled	
trials,	and	has	issues	with	methodology	and	small	sample	sizes;	these	important	
limitations	prevented	a	good	assessment	of	these	AchEI	drugs.	Additionally,	there	
is	no	evidence	in	pre-clinical	studies	in	animals	showing	the	efficacy	of	AchEIs	
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given	after	an	extended	period	of	time	after	TBI	(i.e.	delayed	administration	
paradigm).		
	 Amantadine	is	a	FDA	approved	antiviral	used	for	the	treatment	of	influenza	
A.	Additionally,	it	had	some	efficacy	in	the	treatment	of	Parkinson’s	disease	but	
the	exact	mechanism	is	not	fully	elucidated.	Studies	have	suggested	that	
amantadine	increases	dopamine	(DA)	concentration	either	by	decreasing	DA	
reuptake	or	increasing	DA	synthesis	(Bales	et	al	2009).	Additionally,	there	is	some	
evidence	suggesting	amantadine	increases	post-synaptic	DA	receptor	expression	
(Gianutsos	et	al	1985).	An	interesting	piece	of	evidence	that	might	explain	
amantadine’s	beneficial	effect	for	TBI	patients	is	its	role	as	a	noncompetitive	
antagonist	of	NMDA	receptors	(Stoof	et	al	1992),	which	is	the	main	mediator	of	
excitotoxicity.	One	study	using	CCI	as	a	TBI	model	and	amantadine	treatment	
commenced	one	day	after	TBI	showed	a	modest	beneficial	effect	in	the	Morris	
water	maze	(MWM)	(Dixon	et	al	1999).	However,	the	pre-clinical	animal	studies	
for	amantadine	as	a	treatment	for	TBI	is	still	lacking;	more	research	needs	to	be	
done	on	the	time-course	and	duration	of	amantadine	treatment.	In	addition,	the	
different	types	and	severity	of	TBI	paradigms	need	to	be	tested	in	amantadine	
research.	
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	 Cyclosporine	A	(CsA)	maintains	mitochondrial	membrane	potential	and	
prevents	mitochondrial	induced	damage	after	TBI.	In	various	animal	models	of	
TBI,	cyclosporine	had	shown	positive	effects	in	axonal	injury	and	learning	and	
memory	(Alessandri	et	al	2002,	Heuvel	et	al	2004).	CsA	also	has	immuno-
modulating	effects,	which	is	another	aspect	in	which	it	could	be	potentially	
beneficial	for	TBI	patients.	There	are	several	clinical	studies	that	showed	CsA	
improves	histological	outcomes	such	as	decreased	axonal	damage	and	decreased	
contusion	size.	However,	there	are	fewer	studies	that	showed	improved	
functional	outcomes.	One	study	using	CCI	as	a	TBI	model	did	not	show	CsA	
significantly	improved	cognitive	outcome	in	rat	(Baki	et	al	2010).	However,	more	
research	is	needed	in	regard	to	the	CsA	administration	route	because	CsA	is	
thought	to	have	poor	BBB	permeability.	Additionally,	more	information	about	the	
ideal	time-course	of	CsA	treatment,	and	different	outcome	measures	are	needed	
to	completely	evaluate	CsA	efficacy	as	a	treatment	for	TBI.	
	 Erythropoietin	(EPO)	is	a	cytokine	that	plays	an	important	role	in	
erythropoiesis	and	has	been	found	to	have	positive	effects	after	TBI	such	as	
decreasing	excitotoxicity	and	nitric	oxide	toxicity,	decreasing	cell	death,	increasing	
neurogenesis	and	angiogenesis	(Ozisik	et	al	2007,	Xiong	et	al	2011,	Zhang	et	al	
2010).	Additionally,	EPO	has	antioxidant	and	anti-inflammatory	effects	(Ozisik	et	
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al	2007).	Erythropoietin	acts	through	the	EPO	receptors,	which	are	present	in	
many	cell	type	of	the	CNS.	However,	EPO	might	act	through	other	mechanisms	as	
EPO	receptors	are	not	needed	to	mediate	some	of	the	effects	of	erythropoietin.	
EPO	has	been	extensively	studied	in	the	rodent	system	and	using	different	models	
of	TBI,	and	its	dosing	and	route	of	administration	have	been	well	characterized.	
There	are	different	on-going	clinical	trials	using	EPO	as	treatment	for	severe	TBI.	
One	study	recruiting	patients	with	subarachnoid	hemorrhage	showed	significant	
positive	effects	with	regards	to	vasospasm,	ischemic	deficit	and	improved	
discharge	outcome	when	EPO	was	administered	acutely	(Tseng	et	al	2009).	
Another	non-randomized	retrospective	study	again	with	severe	TBI	patients	
showed	that	EPO	administered	sub-acutely	(within	14	days	of	TBI)	resulted	in	
lower	hospital	mortality	(Heeschen	et	al	2003).	However,	more	pre-clinical	studies	
are	needed	to	explore	EPO	administration	for	moderate	or	mild	cases	of	TBI	or	
more	delayed	administration.	
	 Glyburide	is	a	sulfonylurea	that	binds	to	Sur1	and	thus	blocks	the	KATP	
channels.	It	is	approved	for	use	as	an	insulin	secretagogue	and	is	used	to	treat	
patients	with	adult	onset	diabetes.	Sur1	is	an	adenosine	triphosphate	binding	
cassette	transporter;	Sur1	associates	with	other	pore	forming	subunits	to	form	
ion	channels	(Diaz-Arrastia	et	al	2014).	After	TBI,	non-selective	cation	channels	
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(NCCa-ATP)	in	which	Sur1	is	a	component	of,	are	increased	in	expression	levels	in	
neurons	and	endothelial	cells	of	the	CNS.	Pre-clinical	studies	have	found	
beneficial	effects	of	glyburide	in	animal	TBI	models,	including	reduced	
inflammation,	hemorrhage	and	vasogenic	edema.	One	study	showed	glyburide	
treatment	led	to	reduction	in	secondary	hemorrhage	(Simard	et	al	2009);	and	
another	study	showed	improved	performance	in	the	Morris	water	maze	(Patel	et	
al	2010).	These	studies	administered	glyburide	shortly	after	TBI	(within	10	hours)	
so	more	studies	that	use	a	delayed	treatment	paradigm	are	needed	to	fully	
evaluate	glyburide.	Additionally,	glyburide	has	been	used	in	several	retrospective	
clinical	studies	for	the	treatment	of	ischemic	stroke,	where	glyburide	treated	
patients	suffered	less	hospital	mortality	and	decreased	edema.	A	phase	II	trial	of	
glyburide	for	moderate	to	severe	TBI	has	started.	In	this	study,	glyburide	
treatment	commences	at	8	hours	after	TBI	and	continues	for	72	hours.		
	 Growth	hormone	(GH)	is	secreted	by	the	anterior	pituitary	gland	and	has	
important	anabolic	effects	by	acting	through	the	GH	receptors.	About	20%	of	TBI	
patients	have	GH	deficiencies,	which	might	be	due	to	direct	or	indirect	injury	to	
the	pituitary	or	hypothalamus	(Benvenga	et	al	2000,	Wilkinson	et	al	2012).	Using	a	
rat	model	of	TBI,	one	study	showed	that	increasing	GH	leads	to	increased	motor	
and	cognitive	recovery	(Saatman	et	al	1997).	Clinical	studies	looking	at	TBI	
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patients	with	GH	insufficiency/deficiency	have	found	that	administration	of	
recombinant	human	GH	at	the	chronic	stage	by	daily	subcutaneous	injections	for	
up	to	12	months	showed	improved	cognitive	outcomes	(Devesa	et	al	2013,	
Reimunde	et	al	2011).	However,	other	clinical	studies	suggest	that	GH	given	in	the	
acute	stage	is	detrimental	(Demling	1999,	Takala	et	al	1999).	Overall,	GH	
administration	still	holds	strong	promise	as	an	effective	chronic	TBI	treatment.	
However,	more	preclinical	studies	are	needed	to	study	the	exact	molecular	
mechanism	in	which	GH	acts.		
	 Lithium	is	an	effective	pharmacological	treatment	for	bipolar	disorder.	It	
had	been	found	to	be	neuro-protective	by	reducing	excitotoxicity,	decreasing	
ischemia	related	injury	and	decreasing	cell	death	by	apoptosis,	attenuates	pro-
inflammatory	cascades	and	preserves	the	function	of	the	BBB	(Dash	et	al	2011,	
Shapira	et	al	2007,	Yu	et	al	2012a).	For	instance,	in	an	animal	model	of	TBI,	lithium	
was	given	shortly	after	injury	and	continued	for	3	weeks	showed	reduced	TBI	
lesion	size	and	improved	behavioral	recovery	(Yu	et	al	2012b).	Despite	favorable	
preclinical	studies,	no	well-controlled	clinical	trials	have	test	lithium	for	the	
treatment	of	TBI.	There	are	some	small	case	studies	in	which	lithium	was	given	to	
bipolar	patients	after	TBI	of	varying	severity;	however,	the	primary	outcome	
measurements	were	aggression	and	agitation.	Overall,	lithium	is	a	well-tolerated	
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drug	that	needs	further	clinical	testing	as	a	treatment	for	TBI.	Therapeutic	
windows	and	effective	outcome	measurements	need	to	be	used	to	effectively	
evaluate	the	usefulness	of	lithium.		
	 Methylphenidate	is	used	to	effectively	increase	synaptic	concentration	of	
DA	and	norepinephrine;	it	block	DA	transporters	and	inhibits	DA	and	
norepinephrine	reuptake	(Moeller	et	al	2012).	Atomoxetine	also	increases	
synaptic	concentration	of	DA	and	norepinephrine	through	similar	mechanisms	as	
methylphenidate	(Swanson	et	al	2006).		Both	of	these	drugs	are	FDA	approved	for	
the	treatment	of	attention	deficit	hyperactivity	disorder.	In	animal	TBI	models,	
methylphenidate	treatment	leads	to	increased	striatal	dopaminergic	
neurotransmission	and	subsequently	increased	spatial	learning	and	motor	
recovery	(Wagner	et	al	2009).	Similarly,	atomoxetine	leads	to	better	Morris	water	
maze	performance	after	TBI	(Reid	&	Hamm	2008).	In	the	clinic,	methylphenidate	
is	well	tolerated	in	patients	with	TBI	(Alban	et	al	2004).		The	treatment	windows	
for	several	studies	started	at	several	weeks	to	years	after	injury	(sub-acute	to	
chronic	phase	of	TBI),	and	the	doses	ranged	from	a	single	one-time	dose	to	up	to	
30	days.	Overall,	these	studies	were	not	conclusive	about	the	effects	of	
methyphenidate	due	to	small	sample	size,	limited	outcome	measures	and	not	
well-controlled	injury	and	administration	parameters.	Furthermore,	there	is	
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currently	no	completed	clinical	study	looking	at	the	effect	of	atomoxetine	on	post	
TBI	recovery.	Overall,	methylphenidate	and	atomoxetine	have	promising	effects	
on	TBI	recovery	in	experimental	animal	TBI	models,	yet	further	clinical	work	that	
utilizes	large	sample	sizes	are	needed	to	evaluate	its	true	therapeutic	potential	in	
human	TBI	patients.	
	 Minocycline	is	a	member	of	the	tetracycline	family	of	drugs.	Minocycline	
exhibits	antimicrobial	properties	and	due	to	its	lipophilic	property,	it	readily	
crosses	the	BBB	(Kim	&	Suh	2009).	Minocycline	also	has	anti-inflammatory,	anti-
apoptotic	and	antioxidant	activity	at	larger	doses	(at	six	time	the	normal	dose	
used	to	elicit	antimicrobial	action)	making	it	an	attractive	candidate	for	use	in	TBI	
patients	who	experience	polytrauma.	Minocycline	was	used	in	several	animal	
models	of	TBI,	stroke	and	different	neurodegenerative	diseases	with	beneficial	
effects	shown.	It	is	thought	that	minocycline’s	positive	effects	after	TBI	are	due	to	
its	ability	to	block	caspase	dependent	and	independent	apoptosis	events,	
inhibition	of	microglia	activation	and	direct	action	as	an	antioxidant	by	scavenging	
reactive	oxygen	species	and	decreasing	the	activity	of	metalloproteinases	(Kim	&	
Suh	2009).	In	several	animal	TBI	models	of	CCI	and	weight	drop,	minocycline	was	
given	acutely	at	45	minutes	and	up	to	4	hours	post	injury.	Lesion	volume	was	
smaller	in	minocycline	treated	animals	(Bye	et	al	2007).	In	the	clinics,	high	dose	
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minocycline	is	well	tolerated	in	patients	with	spinal	cord	injuries,	and	markers	for	
inflammation	were	decreased	in	these	patients.	However,	no	completed	clinical	
studies	have	looked	at	Minocycline	as	a	treatment	for	acute	or	chronic	TBI.		
	 NAC	(N-acetyl	cysteine)	is	a	potent	antioxidant	that	had	been	approved	for	
the	treatment	of	acetaminophen	overdose.	NAC	is	processed	in	the	liver	to	
become	cysteine,	which	readily	crosses	the	blood	brain	barrier.	In	the	CNS,	
cysteine	increases	the	level	of	glutathione,	which	is	a	potent	endogenous	
antioxidant.	Cysteine	can	also	increase	the	concentration	of	extracellular	
glutamate	(Olive	et	al	2012).	In	pre-clinical	animal	TBI	studies,	NAC	was	shown	to	
decrease	markers	of	oxidative	damages	(Hicdonmez	et	al	2006),	and	decrease	
inflammatory	mediators	IL-1b	and	TNF-a	via	an	NF-kB	dependent	mechanism	
(Chen	et	al	2008a).	Functionally,	NAC	was	shown	to	decrease	TBI	lesion	volume	(Yi	
&	Hazell	2005)	but	other	measures	of	functional	recovery	were	less	conclusive	
(Thomale	et	al	2006).	Interestingly,	NAC	appears	to	have	synergistic	effects	when	
combined	with	minocycline	treatment	when	used	in	experimental	TBI	(Baki	et	al	
2010).	A	recent	randomized	clinical	trial	using	NAC	(dosed	for	7	days)	to	treat	
soldiers	exposed	to	blast	TBI	injury	showed	significant	improvement	in	recovery.	
Therefore,	NAC	should	be	further	explored	in	more	clinical	studies	as	treatment	
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for	other	types	of	TBI	and	in	a	wider	population.	Additionally,	detailed	therapeutic	
windows	of	NAC	need	to	be	established.		
	 Progesterone	is	an	endogenous	steroid	produced	in	the	CNS,	reproductive	
organs	and	the	adrenal	glands.	Furthermore,	it	is	found	in	high	concentration	in	
the	brain	of	both	males	and	females.	Progesterone	has	several	potential	
mechanisms	in	which	its	effect	might	be	beneficial	to	TBI	patients.	It	has	been	
shown	to	enhance	myelination	(Koenig	et	al	1995),	increase	neurogenesis	(Liu	et	
al	2009)	and	modulate	aquaporin	expression,	which	potentially	decreases	the	
aquaporin	induced	edema	post	TBI.	Additionally,	progesterone	serves	as	a	
precursor	to	other	neurosteroids	with	neuroprotective	effects.	For	instance,	
allopregnanolone	is	elevated	after	oral	progesterone	administration,	which	
exhibits	potent	neuro-protective	effects	(Sayeed	et	al	2006).		In	animal	models	of	
TBI	including	CCI,	progesterone	treatment	showed	decreased	edema(Cutler	et	al	
2007)	reduced	cell	death	by	apoptosis	(Cekic	et	al	2012)	and	attenuation	of	pro-
inflammatory	mediators	such	as	IL-6,	IL-1b,	and	TNFa	(Pan	et	al	2007).	It	also	was	
shown	to	exhibit	antioxidant	properties	with	progesterone	treatment	decreasing	
lipid	peroxidation	(Roof	et	al	1997).	Interestingly,	progesterone	affects	the	Toll-
like	receptor	signaling	pathway	(Chen	et	al	2008b),	which	is	the	primary	
mechanism	of	alcohol	induced	CNS	inflammation.	These	animal	studies	also	
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demonstrated	enhanced	behavioral	recovery	post	TBI	as	a	result	of	progesterone	
treatment	(Djebaili	et	al	2005,	Wali	et	al	2011).	In	clinical	studies	using	
progesterone	or	its	allopregnanolone	metabolite,	it	is	very	well	tolerated	and	
significantly	reduced	mortality	when	it	was	given	in	the	acute	phase	of	TBI	
(Wright	et	al	2007).	Overall,	progesterone	holds	exciting	potential	as	one	of	the	
most	effective	treatment	for	TBI.	However,	more	basic	research	into	the	
mechanism	of	its	therapeutic	effects	is	needed.	Furthermore,	additional	
therapeutic	windows	of	progesterone	should	be	tested.		
	 Simvastatin	is	a	3-hydroxy-3-methylglutaryl	coenzyme	A	(HMGA)	reductase	
inhibitor	used	widely	for	the	reduction	of	serum	cholesterol.	However,	there	is	
experimental	evidence	for	simvastatin	and	other	statins	being	beneficial	to	treat	
both	acute	and	chronic	TBI.	Beneficial	effects	include	reduced	brain	edema,	
improved	BBB	function,	increased	cerebral	blood	flow,	attenuated	CNS	
inflammation,	axonal	injury	and	cell	death	(Diaz-Arrastia	et	al	2014).	Simvastatin	
and	other	statins	have	been	extensively	investigated	in	pre-clinical	animal	models	
of	TBI	primarily	using	CCI.	Most	studies	have	used	oral	as	the	method	of	
administration	and	treatment	started	as	late	as	24	hours	post	injury	and	for	7	to	
14	days	(Abrahamson	et	al	2009,	Li	et	al	2009).	There	is	currently	an	on-going	
clinical	phase	II	study	using	atorvastatin	to	treat	adults	with	mild	TBI	
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(NCT01013870).	Given	the	large	body	of	evidence	for	the	beneficial	effect	of	
statins	in	animal	studies,	more	clinical	studies	are	needed	to	address	other	
aspects	of	statins	in	TBI	treatment	such	as	using	more	delayed	administration	and	
treating	different	severity	of	TBI.		
	Rehabilitation	
	 Given	the	limitation	in	current	pharmacological	approaches	to	the	
treatment	of	TBI,	especially	chronic	TBI	dysfunction	such	as	sensorimotor	deficits,	
cognitive	and	behavioral	impairments,	rehabilitation	remains	the	most	effective	
method	to	treat	chronic	TBI.	Rehabilitation	is	a	holistic	approach	that	involves	the	
patients,	their	family	and	the	health	care	team.	According	to	(Barnes	1999),	
rehabilitation	consists	of	three	approaches:	to	reduce	disability,	acquire	new	skills	
and	strategies	to	reduce	the	impact	of	disability,	and	to	alter	the	environment	as	
to	reduce	the	impact	of	the	disability	as	much	as	possible.	For	instance,	the	
approach	to	reduce	disability	after	TBI	could	be	medications	to	control	spasticity	
or	bladder	control	problems.	An	example	of	acquiring	new	skills	to	cope	with	the	
TBI-acquired	disability	could	be	physical	therapies	designed	to	improve	gait	or	to	
increase	stamina	so	the	patient	could	use	the	wheelchair	for	an	extended	period	
of	time.	The	last	approach,	to	modify	the	environment	to	reduce	the	impact	of	a	
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patient’s	disability	could	be	modification	to	the	patient	home	to	include	a	
powered	lift	or	grab	rails	in	the	toilet.		Goal	setting	is	an	important	part	of	
rehabilitation.	For	instance,	setting	goals	that	are	realistic	and	can	be	broken	
down	into	smaller	component	goals	that	can	be	measured.	Valid	and	reliable	
outcome	measures	also	need	to	be	used	in	evaluating	the	progress	of	the	
rehabilitation	process.	
Alcohol	and	The	Brain	
	 Alcohol	Use	Disorder	(AUD)	is	a	major	problem	in	our	society	with	about	
7.2%	of	adults	in	the	United	States	diagnosed	with	this	disorder.	This	population	is	
approximately	17	million	people.	AUD	is	twice	as	prevalent	in	men	as	compared	
to	women	(NIAAA	2012).	Additionally,	approximately	855,000	adolescents	from	
12-17	years	of	age	are	also	diagnosed	with	AUD.	The	Diagnostic	and	Statistical	
Manual	of	Mental	Disorders	(DSM)	guide	recently	released	a	new	classification	for	
AUD	in	the	new	DSM-5.	AUD	is	categorized	by	DSM-5	based	on	the	symptoms	
reported	by	the	patients.	Out	of	the	11	possible	symptoms,	AUD	is	defined	based	
on	severity.	Mild	is	having	a	combination	of	2	to	3	symptoms,	moderate	as	having	
the	presence	of	4	to	5	symptoms	and	severe	as	having	6	or	more	symptoms	
(Table	2).		
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1	 Had	times	when	you	ended	up	drinking	more,	or	longer,	than	you	
intended?	
2	 More	than	once	wanted	to	cut	down	or	stop	drinking,	or	tried	to,	but	
couldn’t?	
3	 Spend	a	lot	of	time	drinking?	Or	being	sick	or	getting	over	other	
aftereffects?	
4	 Wanted	a	drink	so	badly	you	couldn’t	think	of	anything	else?	
																													**This	is	new	to	DSM-5**	
5	 Found	that	drinking-or	being	sick	from	drinking-often	interfered	with	
taking	care	of	your	home	or	family?	Or	caused	job	troubles?	Or	school	
problems?	
6	 Continued	to	drink	even	though	it	was	causing	trouble	with	your	
family	or	friends?	
7	 Given	up	or	cut	back	on	activities	that	were	important	or	interesting	
to	you,	or	gave	you	pleasure,	in	order	to	drink?	
8	 More	than	once	gotten	into	situations	while	or	after	drinking	that	
increased	your	chances	of	getting	hurt	(such	as	driving,	swimming,	
using	machinery,	walking	in	a	dangerous	area,	or	having	unsafe	sex)?	
9	 Continued	to	drink	even	though	it	was	making	you	feel	depressed	or	
anxious	or	adding	to	another	health	problem?	Or	after	having	had	a	
memory	blackout?	
10	 Had	to	drink	much	more	than	you	once	did	to	get	the	effect	you	
want?	Or	found	that	your	usual	number	of	drinks	had	much	less	
effect	than	before?	
11	 Found	that	when	the	effects	of	alcohol	were	wearing	off,	you	had	
withdrawal	symptoms,	such	as	trouble	sleeping,	shakiness,	
restlessness,	nausea,	sweating,	a	racing	heart,	or	a	seizure?	Or	sensed	
things	that	were	not	there?	
	
	
	
The	presence	of	
at	least	2	of	
these	symptoms	
indicates	an	
Alcohol	Use	
Disorder	(AUD).	
	
The	severity	of	
the	AUD	is	
defined	as:		
	
Mild:	
The	presence	of	
2	to	3	symptoms	
	
Moderate:	
The	presence	of	
4	to	5	symptoms	
	
Severe:	
The	presence	of	
6	or	more	
symptoms	
Table	2:	Guideline	for	the	diagnosis	of	Alcohol	Use	Disorder	(AUD).	Adapted	from	
NIH	Publication	No.13-7999.	
	 The	effects	of	alcohol	are	dependent	on	the	amount	that	is	ingested,	its	
absorption,	metabolism	and	its	level	in	different	organs.	Alcohol’s	main	site	of	
metabolism	is	in	the	liver	where	two	different	enzymes	are	mainly	responsible	for	
its	breakdown.	First,	alcohol	is	oxidized	into	acetylaldehyde	by	the	enzyme	
alcohol	dehydrogense	(ADH);	acetyladehyde	is	further	oxidized	into	acetate	by	
the	enzyme	aldehyde	dehydrogenase	(ALDH)	(Edenberg	2007).		
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	 There	are	multiple	variations	of	both	enzymes	ADH	and	ALDH;	these	
different	variations	of	enzymes	have	different	efficiency	for	converting	alcohol	
into	its	by-products.	Because	of	this,	a	person	is	more	or	less	at	risk	of	developing	
alcoholism	and	dependence	depending	on	which	variants	of	ADH	and	ALDH	they	
express	(Hurley	2002).	For	instance,	there	are	a	few	factors	that	determine	a	
person’s	ability	to	handle	alcohol	and	affect	his	or	her	intoxication	level	and	these	
include	ADH	and	ALDH	alleles,	their	liver	size,	and	the	enzyme	expression	levels.	
All	these	factors	might	be	one	of	the	reasons	why	alcohol	researchers	looking	into	
its	impact	on	post	TBI	recovery	in	patients	are	so	different	in	their	conclusions.	
Binge	Drinking	
	 One	of	the	most	common	ways	in	which	alcohol	is	misused	is	by	binge	
drinking.	According	to	the	National	Institute	on	Alcohol	Abuse	and	Alcoholism	
(NIAAA),	binge	drinking	is	defined	as	having	5	or	more	drinks	for	men	and	4	or	
more	drinks	for	women	within	a	2	hour	time	window	to	reach	a	blood	alcohol	
level	(BAL)	of	0.08-gram	percent	or	more.	Binge	drinking	is	very	prevalent,	as	it	is	
estimated	that	1	in	6	adults	in	the	USA	binge	drink	(38	million	people)	and	they	do	
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so	very	often	(approximately	4	times	a	month).	On	average,	each	person	has	8	
drinks	each	time	they	binge	(CDC	Vitalsigns,	2012).	While	most	binge	drinkers	are	
not	technically	categorized	in	the	DSM-5	as	having	AUD,	it	is	still	a	major	problem	
because	intoxication	due	to	binge	drinking	leads	to	increased	chances	of	health	
problems.	For	instance,	one	study	indicated	that	alcohol	consumption	leads	to	a	
greater	chance	of	dying	from	injuries	and	sustaining	nonfatal	injuries	(Miller	&	
Spicer	2012).		Furthermore,	recent	statistics	indicated	that	88,000	deaths	annually	
are	alcohol	related	and	about	31%	of	driving	deaths	are	due	to	alcohol-impaired	
driving	(NIAAA	Alcohol	Facts	and	Statistics	2015).	
	 A	high	level	of	alcohol	in	the	human	body	is	very	toxic	especially	to	the	
liver,	which	performs	most	of	the	alcohol	metabolism	in	the	body.	According	to	a	
recent	report,	alcohol	is	the	leading	cause	of	liver	cirrhosis	(Musso	et	al	2014).	
Alcohol	exposure	during	the	developmental	stage	of	human	life	leads	to	fetal	
alcohol	spectrum	disorders	(FASD)	and	is	estimated	to	be	as	prevalent	as	20	to	25	
cases	per	1,000	births	(May	et	al	2009).	In	terms	of	the	CNS,	high	levels	of	alcohol	
have	been	found	to	have	various	negative	effects.	For	instance,	(Collins	et	al	
1996),	found	that	binge	administration	paradigm	of	alcohol	3	times/day	
continuous	for	4	days	which	achieved	BAL	higher	than	300mg/dL	in	rats	leads	to	
neuronal	degeneration	in	several	key	cerebral	and	olfactory	brain	regions.	
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Interestingly,	the	degeneration	in	the	olfactory	region	of	the	brain	might	explain	
why	olfactory	memory	deficits	are	observed	in	human	alcoholic	patients	(Shear	et	
al	1992).	Additionally,	alcohol	has	been	shown	in	vitro	to	increase	reactive	oxygen	
species	(ROS)	in	brain	endothelial	cell	lines,	which	might	indicate	that	alcohol	
decreased	BBB	functions	(Haorah	et	al	2005).	In	fact,	the	metabolism	of	alcohol	
via	ADH	has	been	shown	to	generate	free	radicals	and	increase	ROS	in	neuronal	
cell	lines	(Haorah	et	al	2008)	and	lead	to	lipid	peroxidation	(Altura	et	al	2002)	a	
definitive	molecular	marker	for	the	presence	of	elevated	ROS.	High	levels	of	
alcohol	administration	in	rats	also	lead	to	neuro-inflammation	characterized	by	
elevated	inflammatory	mediators	such	as	arachidonic	acid	and	TNFa	(Crews	et	al	
2004).	However,	it	is	not	known	whether	this	neuro-inflammation	is	a	response	to	
the	preceding	neuronal	degeneration	or	the	cause	of	the	degeneration.	
Interestingly,	after	administration	of	ethanol	into	organotypic	slice	cultures,	one	
study	observed	that	there	were	apparent	edema	effects,	which	could	be	blocked	
by	the	diuretic	furosemide	(Collins	et	al	1998).	Therefore,	aquaporin	is	suspected	
to	be	playing	a	role	in	ethanol	induced	edema	in	the	brain.	Alcohol	induced	
neuro-inflammatory	responses	such	as	elevated	TNFa	and	arachidonic	acid	might	
be	due	to	glial	TLR-4	activation	by	alcohol	(Alfonso-Loeches	et	al	2010).	The	
important	process	of	neurogenesis,	in	which	the	brain	generates	new	cells,	is	also	
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potently	affected	by	the	presence	of	alcohol.	For	Instance,	one	study	found	that	
using	in	vitro	cultures,	ethanol	decreased	neural	stem	cell	proliferation	(Crews	et	
al	2003).	Another	study	found	that	in	rats,	in	response	to	a	binge	paradigm	of	
5g/kg	alcohol,	hippocampal	neurogenesis	was	inhibited	(Nixon	&	Crews	2002).			
Alcohol	and	TBI	in	The	Human	Population	
	 Because	intoxicated	people	are	more	likely	to	get	into	dangerous	situations	
that	might	result	in	injuries,	it	is	not	surprising	that	data	from	trauma	centers	
indicated	that	up	to	43%	of	patients	entering	the	emergency	department	for	
severe	TBI	have	blood	alcohol	levels	above	0.08%	(Talving	et	al	2010).	Several	
researchers	studied	a	group	of	patients	having	mild	to	severe	TBI	with	and	
without	having	been	alcohol	intoxicated	at	the	time	of	injury.	They	used	
functional	and	cognitive	outcome	measurements	that	were	known	to	be	sensitive	
to	the	effect	of	TBI.	They	found	that	having	alcohol	intoxication	significantly	
decreased	the	Glasgow	coma	scale	score,	a	functional	measure	for	the	severity	of	
TBI	(Schutte	&	Hanks	2010).	Short-term	(measured	at	the	time	of	admission	to	
inpatient	rehabilitation)	functional	measures	showed	a	significant	negative	effect	
of	alcohol	intoxication.	However,	functional	and	cognitive	measures	looking	at	
post	rehabilitation	or	at	1	year	post-TBI	showed	no	alcohol	effects.	One	clinical	
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study	pointed	out	that	alcohol	intoxicated	patients	might	preferentially	have	a	
history	of	other	substance	abuse,	thus	the	negative	functional	effects	might	not	
only	be	due	to	alcohol	intoxication	at	the	time	of	injury	(Corrigan	1995).	On	the	
contrary,	some	other	reports	on	the	effect	of	alcohol	on	TBI	arrived	at	different	
conclusions.	One	example	is	a	recent	clinical	study	showing	evidence	for	the	
positive	impact	of	BAL	at	the	time	of	trauma	center	admission	on	recovery	
(Mohseni	2016).	However,	there	were	some	important	issues	with	the	patient	
population	included	in	this	study.	For	instance,	the	patients	with	positive	BAL	
where	significantly	younger	and	had	less	comorbidity.		
Animal	Models	of	Alcohol	and	TBI	
	 Due	to	the	prevalence	of	alcohol	intoxication	in	TBI	patients	seen	in	the	
clinics,	a	number	of	laboratories	had	tried	to	develop	a	clinically	relevant	model	to	
study	the	biological	effect	of	alcohol	on	TBI.	For	instance,	one	group	found	some	
interesting	effects	of	a	chronic	alcohol	paradigm	on	recovery	after	TBI	(Zhang	et	al	
1999).	Rats	were	fed	with	a	liquid	diet	containing	ethanol	(6.6%).	Importantly,	at	
the	time	of	TBI,	the	animals	had	been	withdrawn	from	the	alcohol	diet	for	2	days.	
The	average	daily	ethanol	consumption	was	11.2-13g/kg/day,	which	was	very	high	
compared	to	the	acute	model	that	our	laboratory	used	(3g/kg/day).	Additionally,	
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the	BAL	that	was	attained	at	the	end	of	alcohol	feeding	(6	weeks)	was	154mg/dL,	
which	indicated	there	was	significant	tolerance	to	alcohol	in	these	animals.	There	
were	no	significant	overall	differences	in	the	beam	walk	scores	after	TBI	between	
alcohol/TBI	versus	vehicle/TBI	groups	with	the	exception	that	on	day	#2	after	
surgery,	the	vehicle/TBI	group	did	significantly	worse.	In	a	spatial	learning	test,	
there	was	a	significant	main	effect	of	injury	in	that	TBI	lowered	the	performance	
score;	however,	having	alcohol	with	TBI	did	not	significantly	affect	performance	in	
comparison	to	the	control	diet.	
	 A	different	group	investigated	the	effect	of	longer	chronic	ethanol	
administration	(CEAn).	They	increased	the	length	of	time	to	three	months,	and	in	
addition,	made	the	animals	intoxicated	at	the	time	of	injury	(Masse	et	al	2000).		
Yet,	they	observed	no	significant	effect	of	ethanol	on	the	post-TBI	behavioral	task	
of	the	Morris	water	maze	(MWM).	However,	ethanol	fed	groups	appeared	to	do	
better	in	certain	parameters	of	the	MWM.	There	were	no	other	differences	in	TBI	
parameters	such	as	survival	rate	or	cortical	lesion	volume.	Interestingly,	there	was	
significant	BAL	tolerance	when	examining	the	BAL	level	at	different	time	points	
during	the	CEAn	paradigm.		
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	 Another	group	investigated	the	effect	of	binge	ethanol	consumption	on	the	
outcome	of	TBI	using	the	lateral	fluid	percussion	model	(LFP)	(Prasad	et	al	2001).	
Alcohol	was	given	intragastrically	at	3g/kg,	Thursday	and	Friday	for	four	
consecutive	weeks	follow	by	moderate	injury	(animals	are	intoxicated	at	time	of	
injury).	Then	as	before,	they	used	MWM	to	analyze	post	injury	recovery.	There	
were	no	noticeable	histological	differences	between	alcohol/TBI	and	vehicle/TBI	
groups.	Interestingly,	in	certain	measures	of	the	MWM	such	as	mean	search	
latency,	alcohol	TBI	group	did	worse	than	vehicle	TBI.	One	of	the	drawbacks	of	the	
studies	performed	by	the	Prasad	group	is	the	use	of	the	MWM;	this	behavioral	
task	is	mainly	to	assess	deficits	in	spatial	memory	and	learning;	to	detect	finer	
deficit	in	motor	skills,	other	test	should	have	been	used.	What	this	group	had	
shown	is	that	acute	binge	alcohol	consumption	was	more	detrimental	to	post	
injury	recovery	than	an	“alcoholic”-type	of	consumption.		
	 Acute	single	dose	alcohol	had	some	interesting	effects	when	given	shortly	
before	a	fluid	percussion	model	of	TBI	(Yamakami	et	al	1995).	In	this	study,	the	
dose	of	alcohol	was	divided	into	low	(1.5g/kg)	and	high	(3g/kg)	and	given	to	rats	2	
hours	before	TBI.	For	either	moderate	or	high	severity	TBI,	there	were	3	
conditions,	saline,	low	alcohol	and	high	alcohol.	Interestingly,	significantly	
prolonged	hypotension	was	observed	in	both	alcohol	level	conditions.	
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Neurological	motor	function	was	assessed	and	there	was	no	significant	difference	
observed	between	either	the	alcohol	group	or	vehicle	group	in	moderate	TBI.	
However,	following	more	severe	TBI,	the	high	alcohol	level	group	experienced	
higher	mortality	and	worse	motor	recovery	at	24	hours	post	injury.	Furthermore,	
post-traumatic	cerebral	alkalosis	was	observed	in	both	ethanol	treated	groups.		
	 Our	laboratory	used	an	acute	binge	alcohol	administration	paradigm	to	
investigate	its	effect	on	behavioral	recovery	after	TBI	(Vaagenes	et	al	2015).	
Alcohol	was	given	at	2g/kg/day	(i.p.)	for	three	consecutive	days.	At	the	time	of	TBI	
injury,	rats	were	intoxicated	and	had	a	blood	alcohol	level	of	more	than	
200mg/dL.	Rats	were	given	a	TBI	in	the	forelimb	area	of	the	sensorimotor	cortex	
using	the	CCI	model.	We	used	the	skilled	forelimb	reaching	task	to	assess	the	
recovery	of	injured	rats	for	up	to	7	weeks	after	TBI	and	found	that	the	alcohol	
administered	group	had	a	significantly	slower	recovery	curve	with	a	significantly	
lower	recovery	plateau	compared	to	the	vehicle	administered	group.		
	 There	are	several	mechanisms	that	could	support	why	alcohol	consumption	
prior	to	TBI	and	intoxication	during	TBI	could	result	in	worse	functional	outcomes.	
For	instance,	there	is	evidence	that	alcohol	intoxication	could	lead	to	aquaporin	
channel	dysregulation,	which	might	potentiate	edema	processes	after	TBI	
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(Sripathirathan	et	al	2009).		Furthermore,	alcohol	administration	can	elicit	an	
inflammatory	response,	and	when	combined	with	TBI,	further	potentiate	that	
inflammatory	cascade	in	the	secondary	injury	process	(McClain	et	al	2011).	
Another	possible	mechanism	in	which	alcohol	might	negatively	synergize	with	TBI	
to	further	worsen	TBI	outcomes	is	elevated	reactive	oxygen	species	(ROS).	Alcohol	
metabolism	is	characterized	by	the	production	of	ROS.	TBI	inflammatory	cascades	
produce	elevated	ROS,	so	it	is	possible	that	the	ROS	produced	by	alcohol	
metabolism	in	combination	with	the	ROS	produced	by	TBI	is	responsible	for	the	
negative	effects	of	alcohol	on	post-TBI	functional	recovery	(Le	Belle	et	al	2011).	
Another	possible	CNS	pathway	which	both	alcohol	intoxication	and	TBI	share	is	
neurogenesis.	High	levels	of	alcohol	alone	negatively	impact	neurogenesis	
(Hansson	et	al	2010).	We	know	that	after	TBI,	there	is	a	natural	boost	in	
subventricular	and	hippocampal-derived	neurogenesis	and	these	newly	produced	
cells	might	contribute	to	the	recovery	process.	It	is	possible	that	alcohol,	by	
decreasing	neurogenesis,	leads	to	worse	or	delayed	functional	recovery	as	shown	
previously	in	our	lab.		
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Neurogenesis	
	 For	a	long	time	it	was	thought	that	we	are	born	with	all	the	neurons	that	
we	would	have	in	our	entire	lifetime,	and	this	dogma	was	partly	solidified	by	Cajal	
and	other	neuroscientists	of	the	nineteenth	century.	However,	in	1912,	it	was	
noted	by	Ezra	Allen	that	there	is	a	zone	of	proliferation	in	the	area	adjacent	to	the	
cerebral	lateral	ventricle	(Allen	1912).	However,	it	was	not	until	the	1960’s	when	
Altman’s	lab	released	a	seminal	paper	documenting	the	existence	of	postnatal	
neurogenesis	in	the	mammalian	brain	using	tritiated	thymidine	autoradiography	
(Altman	1962).		Since	then,	many	studies	have	confirmed	these	two	original	
observations	that	there	are	continual	new	cells	being	produced	(neurogenesis)	in	
the	adult	mammalian	brain	in	mainly	two	sites,	the	subventricular	zone	(SVZ),	and	
the	hippocampal	sub-granular	zone	(SGZ)	(Ihrie	&	Alvarez-Buylla	2011,	Spalding	et	
al	2013).		
SVZ	Neurogenesis	
	 Particularly	important	in	the	context	of	disease	and	injuries	to	the	CNS	is	
that	these	newborn	cells	from	the	SVZ	have	been	detected	in	the	injury	sites	
(Young	et	al	2011).	The	main	purpose	of	SVZ	neurogenesis	in	the	rodent	brain	is	
to	produce	cells	to	replace	those	in	the	olfactory	bulb	(OB).	However,	the	
45	
	
connection	between	proliferation	in	the	SVZ	and	the	presence	of	new	cells	in	the	
OB	was	not	made	until	relatively	recently	(1994)	by	the	laboratory	of	Arturo	
Alvarez-Buylla.	Before	that,	it	was	believed	that	the	SVZ	is	a	vestigial	structure	and	
new	cells	generated	from	it	were	meant	to	die	off	as	these	cells	are	not	well	
retained	in	the	SVZ	or	structures	nearby	such	as	the	striatum	(Morshead	&	van	
der	Kooy	1992).	One	important	study	showed	that	cells	labeled	by	the	
proliferation	marker	BrdU	do	not	remain	in	the	SVZ	for	an	extended	amount	of	
time,	but	instead	of	dying,	they	migrate	to	the	OB	and	mature	into	neurons	(Lois	
&	Alvarez-Buylla	1994).	Additional	work	since	then	has	clarified	the	SVZ	to	OB	
migration	process	(figure	2).		
	 It	has	been	estimated	that	tens	of	thousands	of	interneurons	are	replaced	
daily	by	this	neurogenesis	mechanism	(Chang	et	al	2016).	The	SVZ	is	the	thin	layer	
of	cells	covering	the	lateral	ventricles;	newborn	cells	in	the	SVZ	migrate	toward	
the	OB	via	a	well-characterized	path	called	the	rostral	migratory	stream	(RMS).	
The	SVZ	is	considered	a	niche,	a	unique	environment	that	is	home	to	quiescent,	
neural	stem	cells	(referred	to	as	type	B	cells)	with	astrocytic	features.	Type	B	
neural	stem	cells	become	activated	and	divide	in	a	process	called	asymmetric	
division	to	generate	two	daughter	cells.	One	daughter	is	another	type	B	stem	cell	
and	another	is	a	transit-amplifying	progenitor	called	type	C	cell.		Type	C	cells	can	
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divide	many	rounds	by	symmetric	division	to	give	rise	to	a	much	larger	population	
of	another	cell	type	called	neuroblasts	(type	A	cells).	Type	A	cells	are	committed	
to	a	neuronal	lineage	but	are	not	terminally	differentiated.	Neuroblasts	migrate	
through	the	RMS	toward	the	OB	in	a	process	called	tangential	migration.	The	
distinct	migration	path	of	neuroblasts	is	well	characterized,	and	is	termed	“chain	
migration”	because	chains	of	neuroblasts	in	close	contact	move	forward	by	
contacting	each	other	in	a	chain	like	fashion	(Lois	et	al	1996).	Once	neuroblasts	
reach	the	OB	core,	they	migrate	radially	into	the	OB	parenchyma.	Here,	they	
finish	their	maturation	and	terminally	differentiate	into	GABAergic	and	
periglomerular	interneurons.	A	very	small	percentage	also	become	glutamatergic	
juxtaglomerular	cells	(Lazarini	&	Lledo	2011).Besides	producing	new	neurons,	SVZ	
neurogenesis	can	generate	new	oligodendrocytes	and	astrocytes.	New	
oligodendrocytes	migrate	dorsally	and	are	found	in	the	corpus	callosum	(Menn	et	
al	2006).	The	newly	generated	astrocytes	have	been	found	to	migrate	toward	
injured	areas	of	the	brain	(Benner	et	al	2013).		SVZ	neurogenesis	has	also	been	
detected	in	the	adult	human	brain	and	other	primates;	however,	its	purpose	is	
less	well	known	(Chang	et	al	2016).	
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SVZ	Neurogenesis	and	Its	Contribution	to	OB	Neuro-circuitry	
	
Figure	2:	subventricular	zone	(SVZ)	neurogenesis	and	olfactory	bulb	(OB)	
migration,	differentiation	and	maturation.	A	Sagittal	view	of	the	rat	brain	showing	
the	connection	between	the	SVZ,	rostral	migratory	stream	(RMS)	and	OB.	B	
Enlargement	of	the	boxed	area	in	part	A,	showing	the	different	neuronal	layers	of	
the	OB.		The	neuroblasts	leave	the	RMS	in	single	cell	fashion	and	differentiate	into	
granule	cells	(GC)	and	periglomerular	cells	(PGC).	C	Depiction	of	the	chain	
migration	of	type	A	cells	also	known	as	neuroblasts.	D	Type	A	cells	differentiate	
into	either	GC	or	PCG;	each	can	be	distinguished	by	a	unique	combination	of	
cellular	markers	and	their	neurotransmitter	phenotype.	Adapted	from	(Lim	&	
Alvarez-Buylla	2016).	
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	 Migration	is	an	important	component	of	neurogenesis	during	development	
and	the	adult.	Migration	allows	cells	to	move	from	the	place	where	they	were	
born	to	their	eventual	destinations.	Along	their	migratory	path,	they	encounter	
different	interactions	such	as	cell-to-cell,	trophic	factors	and	extra-cellular	matrix;	
these	interactions	play	a	large	role	in	the	development	of	new	neural	cells.	There	
are	three	distinct	migratory	modes	that	can	be	seen	during	adult	neurogenesis,	
i.e.,	tangential,	radial,	and	chain	migration.	
	 Chain	migration	is	the	unique	migratory	pattern	seen	in	the	RMS.	Type	A	
cells	produced	in	the	SVZ	traverse	the	millimeters-long	RMS	pathway	that	
connects	the	SVZ	and	the	OB.	These	migratory	cells	use	each	other	as	tracks	to	
move	forward	(Lois	&	Alvarez-Buylla	1994).	This	pattern	of	migration	is	referred	to	
as	homotypic	because	the	type	A	cells	slide	along	each	other.	The	leading	cell	will	
extend	a	growth	cone	that	serves	as	a	track	for	the	few	following	cells	
(Kempermann	2011).	Interestingly,	in	rodent,	the	RMS	is	ensheathed	in	a	tube-
like	structure	made	up	of	glial	cells;	however,	functionally,	little	is	known	about	
this	glial	structure	(Gritti	et	al	2002).	One	study	disrupted	this	glial	structure	by	
manipulating	the	Beta1	Integrin	level	and	found	that	chain	migration	still	
occurred;	however,	type	A	cells	moved	away	from	the	stream	prematurely	
(Belvindrah	et	al	2007).	In	humans,	chain	migration	and	the	existence	of	the	RMS	
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had	not	been	extensively	confirmed	due	to	the	difficulty	in	observing	this	
anatomical	feature.	Human	neuroblasts	have	been	seen	migrating	along	the	
obliterated	olfactory	ventricle	in	a	manner	different	than	that	of	rodents	and	
without	the	characteristic	cluster	of	migrating	cells	(Curtis	et	al	2007).		
	 Radial	migration	is	seen	both	in	developing	CNS	as	well	as	in	the	adult	
brain.	During	development,	radial	migration	is	seen	when	new	neurons	from	the	
ventricular	plate	migrate	out	to	their	terminal	location	in	the	different	cortical	
layers.	Radial	migration	during	the	developmental	phase	relies	on	radial	glia	as	
the	guiding	tracks	(Poluch	&	Juliano	2007).	In	adult	neurogenesis,	once	type	A	
cells	reach	the	core	of	the	olfactory	bulb,	these	immature	neurons	switch	their	
mode	of	migration	and	start	moving	radially	toward	the	granular	and	
periglomerular	layers.	In	the	OB,	blood	vessels	serve	as	radial	scaffold	for	the	
migration	of	type	A	cells	(Bovetti	et	al	2007).	On	the	other	hand,	tangential	
migration	is	the	process	in	which	interneurons	move	in	parallel	direction	to	the	
plane	of	the	ventricular	plate;	this	migratory	process	is	independent	of	radial	glia.	
In	adult	rodents,	it	has	been	shown	that	GABAergic	neurons	are	generated	in	the	
SVZ	and	migrate	tangentially	toward	key	structures	of	the	brain	such	as	the	
cortex,	striatum	and	nucleus	accumbens	(Inta	et	al	2008).		
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SGZ	Neurogenesis	
	 The	hippocampus	is	another	brain	structure	that	was	found	to	produce	new	
brain	cells.	Specifically,	the	subgranular	zone	(SGZ)	of	the	dentate	gyrus,	which	is	
at	the	junction	of	the	hilus	and	the	granule	cell	layer,	is	the	niche	for	neural	stem	
cells.	Neural	stem	cells	in	the	SGZ	have	a	different	cellular	organization	compared	
to	their	SVZ	equivalents.	SGZ	stem	cells	are	not	located	next	to	a	ventricle	and	are	
surrounded	by	other	neurons	(Kempermann	2011).	Interestingly,	SGZ	stem	cells	
have	long	processes	that	extend	to	the	granular	and	molecular	layers	of	the	
hippocampus.	These	quiescent	stem	cells	in	the	SGZ	are	called	type	1	cells,	which	
in	turn	divide	asymmetrically	to	produce	progenitors	called	type	2a	and	2b	cells.	
Type	2a	and	2b	progenitors	divide	symmetrically	to	produce	neuroblasts	which	
eventually	mature	and	terminally	differentiate	into	glutamatergic	dentate	granule	
cells	(figure	3).	Newborn	hippocampal	neurons	are	hyperexcitable	during	the	
critical	maturation	period	of	3-6	weeks	after	their	birth.	These	new	cells	receive	
excitatory	glutamatergic	inputs	from	the	entorhinal	cortex,	however,	without	
having	inhibitory	GABAergic	inputs,	they	have	a	low	threshold	for	the	induction	of	
long-term	potentiation	(LTP).	
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Hippocampal	Neurogenesis	
	
Figure	3:	Neurogenesis,	differentiation	and	maturation	in	the	dentate	gyrus	of	the	
hippocampus.	A.	Sagittal	view	of	the	rodent	brain	(left)	showing	the	relative	
location	of	the	dentate	gyrus	of	the	hippocampus	(HP)	to	that	of	the	SVZ	and	
lateral	ventricle	(LV)	and	the	olfactory	bulb	(OB).	Right:	enlargement	of	
hippocampus	showing	cellular	connections	between	the	sub-structures	of	the	
hippocampus.	Perforant	path	compose	of	entorhinal	cortex	input	signal	by	
forming	synapse	with	dentate	granule	cells,	which	are	continually	generated	by	
neurogenesis.	Granule	cells	form	synapses	with	pyramidal	cells	of	CA3,	and	these	
cells	in	turn	form	synapses	with	CA1	neurons.	B.	Summary	of	neurogenesis	in	the	
hippocampus.	Radial	glia-like	(RGL)	neural	stem	cells	divide	to	become	
intermediate	progenitor	cells	(IPCs),	which	in	turn	proliferate	into	neuroblasts.	
These	new	neuroblasts	undergo	several	immature	stages	to	finally	become	
mature	granule	cells.	Adapted	from	(Christian	et	al	2014).	
	
52	
	
Molecular	Regulators	of	Neurogenesis	
	 Neural	stem	cells	and	progenitors	in	the	SVZ	and	dentate	gyrus	are	exposed	
to	complex	microenvironments	composed	of	local	cells	and	diffusible	molecules.	
Many	of	the	common	neurotransmitters	in	the	brains	have	regulatory	functions	in	
neurogenesis.	For	instance,	NMDA	receptor	dependent	activity	is	inversely	
correlated	with	hippocampal	proliferation	(Zhao	et	al	2008).	Glutamate,	the	
predominant	excitatory	neurotransmitter	in	the	CNS	is	the	main	ligand	for	NMDA	
receptors.	Furthermore,	an	in	vitro	study	using	hippocampal	stem/progenitor	cells	
showed	glutamate	increasing	neuronal	differentiation	(Deisseroth	et	al	2004).	
Similarly,	the	neurotransmitter	GABA	binds	to	type	2	progenitor	cells	in	the	
hippocampus	leading	to	calcium	influx	and	depolarization	and	subsequent	
increased	expression	of	NeuroD,	a	neuronal	differentiation	factor	(Tozuka	et	al	
2005).		
	 The	growth	factor	family	of	molecules	also	potently	affects	neurogenesis.		
In	vivo	studies	demonstrated	that	both	epidermal	growth	factor	(EGF)	and	
fibroblast	growth	factor	2	(FGF2)	increase	SVZ	stem	cell	proliferation	(Kuhn	et	al	
1997).	Additionally,	FGF2	administration	leads	to	increased	incorporation	of	new	
neurons	to	the	olfactory	bulb.	FGF2	signaling	might	also	play	a	crucial	role	in	
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hippocampal	neurogenesis	as	one	study	showed	that	by	deleting	its	receptor	
fgfr1,	SGZ	neurogenesis	was	decreased	(Zhao	et	al	2007).	Another	key	regulator	of	
neurogenesis	is	brain-derived	neurotrophic	factor	(BDNF).	Transgenic	animals	
lacking	BDNF	receptor	p75	have	smaller	olfactory	bulbs	and	impaired	SVZ	
neurogenesis.	Interestingly,	BDNF	appears	to	mediate	antidepressant-induced	
increase	in	hippocampal	neurogenesis.	One	study	showed	that	using	transgenic	
mice	with	deficits	in	TrkB	signaling	(the	main	receptor	for	BDNF),	antidepressant	
treatment	failed	to	increase	SGZ	cell	proliferation	(Duman	&	Monteggia	2006).		
	 ROS	have	traditionally	been	thought	to	be	detrimental	to	cellular	activities.	
ROS	accumulation	is	a	result	of	oxidative	stress	and	is	a	contributor	to	many	
diseases	and	neurodegeneration	in	the	brain.	The	effect	of	ROS	on	stem	cells	is	
intriguing;	for	instance,	hematopoietic	stem	cells	(HSCs)	maintain	a	low	
endogenous	level	of	ROS,	which	is	critical	for	the	maintenance	of	quiescence.	This	
is	important	to	prevent	the	exhaustion	of	the	available	pool	of	stem/progenitor	
cells	(Jang	&	Sharkis	2007).	Intracellular	ROS	had	emerged	to	be	a	critical	second	
messenger	in	a	tightly	controlled	signal	transduction	system	to	control	cellular	
proliferation	(Kwon	et	al	2004).	Endogenous	ROS	levels	are	controlled	by	
mitochondrial	activity	and	several	NADPH	oxidase	(NOX)	enzymes	(Lambeth	et	al	
2008).	In	contrast	to	the	HSCs,	neural	stem	cells	(NSCs)	are	dependent	on	the	ROS	
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as	the	mediator	of	the	proliferative	response	(Figure	4).	One	important	study	
found	higher	ROS	levels	in	the	neural	stem/progenitor	cells	in	the	SVZ	(Le	Belle	et	
al	2011).	Additionally,	when	ROS	was	artificially	increased	by	the	addition	of	non-
toxic	concentration	of	H2O2	in	vitro,	SVZ	stem	cell	proliferation	significantly	
increased.	This	same	study	also	showed	that	NOX2	mutant	mice	had	impaired	SVZ	
proliferation	and	smaller	olfactory	bulbs	(Le	Belle	et	al	2011).	
																													 	
Figure	4:	Reactive	Oxygen	Species	(ROS)	regulation	and	its	role	in	SVZ	
neurogenesis.	Adapted	from	(Le	Belle	et	al	2011).		
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Systemic	Regulators	of	Neurogenesis	
		 It	is	well	known	that	aging	is	associated	with	a	progressive	decrease	in	
cognitive	functions	such	as	memory	formation.	Furthermore,	strong	evidence	
exists	in	animal	models	for	the	decline	in	total	neurogenesis	in	aged	animals	(Zhao	
et	al	2008).	The	hippocampus	is	the	brain	structure	most	often	associated	with	
memory	formation.	In	aged	animals,	both	hippocampal	volume	and	the	level	of	
neurogenesis	significantly	decrease	(Driscoll	et	al	2006).	Other	reports	utilizing	
transgenic	mice	demonstrated	that	in	the	SGZ	of	aged	animals,	there	were	
significant	reductions	in	both	the	number	of	stem/progenitor	cells	and	the	
proliferative	rate	of	those	cells	(Walter	et	al	2011).	However,	cognitive	
impairment	in	the	aged	animals	did	not	necessarily	correlate	with	decreased	
neurogenesis.	One	study	used	the	MWM	to	demonstrate	that	in	aged	rats,	
animals	with	impaired	learning	ability	have	higher	proliferative	rate	in	the	SGZ	
compared	to	a	similarly	aged	group	with	intact	learning	ability	(Bizon	et	al	2004).	
Additionally,	aging	also	affects	the	SVZ-OB	area	and	its	function	in	both	humans	
and	experimental	animal	models.	For	instance,	in	humans,	olfactory	
discrimination	abilities	decrease	with	age	(Kaneda	et	al	2000).	One	important	
study	using	a	mice	model	of	aging	found	that	aged	animals	exhibit	decreased	SVZ	
proliferation	and	less	OB	new	interneurons	compared	to	younger	mice	(Enwere	et	
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al	2004).	Additionally,	the	aged	mice	performed	the	same	as	young	mice	when	
discriminating	two	discrete	odors;	but	performed	significantly	worse	at	
discriminating	similar	odors.	This	finding	indicates	that	SVZ-OB	neurogenesis	is	
important	in	fine	olfactory	discrimination	tasks.	This	same	group	also	found	that	
the	OB	of	aged	mice	expressed	less	epidermal	growth	factor	(EGF)	and	its	
corresponding	receptor	(EGFR).	
	 Stress	is	another	potent	negative	regulator	of	neurogenesis.	Increased	
stress	leads	to	decreased	cell	proliferation	in	the	dentate	gyrus	of	the	
hippocampus.	This	phenomenon	had	been	reported	in	various	species	including	
mouse,	rat,	tree	shrew	and	marmoset	(Mirescu	&	Gould	2006).	Various	stressors	
were	used	in	these	animal	models	to	demonstrate	this	effect	including	
subordination,	resident-intruder,	foot-shock,	restraint,	isolation,	cold	
immobilization,	cold	swim	and	predator	odor	(Gould	et	al	1997,	Gould	et	al	1998,	
Malberg	&	Duman	2003,	Pham	et	al	2003).	Furthermore,	both	acute	and	chronic	
stressors	cause	decreased	hippocampal	neurogenesis	(Mirescu	&	Gould	2006).	
The	cause	for	decreased	hippocampal	neurogenesis	following	stress	is	linked	to	
stress	hormones	like	glucocorticoids.	Glucocorticoids	directly	regulate	
hippocampal	neurogenesis.	For	instance,	the	cells	of	the	hippocampus	express	
adrenal	steroid	receptors.	Furthermore,	modulating	circulating	levels	of	these	
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stress	hormones	changes	hippocampus	structure	and	functions	(McEwen	1999).	
Studies	in	which	either	the	adrenal	gland	was	removed	or	pharmacological	
methods	were	used	to	inhibit	the	HPA	axis	(CRF-1	and	V1b	receptor	antagonists)	
showed	an	increase	in	hippocampal	neurogenesis	(Cameron	&	McKay	1999);	
(Alonso	et	al	2004).	In	contrast,	administering	exogenous	corticosterone	to	
postnatal	and	adult	rodents	leads	to	an	opposite	decrease	in	hippocampal	
neurogenesis	(Cameron	&	Gould	1994,	Gould	et	al	1991).	Taken	together,	these	
findings	indicate	that	glucocorticoids	are	the	major	mediator	of	stress-induced	
effects	on	hippocampal	neurogenesis.		
	 In	contrast	to	age	and	stress	as	two	of	the	most	characterized	negative	
regulators	of	neurogenesis,	various	environmental	factors	contribute	positively	to	
neurogenesis.	For	instance,	voluntary	running	had	been	shown	to	promote	SGZ	
cell	proliferation	(Kee	et	al	2007).	Exposure	to	an	enriched	environment	was	
shown	to	increase	new	hippocampal	neuron	survival	(Olson	et	al	2006).	
Importantly,	both	voluntary	exercise	and	environmental	enrichment	lead	to	an	
increase	in	performance	of	animals	in	the	MWM	(Zhao	et	al	2008).	One	study	
used	a	transgenic	strain	of	mice	lacking	presenilin-1,	which	is	a	protein	critical	to	
the	memory	function	of	the	hippocampus	and	showed	that	environmental	
enrichment	did	not	elicit	a	response	in	neurogenesis	in	these	animals	(Feng	et	al	
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2001).	Taken	together,	these	studies	demonstrate	the	hippocampal	functional	
implications	of	increased	neurogenesis	caused	by	positive	environmental	
regulators.		
	 Neural	activity	has	also	been	shown	to	positively	regulate	neurogenesis.	
The	relationship	between	learning	and	SGZ	neurogenesis	is	complex	with	
specificity	toward	experimental	tasks,	phases	of	learning	and	SGZ	
stem/progenitor	cell	types	(Zhao	et	al	2008).	The	enhanced	survival	of	new	
hippocampal	neurons	is	only	seen	in	learning	tasks	that	are	specifically	dependent	
on	the	hippocampus.	For	instance,	trace	eyeblink	conditioning	and	the	Morris	
water	maze	lead	to	higher	survival	of	newborn	SGZ	neurons	while	the	active	
shock	avoidance	and	delayed	eyeblink	conditioning	did	not	(Leuner	et	al	2006).	
Hippocampal	learning	does	not	simply	lead	to	a	general	increase	in	SGZ	
proliferation	and	survival.	One	interesting	study	showed	that	training	in	the	
MWM	increased	apoptosis	of	the	early	proliferating	cells	and	that	blocking	this	
apoptosis	event	led	to	worse	subsequent	performance	(Dupret	et	al	2007).	
Additionally,	learning	tasks	such	as	the	MWM	can	be	broken	down	into	specific	
stages,	such	as	the	early	phase	where	rapid	improvement	of	performance	is	seen	
and	late	asymptotic	phase.	Each	of	these	phases	affects	hippocampal	
neurogenesis	differently.	No	SGZ	cell	proliferation	is	observed	during	the	early	
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phase	while	during	the	late	asymptotic	phase,	increased	hippocampal	cell	
proliferation	is	observed	(Döbrössy	et	al	2003).	These	findings	illustrate	the	
complexity	and	specificity	of	learning-induced	increases	in	hippocampal	
neurogenesis	and	suggest	the	functional	importance	of	integration	of	only	a	
subset	of	newborn	neurons.	
Functions	of	SVZ	and	SGZ	Neurogenesis	
	 The	field	of	neurogenesis	is	still	in	its	infancy;	however,	the	roles	of	new	
neurons	that	are	produced	by	neurogenesis	are	starting	to	be	clarified	by	studies.	
While	neurogenesis	is	not	required	for	survival	in	laboratory	animals,	functional	
deficits	are	evident	using	sensitive	behavioral	tasks.	For	instance,	new	neurons	
that	are	produced	in	the	SVZ	and	migrate	to	the	OB	integrate	into	the	existing	
interneuron	circuits	and	significantly	contribute	to	the	network	activity.	The	
olfactory	system	processes	odorant	signals	from	the	environment.	Specifically,	
odorant	molecules	enter	the	nasal	cavity	and	bind	to	olfactory	receptors,	which	
are	expressed	by	olfactory	sensory	neurons	(OSNs).	These	sensory	neurons	have	
axons	that	pass	through	the	cribiform	plate	and	innervate	the	OB.	Mitral	and	
tufted	cells	are	the	main	projection	neurons	that	receive	the	signals	from	OSNs	
and	send	them	to	higher	olfaction	processing	centers	(Munger	et	al	2009).	
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Periglomerular	and	granule	cells	are	GABAergic	inhibitory	neurons	that	are	being	
continually	generated	by	neurogenesis	in	the	SVZ.	These	cells	make	contact	with	
OSN	axon	terminals	and	the	dendrites	of	mitral	and	tufted	cells	and	modulate	the	
incoming	olfactory	signals.	In	effect,	these	new	inhibitory	interneurons	play	
important	roles	in	fine	tuning	the	olfaction	signals	(Lazarini	&	Lledo	2011).	These	
new	neurons	are	not	necessary	for	the	detection	or	discrimination	of	odorants,	
but	seem	to	have	some	roles	in	the	cognitive	processing	of	odorant	context.	An	
example	of	this	process	is	learning	to	discriminate	two	or	more	similar	odors	
(Moreno	et	al	2009).	Intriguingly,	when	OB	neurogenesis	is	prevented,	which	
leads	to	the	depletion	of	OB	interneurons,	no	sensory	deficits	were	observed	with	
tasks	such	as	smell	discrimination	(Imayoshi	et	al	2008).	Yet,	similar	irradiations	of	
the	OB	resulted	in	significant	impairments	in	olfactory	fear	conditioning	(Lazarini	
et	al	2009).				
	 In	the	hippocampus,	newly	produced	granule	neurons	participate	in	a	
similar	process	that	is	called	pattern	separation.	This	is	when	similar	inputs	are	
differentiated	and	processed	as	distinct	conditions	(Clelland	et	al	2009).	Pattern	
separation	manifests	as	the	ability	to	discriminate	subtle	differences	in	spatial	
patterns.	This	can	be	traditionally	assessed	by	the	spatial	memory	task,	the	
MWM,	in	which	animals	have	to	use	environmental	visual	cues	to	find	the	hidden	
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platform	in	a	pool	of	water	(Garthe	&	Kempermann	2013).	Studies	that	ablate	
hippocampal	neurogenesis	consistently	resulted	in	deficits	in	the	MWM	
performance.	In	contrast,	studies	that	use	methods	to	stimulate	hippocampal	
neurogenesis	lead	to	improvement	in	the	MWM	task	(Lacar	et	al	2014,	Sahay	et	al	
2011a).	These	studies	demonstrate	that	hippocampal	neurogenesis	in	rodents	is	
important	for	acquisition	of	the	platform	location,	probe	trial	performance	(when	
the	platform	is	removed	to	access	the	length	of	time	animals	are	in	the	goal	
quadrant),	and	reversal	(when	the	platform	is	move	to	a	random	new	location	
and	the	animals	have	to	re-learn)	(Garthe	&	Kempermann	2013).	
	 While	the	functional	relevance	of	adult	neurogenesis	in	rodents	has	been	
well	established,	their	roles	in	adult	humans	are	less	well	understood.	However,	
adult	neurogenesis	is	implicated	in	a	number	of	diseases	such	as	epilepsy	and	
major	depression,	(Braun	&	Jessberger	2014).	A	decrease	in	adult	hippocampal	
neurogenesis	does	not	contribute	to	the	development	of	depression.	However,	
hippocampal	neurogenesis	is	necessary	for	the	efficacy	of	antidepressants	(Sahay	
&	Hen	2007).	On	the	other	hand,	aberrant	hippocampal	neurogenesis	has	been	
implicated	in	epileptogenesis	(Parent	&	Murphy	2008).	New	hippocampal	neurons	
after	either	seizure	or	traumatic	brain	injury	can	form	abnormal	networks	that	
can	play	a	role	in	future	propagation	of	seizure	activity.	Furthermore,	striatal	
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interneurons	are	being	generated	throughout	the	human	adult	lifetime	by	adult	
neurogenesis.	This	same	population	of	interneurons	has	been	found	to	be	
depleted	in	Huntington’s	disease	(HD)	patients	raising	the	possibility	that	the	lack	
of	adult	neurogenesis	might	contribute	to	the	HD	disease	state	(Jessberger	&	
Gage	2014).		
SVZ	Neurogenesis	in	TBI	
	 Mechanical	forces	involved	in	primary	TBI	can	affect	the	SVZ	directly	and	
therefore	affect	neurogenesis.	For	instance,	cranial	compressive	force	can	tear	
the	lateral	ventricle	lining	and	increase	intracranial	pressure.	Hemorrhages	
(epidural,	intracranial,	extradural)	can	cause	a	persistent	increase	in	intracranial	
pressure	and	increase	in	lateral	ventricular	pressure.	Hemorrhages	can	lead	to	
obstructive	hyrocephalus	and	lead	to	lateral	ventricular	hydrostatic	pressure.	
Hydrocephalus	has	been	shown	to	cause	mechanical	damage	to	the	lateral	
ventricular	wall	(Bruni	et	al	1985,	Sarnat	1995).	Additionally,	brain	edema,	which	
is	part	of	the	mid-term	secondary	injury	process,	leads	to	elevated	intracranial	
pressure.	In	contrast,	cortical	lesions	with	extensive	brain	matter	loss	lead	to	
enlarged	ventricle	volume	(Reider-Groswasser	et	al	2002).	These	are	the	possible	
mechanical	stresses	that	can	affect	the	SVZ	stem	cell	environment.																						
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The	mechanism	for	stem	cell	responses	to	mechanical	forces	has	been	described:	
for	instance	β-catenin/Wnt	signaling	:	β-catenin	can	translocate	to	the	nucleus	in	
response	to	increased	mechanical	force.	In	the	nucleus,	β-catenin	inhibits	cell	
cycle	exit	and	this	leads	to	an	increase	in	proliferation	(Chenn	&	Walsh	2002).		
	 Ependymal	cells	are	ciliated	cells	lining	the	lateral	ventricle	wall	and	are	the	
first	part	of	the	SVZ	structure.	These	ciliated	cells	affect	SVZ	fluid	dynamics	and	
form	a	barrier	that	separates	the	fluid	of	the	lateral	ventricle	and	the	SVZ	cells	by	
tight	junctions	with	each	other	(Mitro	&	Palkovits	1981).	It	is	thought	that	TBI	
affects	the	strength	of	these	ependymal	tight	junctions	in	addition	to	other	
extracellular	interactions,	which	can	lead	to	enlarged	ventricles.	Ventricular	
enlargement	can	be	modeled	in	the	rat	by	kaolin	administration,	which	leads	to	
communicating	hydrocephalus.	This	model	demonstrated	that	there	is	a	transient	
increase	in	the	number	of	SVZ	Nestin+	cells,	which	are	mature	neurons,	in	
communicating	hydrocephalus.		
	 There	is	some	evidence	to	suggest	that	more	neuroblasts	survive	after	TBI	
compared	to	normal	animals.	For	instance,	in	a	mouse	transgenic	model	of	TBI	
using	CCI,	SVZ	proliferative	cells	were	labeled	by	yellow	fluorescence	protein	
(YFP).	After	a	period	of	6	weeks	post-TBI,	the	number	of	YFP+/DCX+	double	
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positive	cells	was	increased	in	the	dorsolateral	SVZ	but	few	were	found	in	the	TBI	
lesion	area	(Mierzwa	et	al	2014).	Another	separate	study	found	very	few	mature	
neurons	in	the	perilesional	area	28	days	after	injury	(Goodus	et	al	2014).	
Furthermore,	the	SVZ	is	a	distinct	niche	compared	to	areas	that	the	neuroblast	
migrate	to	such	as	the	corpus	callosum	or	the	cortex;	and	these	different	niches	
affect	differentiation	of	newly	proliferated	cells	differently.	For	instance,	one	
interesting	study	found	that	newly	generated	SVZ	cells	that	migrated	to	the	
corpus	callosum	after	TBI	became	oligodendrocytes.	In	contrast,	those	that	
migrated	to	the	perilesional	area	became	astrocytes	(Goings	et	al	2004).	Another	
study	found	that	most	BrdU	positive	cells	in	the	perilesional	area	were	either	
positive	for	Iba1	or	GFAP	but	not	NeuN	(Radomski	et	al	2013).	Overall,	there	is	
strong	evidence	for	TBI	increasing	the	survival	and	migration	of	SVZ	derived	cells;	
yet	evidence	for	the	differentiation	of	these	new	SVZ-derived	cells	into	
functionally	relevant	new	cortical	neurons	is	limited.		
Detection	of	Neurogenesis	by	Measuring	Cell	Proliferation	
	 Cell	proliferation	is	a	critical	parameter	of	neurogenesis:	Cell	proliferation	
gives	rise	to	new	cells	in	the	SVZ	because	it	contains	cells	with	proliferative	
capacity	(stem	cells).	Cell	proliferation	is	most	commonly	assessed	using	5-Bromo-
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2”-deoxyuridine	(BrdU)	labeling.	BrdU	is	injected	into	an	animal	or	introduced	into	
the	media	of	an	in	vitro	system,	and	cells	that	are	actively	dividing	will	take	up	this	
DNA	nucleotide	analog	and	incorporate	it	into	the	genome.	Monoclonal	
antibodies	against	BrdU	are	used	to	detect	it	in	cells.	BrdU	labeling	detects	cells	
that	are	in	the	S-phase	of	the	cell	cycle;	however,	there	are	some	thoughts	that	
reporting	a	pure	number	of	BrdU+	cell	is	less	useful	than	measuring	what	is	called	
the	“labeling	index”	which	is	basically	the	percentage	of	cells	that	are	BrdU+	
(Chang	et	al	2016).	In	addition	to	using	BrdU	to	detect	the	population	of	cells	that	
have	undergone	proliferation,	intrinsic	markers	of	the	cell	cycle	can	also	be	used.	
For	instance,	proliferative	cell	nuclear	antigen	(PCNA)	and	Ki67	are	the	two	most	
widely	used	markers.		
	 There	are	some	interesting	differences	in	how	the	SVZ	of	rat	and	mouse	
response	to	a	cortical	injury	with	the	caveat	that	these	results	are	from	multiple	
labs	using	different	models	of	TBI.	Generally,	proliferation	increases	after	TBI,	but	
only	transiently	before	going	back	to	baseline.	There	are	several	studies	in	the	
mouse	that	indicate	that	proliferation	decreases	after	TBI	(Goings	et	al	2002,	
Jankovski	et	al	1998).	In	the	rat,	multiple	studies	looking	at	proliferation	at	
different	time	points	after	TBI	seem	to	indicate	that	there	are	four	distinct	phases	
in	the	SVZ	proliferative	response	(Chang	et	al	2016).	During	the	first	five	days,	
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proliferation	appears	to	be	unchanged;	between	5	days	and	seven	days,	
proliferation	peaks	with	about	100%	increase	over	baseline;	from	the	peak	at	7	
days,	proliferation	remains	high	but	slowly	declines	and	comes	back	to	baseline	at	
4	weeks	after	TBI	(Bye	et	al	2011).	However,	by	8	weeks	after	TBI,	baseline	
proliferation	is	decreased	by	about	50%	(Acosta	et	al	2013).			
SVZ	Proliferation	in	Humans	After	TBI	
	 	There	is	considerable	evidence	for	SVZ	proliferation	in	humans.	For	
instance,	children	two	years	old	and	younger	have	a	high	level	of	constitutive	SVZ	
proliferation.	However,	in	adults,	evidence	has	not	been	as	strong.	One	study	
found	that	after	18	months	of	age,	proliferation	along	the	RMS	and	SVZ	are	not	
detectable	(Sanai	et	al	2011).	On	the	contrary,	another	study	found	that	there	are	
migrating	doublecortin	positive	cells	(DCX+)	in	the	RMS	and	olfactory	bulb	in	
adults	(Wang	et	al	2011).	Furthermore,	using	a	novel	technique	of	carbon	(14C)	
dating,	proliferative	SVZ	and	striatal	neurogenesis	was	detected	in	adult	brains	
(Bergmann	et	al	2012,	Ernst	et	al	2014).	14C	is	an	isotope	of	carbon	that	is	
elevated	following	terrestrial	nuclear	bomb	testing.	The	use	of	this	carbon	dating	
technique	is	very	useful	in	birth	dating	neural	cells;	however,	it	requires	highly	
specialized	equipment.	Other	alternative	techniques	that	had	recently	been	used	
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to	investigate	human	neurogenesis	are	non-invasive	magnetic	resonance	imaging	
(MRI)	and	positron	emission	tomography	(PET)	(Jessberger	&	Gage	2014).	
However,	these	imaging	techniques	at	this	point	still	lack	specificity	and	
resolution	to	accurately	detect	neurogenesis	in	humans.	
	 Following	TBI,	one	post-mortem	study	looked	at	brain	tissue	of	a	group	of	
children;	6	had	TBI	and	7	were	non-TBI	controls.	They	detected	no	differences	in	
the	number	of	DCX+	cells	(Taylor	et	al	2013).	On	the	contrary,	a	separate	group	
found	that	adult	patients	following	TBI	expressed	a	higher	number	of	cortical	
DCX+,	PSA-NCAM+	and	SOX2+	cells,	all	of	which	are	markers	indicative	of	
neurogenesis	(Zheng	et	al	2013).	Overall,	more	complete	human	studies	are	
needed	to	definitively	evaluate	if	TBI	has	an	effect	on	SVZ	proliferation;	for	
instance,	better	use	of	markers	for	proliferation,	better	control	of	TBI	type,	age,	
and	timing	are	needed	for	conclusive	results.		
	 It	had	been	thought	that	for	the	therapeutic	potential	of	stem	cells	to	be	
fully	realized,	the	newly	produced	cells	must	migrate	from	the	site	that	they	are	
produced	(in	this	case	the	SVZ)	to	the	lesion	area.	In	adult	rodents,	newly	
produced	immature	neurons,	i.e.,	neuroblasts,	migrate	from	the	SVZ	to	the	OB	
along	the	RMS	in	strings	in	chain	migration,	which	is	in	part	assisted	by	a	network	
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of	astrocytes	(Jankovski	&	Sotelo	1996,	Lois	et	al	1996).	In	the	event	of	a	CNS	
injury,	the	stream	of	migrating	neuroblasts	are	induced	to	migrate	out	in	both	
chains	and	as	individual	cells.	Diffusible	protein	signaling	is	thought	to	be	playing	a	
role	in	attracting	neuroblast	migration	toward	the	lesion	area	(chemoattractants).	
Astrocytes	in	the	lesion	area	secrete	SDF-1,	which	has	been	shown	to	increase	
mobility	of	neuroblasts	(Kokovay	et	al	2010).	In	the	mouse,	OB	transection	
experiments	in	which	the	RMS	is	cut	has	shown	that	neuroblasts	accumulate	
posterior	to	the	cut	and	that	these	cells	migrate	toward	the	cortical	lesion	and	
striatum	(Jankovski	et	al	1998).	It	was	found	that	in	response	to	cortical	TBI,	
neuroblasts	migrate	out	of	the	RMS	in	chain	formation	and	enter	into	the	corpus	
callosum;	however,	when	they	go	into	the	cortex,	they	migrate	as	individual	cells	
which	suggest	there	are	multiple	mechanisms	of	migration	of	neuroblasts	after	
injury	(Kempermann	2011).	The	evidence	for	neuroblast	migration	toward	the	
injury	site	in	humans	is	less	convincing.	One	post-mortem	study	looking	at	brain	
tissue	from	children	less	than	10	years	old	detected	the	presence	of	DCX+	cells	
that	had	the	morphology	of	migratory	cells;	these	DCX+	cells	were	negative	for	
astrocyte,	microglia	or	macrophage	markers	(Taylor	et	al	2013).		
The	limited	endogenous	stem	cell	response	means	that	finding	a	
pharmacological	means	of	increasing	this	intrinsic	stem	cell	response	might	be	
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useful	in	treating	TBI.	To	this	end,	there	are	many	potential	therapies	that	have	
shown	good	promise	in	experimental	models.	A	study	using	activated	protein	C	
delivered	intraperitoneally	to	mice	increased	post-TBI	neuroblast	proliferation	
and	migration	to	the	perilesional	area	(Petraglia	et	al	2010).	Furthermore,	
administration	of	colony-stimulating	factor	(GCSF)	after	TBI	was	shown	to	lead	to	
increased	DCX+	cells	in	the	SVZ	(Yang	et	al	2010).	One	group	showed	that	either	
GCSF	and/or	human	umbilical	cord	blood	cell	(hUBC)	significantly	increased	SVZ	
and	hippocampal	DCX+	cells	8	weeks	after	TBI	(Acosta	et	al	2014).	Infusion	of	
growth	factors	was	shown	to	increase	some	aspect	of	SVZ	neurogenesis	and	could	
theoretically	be	a	potential	treatment	for	TBI.	For	instance,	administration	of	
BDNF	and	its	molecular	mimetic	resulted	in	SVZ	derived	cells	migrating	toward	
adjacent	nuclei	(Benraiss	2001).	EGF	and	FGF2	administration	led	to	higher	SVZ	
proliferation	(Kuhn	et	al	1997).	TGF-a	administration	resulted	in	higher	striatal	
accumulation	of	SVZ	derived	cells	(Craig	et	al	1996).	Extra-cellular	matrix	(ECM)	
molecules	and	cell	surface	protein	can	also	play	a	role	in	neurogenesis.	Matrix	
metalloproteinase	(MMP)	regulates	ECM	molecules	by	degrading	them	and	also	
plays	a	role	in	regulating	neurogenesis.	The	cell	surface	proteins	EphrinB3	and	
EphB3	can	control	SVZ	neurogenesis	via	a	p53	dependent	mechanism	(Theus	et	al	
2010).	While	these	experimental	means	to	increase	neurogenesis	have	yielded	
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interesting	cellular	responses,	further	work	needs	to	be	done	to	evaluate	their	
functional	relevance	and	to	identify	any	negative	outcomes.	Overall,	in	order	to	
identify	worthwhile	therapies	for	use	in	the	clinics,	significant	improvements	in	
the	standardization	of	animal	models	for	TBI	and	the	behavioral	tasks	used	to	
evaluate	these	animals	are	needed.	
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CHAPTER	THREE	
METHODS	
Animal	Subjects	
	 Male	Sprague	Dawley	rats	(Harlan,	IN),	2	month	old	at	the	beginning	of	the	
experiments,	were	used	in	our	study	(total	animal	number:76)	(Table	3	and	4).	
Rats	were	housed	as	a	pair	in	each	cage	in	a	fully	accredited	animal	care	facility	
with	a	12-hour	light/dark	cycle.	Food	and	water	was	available	ad	libitum.	
Experiments	were	approved	by	the	Hines	VA	Institutional	Animal	Care	and	Use	
Committee.		All	animals	were	number	coded	and	investigators	were	blinded	to	
the	animal	treatment	groups.		
Alcohol	Administration	
	 Rats	were	administered	three	consecutive	doses	of	alcohol	by	gastric	
gavage	at	a	dose	of	(3g/kg,	i.g.	of	40%	alcohol)	once	per	day	for	three	days	
(Figures	5	and	6).	A	curved	stainless	steel	gavage	needle	with	a	smooth	rounded	
ball	head	was	used	along	with	a	5cc	syringe	to	administer	the	alcohol	(Oregon	
State	University,Laboratory	Animal	Resources	Center,	2011).	Additionally,	the	
gavaging	needle	was	lubricated	with	food-safe	lubricant;	all	animals	tolerated	the	
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gavage	procedure	with	no	adverse	effects.		Control	animals	received	an	equal	
volume	of	water,	given	using	an	identical	dosing	schedule.	This	alcohol	dose	leads	
to	blood	alcohol	levels	typical	of	a	TBI	patient	entering	the	emergency	room	
(150mg/dl)	(Bombardier	&	Thurber	1998)	and	was	well	tolerated	by	these	rats	
which	lead	to	no	adverse	weight	loss	during	the	three	days	administration	
window.	Furthermore,	this	dosing	regimen	has	been	adapted	from	one	previously	
used	to	mimic	binge	drinking	(Przybycien-Szymanska	et	al	2010).	One	hour	after	
the	last	gavage	administration,	animals	were	either	subjected	to	a	moderate	brain	
injury	using	the	controlled	cortical	impact	model	(CCI)	of	TBI	or	given	a	sham	
surgery	(Figures	5	and	6).		
Blood	Alcohol	Level	Quantification	
	 Approximately	250ul	to	500ul	of	blood	was	drawn	for	the	tail	vein	of	each	
rat	immediately	following	the	TBI	surgery.	Blood	was	then	allowed	to	clot	on	ice	
for	five	minutes	and	centrifuged,	to	separate	the	serum.	Alcohol	concentration	
was	measured	using	alcohol	reagent	set	(Pointe	Scientific,	Canton	MI,	USA).	The	
alcohol	reagent	set	relies	on	an	enzymatic	method	to	detect	ethyl	alcohol:	 
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Table	3	and	4:	Animal	numbers	and	groups	for	Aim	1	and	Aim	2	respectively.	
Animals	were	randomly	assigned	to	each	of	the	4	experimental	groups,	either	
with	alcohol	or	vehicle	and	TBI	or	sham.		
Alcohol	dehydrogenase	(ADH)	catalyzes	the	reaction	of	ethanol	to	acetaldehyde	
with	the	concomitant	reduction	of	NAD+	to	NADH;	this	leads	to	a	change	in	
absorbance	at	340	nm	which	is	directly	proportional	to	the	ethanol	concentration	
in	the	sample.	The	serum	samples	were	de-proteinized	using	6.25%	
trichloroacetic	acid;	0.9%	sodium	chloride	was	used	as	the	non-serum	blank.	
Samples	were	loaded	onto	96	well	plates	at	a	sample/reagent	ratio	of	1:201,	
incubated	at	30°C	for	5	minutes,	and	the	absorbance	was	read	at	30°C.	A	
standard	curve	was	generated	for	each	assay	run	from	the	known	ethanol	
samples.	Sample	measurements	were	done	in	duplicate	and	the	values	averaged	
Table 3. Experimental Groups for Aim 1 
Group Alcohol TBI 24 
hrs 
1 week 
1 - - 6 6 
2 - + 6 7 
3 + - 6 6 
4 + + 6 7 
Subtotal 24 26 
Total 50 
Table 4. Experimental Groups for Aim 2 
Group Alcohol TBI 6 weeks 
1 - - 6 
2 - + 7 
3 + - 6 
4 + + 7 
Total 26 
74	
	
for	each	animal.	Known	high	and	low	alcohol	controls	were	always	run	along	with	
unknown	samples	and	the	resultant	alcohol	concentration	values	for	the	controls	
were	always	within	acceptable	range	(+/-	5%).		
Figure	5:	Experimental	design	for	Aim	1.	Rats	experienced	3	consecutive	daily	
doses	of	alcohol	binge.	One	hour	after	the	last	alcohol	dose,	animals	undergo	TBI	
surgery.	Animals	sacrificed	at	24	hours	after	TBI	received	only	1	dose	of	BrdU	
injection	by	i.p	at	the	time	of	TBI.	Animals	sacrificed	at	7	days	received	7	
consecutive	daily	doses	of	BrdU.		
Figure	6:	Experimental	design	for	Aim	2.	Rats	experienced	binge	alcohol,	TBI	and	
BrdU	injections	identically	to	those	in	Aim	1.	Animals	survived	for	6	weeks	
following	TBI.	
	
	
	
TBI BrdU Injections (100mg/kg/day, 
7days) 
3 Days Alcohol Binge  
(3g/kg/day) 
Lesion Analysis 
Immunohistochemistry 
Stereology Euthanize at 6 
weeks post 
TBI 
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TBI	Model	
	 All	rats	were	anesthetized	using	75mg/ml	of	isoflurane	delivered	as	an	
inhalant	with	5%	oxygen.	The	TBI	was	delivered	using	a	double	acting	magnetic	
piston	mounted	on	a	stereotaxic	crossbar,	angled	for	cortical	impact	(diameter:	3	
millimeters,	velocity:	2.5	meters/second,	depth:	2	millimeters,	dwell	time:	250	
milliseconds).	Animals	were	secured	in	a	stereotaxic	frame	and	a	midline	incision	
was	made	and	the	skin	was	pulled	back.	The	analgesic	buprenorphine	was	
administered	locally	near	the	skin	incision	(0.1cc).	Using	a	trephine,	a	disc	of	skull	
bone	was	removed	above	the	forelimb	area	of	the	sensorimotor	cortex	(1	
millimeter	anterior,	1.5	millimeter	lateral	from	bregma)	on	the	right	hemisphere.	
Saline	solution	(0.9%)	was	used	during	the	trephine	process	to	minimize	heat.	
Before	the	impactor	was	placed	in	position,	the	dura	layer	covering	the	brain	was	
carefully	removed.	This	impact	resulted	in	a	reproducible	lesion,	typified	by	both	
focal	and	diffuse	brain	damage.	Sham	animals	were	treated	identically	
(anesthetized,	skin	incision,	etc),	apart	from	the	piston.	The	CCI	model	has	the	
advantage	that	it	allows	the	experimenter	to	control	precisely	the	physical/kinetic	
variables	of	the	injury	(velocity,	dwell-time,	diameter,	etc).	In	our	model,	this	
injury	leads	to	prolonged	deficit	on	the	skilled	forelimb-reaching	task.	Most	
importantly,	the	CCI	model	is	clinically	relevant,	leading	to	the	histological	
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sequelae	often	seen	in	humans	after	TBI:	epidural	and	subdural	hematoma	as	well	
as	intraparenchymal	petechial	hemorrhages.	Following	the	surgery,	rats	were	
closely	monitored	for	complications;	rats	were	able	to	ambulate	and	eat	normally	
in	less	than	three	hours	post	injury.		
Bromodeoxyuridine	(BrdU)	Administration	
	 Bromodeoxyuridine	(BrdU)	is	an	analog	of	the	nucleoside	thymidine	that	
can	be	incorporated	into	the	DNA	during	DNA	synthesis.	During	cell	division,	
extensive	DNA	synthesis	occurs	in	the	genome	prior	to	physical	cell	division	thus	
BrdU	incorporation	is	a	stable	marker	for	proliferation	(Taupin	2007).	Commonly,	
BrdU	is	administered	through	intraperitoneal	(i.p.)	injection,	and	it	is	estimated	
that	BrdU	is	available	for	labeling	proliferating	cells	in	the	brain	for	approximately	
two	hours	after	administration	(Taupin	2007).	BrdU	can	be	detected	histologically	
using	monoclonal	antibodies	and	combined	with	labeling	various	cell	phenotype	
markers;	this	essentially	allows	for	the	birthdating	and	cell-type	determination	of	
newborn	cells.		
	 There	is	a	dose-dependent	effect	of	BrdU	administration	on	the	number	of	
labeled	cells	in	the	proliferative	brain	regions	saturating	at	around	200mg/kg.	This	
dose	has	been	found	to	maximally	label	proliferating	cells	in	the	dentate	gyrus	
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after	stimulating	proliferation	with	exercise	(Cameron	&	Mckay	2001,	Eadie	et	al	
2005).	For	long-term	assessment	of	newborn	cell	phenotypes,	it	is	necessary	to	
administer	multiple	doses	of	BrdU	spaced	further	apart	to	mitigate	the	effects	of	
BrdU	dilution	over	successive	cell	divisions.		
	 In	this	dissertation,	two	separate	BrdU	injection	paradigms	were	used.	In	
both	cases,	BrdU	was	prepared	at	20mg/mL	in	sterile	saline.	The	solution	was	
warmed	in	a	water	bath	and	repeatedly	vortex-mixed	until	dissolved	and	then	
sterile-filtered	through	a	0.22	um	syringe	filter.	To	measure	short-term	cellular	
proliferation,	a	single	injection	of	BrdU	at	100mg/kg	body	weight	(i.p.)	was	
injected	immediately	after	TBI	followed	by	sacrifice	24	hours	after.	For	mid-term	
determination	of	cell	proliferation	and	long-term	determination	of	newborn	cell	
phenotypes,	BrdU	was	injected	at	100mg/kg	(i.p.)	starting	immediately	following	
TBI	and	continuing	once	a	day	for	the	next	six	days.	Rats	were	anesthetized	with	
isoflurane	during	BrdU	injection	to	minimize	discomfort.					
	 BrdU	labeling	is	advantageous	compared	to	staining	for	endogenous	
proliferation	markers	such	as	Ki67	or	PCNA	(Proliferating	Cell	Nuclear	Antigen)	
because	of	its	short	half-life;	this	property	of	BrdU	essentially	allows	us	to	birth-
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date	the	new	cells.	BrdU	was	injected	after	TBI,	labeling	only	the	proliferative	
response	after	TBI.	
Perfusion,	Tissue	Processing,	and	Histology	
	 At	various	time	points,	rats	were	overdosed	with	Euthasol	
(phenytoin/pentobarbital;	390	mg/kg	i.p.)	and	transcardially	perfused	with	cold	
heparinized	saline	followed	by	4%	paraformaldehyde	(PFA).	Brains	were	extracted	
and	post-fixed	overnight	at	4°C	in	4%PFA,	then	cryoprotected	in	30%	sucrose	in	
phosphate	buffer	pH	7.4	until	sinking.	Brains	are	then	frozen	in	Optimal	Cutting	
Temperature	Compound	(OCT)	for	cryosectioning.	Sections	(40	μm)	were	cut	on	a	
cryostat	and	stored	in	ethylene	glycol-based	antifreeze	cryoprotectant	at	-20°C	
until	use.	BrdU	requires	an	antigen	retrieval	procedure	to	be	identified	
immunohistochemically.	Our	method	was	adapted	from	(Tang	et	al	2007),	where	
tissue	sections	were	subjected	to	high	heat	(99-100°	C)	sodium	citrate	solution	for	
10-15	min.	This	method	was	preferable	to	hydrochloric	acid-based	procedures	
since	this	severely	weakens	subsequent	DNA	staining,	such	as	with	DAPI	or	
Hoechst.	However,	incubation	of	free-floating	sections	in	boiling	sodium	citrate	
leads	to	excessive	wrinkling	of	the	tissue	that	impairs	downstream	processing	
steps.	Therefore,	we	adapted	a	staining	method	where	the	tissue	sections	were	
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extensively	washed	in	phosphate	buffer	pH	7.4,	mounted	on	plus-charged	slides,	
and	then	allowed	to	dry	overnight	at	room	temperature.	The	following	day,	the	
slides	were	incubated	in	99-100°	10	mM	sodium	citrate	pH	6,	which	had	been	
placed	in	a	container	in	a	boiling	water	basin,	for	10	minutes.	The	slides	were	then	
removed	and	immediately	immersed	in	room	temperature	phosphate	buffer	pH	
7.4.	From	there,	the	tissue	sections	were	carefully	removed	from	the	slides	using	
a	razor	blade	and	rinsed	in	phosphate	buffer.	We	found	that	using	this	strategy,	
tissue	wrinkling	was	nearly	eliminated,	while	still	allowing	us	to	perform	free-	
floating	tissue	staining	(which	allows	for	better	antibody	penetration)	on	thick	
tissue	sections	(which	are	required	for	the	optical	fractionator	stereology	probe).	
	 This	procedure	led	to	bright	BrdU	staining	that	was	compatible	with	general	
DNA	labeling	using	DAPI,	as	described	by	Tang	and	colleagues	(Tang	et	al	2007).	
However,	we	experienced	very	high	white	matter	nonspecific	fluorescence,	as	if	
the	white	matter	had	become	extremely	“sticky”	to	antibodies.	This	was	traced	to	
the	use	of	high	concentrations	of	the	detergent	Triton	X100	in	the	incubation	
buffers.	Switching	to	Tween-20	greatly	reduced	the	background	fluorescence	and	
was	therefore	used	in	all	steps	after	high	heat	antigen	retrieval.		
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	 Immunostaining	was	performed	by	diluting	primary	antibodies	in	
phosphate-	buffered	saline	(PBS)	pH	7.4	plus	0.2%	Tween-20	(when	high	heat	
antigen	retrieval	was	used)	or	0.3%	Triton-X100	(when	no	antigen	retrieval	was	
used).	Tissue	sections	were	then	incubated	in	primary	antibody	solution	overnight	
at	4°	C	with	gentle	agitation.	The	following	day,	the	tissue	sections	were	
extensively	washed	in	PBS/0.2%	Tween	20	(for	high	heat	antigen	retrieval)	or	
phosphate	buffer	pH	7.4	(when	antigen	retrieval	was	not	performed).	The	
sections	were	then	incubated	in	fluorophore-	or	biotin-conjugated	secondary	
antibodies	in	the	same	dilution	buffers	listed	above	for	2	hours	at	room	
temperature	with	shaking,	and	then	washed.	For	fluorescent	imaging,	nuclei	were	
counterstained	with	DAPI,	then	mounted	on	gelatin-subbed	slides	and	
coverslipped	with	Fluoromount	G	anti-fade	mounting	media.	For	signal	detection	
with	the	chromogenic	substrate	diaminobenzidine	(DAB),	tissue	sections	were	
incubated	in	avidin-biotin-	peroxidase	complex	(Vector	Laboratories,	1	drop	
component	A	plus	1	drop	component	B	per	5	mL	dilution	buffer,	as	above)	for	1	
hour	at	room	temperature.	Lastly,	sections	were	reacted	in	nickel-enhanced	DAB	
in	the	presence	of	hydrogen	peroxide	to	visualize	the	target	antigens.	
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Marker/Antigen	 Abbreviation	 Class	or	
function	
Associated	
cell	type	
Antibody	
source;	host;	
concentration	
Glial	fibrillary	
acidic	protein	
GFAP	 Intermediate	
filament	
Astrocytes;	
neural	stem	
cells	in	SVZ	
and	DG	
DAKO	Z0334;	
Rabbit;	
1:1000	(IF)	
Doublecortin	 DCX	 Microtubule-
associated	
protein	
Immature	
neurons	in	
SVZ	and	DG	
	
CellSignaling;	
Rabbit;	1:500	
(IF)	
Ionized	binding	
adapter	
molecule	1	
Iba1	(aka	
AIF1)	
EF-hand	
containing	
calcium	
binding	
protein	
Microglia,	
macrophages	
Wako	019-
19741;	
Rabbit,	
1:5000	(IHC)	
5-bromo-2’-
deoxyuridine	
BrdU	 Thymidine	
analog	
Incorporate	
into	cell	
during	DNA	
synthesis,	a	
marker	of	
proliferation	
Thermo	MA3-
071;IgG2a;	
1:500(IF);	
1:4000	(IHC)	
Neuronal	nuclei	 NeuN	(aka	
Fox3)	
RNA	splicing	
factor	
Mature	
neurons	
Millipore	
MAB377	(Ms	
IgG1);	ABN78	
(rabbit);	
1:1000	(IF)	
4’,6-diamidino-
2-phenylindole	
DAPI	 DNA	minor	
groove	
binder	
DNA	 IF	
Table	5:	Summary	of	cell-type	markers	and	antibodies	used	in	this	dissertation.	IF:	
immunofluorescence;	IHC:	Immunohistochemistry	(with	avidin-peroxidase	
complex	and	DAB	detection).	
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Unbiased	stereology		
	 Unbiased	stereology	is	a	method	of	estimating	properties	(number,	length,	
volume,	etc.)	of	three-dimensional	structures	from	tissue	sections	without	making	
assumptions	about	the	size,	shape,	or	orientation	of	the	objects	of	interest	
(Peterson	1999).	Various	stereology	“probes”	can	be	applied	to	tissue	sections	to	
estimate	these	quantities	(Table	6).	One	of	these	probes,	the	optical	fractionator,	
is	designed	to	quantify	the	number	of	features	(for	example,	cells)	within	a	region	
of	interest.	The	software-based	optical	fractionator	probe	superimposes	a	grid	
with	counting	boxes	at	systematically-spaced	intervals,	and	features	within	the	
box	are	counted	with	specific	counting	rules	after	excluding	“guard	zones”	at	the	
tissue	surfaces	(Figure	7).	An	estimate	of	the	total	number	of	features	within	the	
brain	structure	of	interest	is	calculated	by:	
	
	 Where	‘N’	is	an	estimate	of	the	total	number	of	features,	ΣQ-	is	the	the	sum	
of	the	counted	features,	ssf	is	the	section	sampling	fraction	(for	example,	1/6	if	1	
of	every	6	sections	is	examined),	asf	is	the	area	sampling	fraction	(the	proportion	
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where ‘N’ is an estimate of the total number of features, ΣQ- is the the sum of the counted 
features, ssf is the section ampling fraction (for exa e, 1/6 if 1 of every 6 sections is 
examined), asf is the area sampling fraction (the proportion of the initially defined area that 
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of	the	initially	defined	area	that	is	sampled),	and	tsf	is	the	thickness	sampling	
fraction	(the	fraction	of	the	tissue	section	thickness	that	is	sampled).		
	 Use	of	the	optical	fractionator	is	warranted	in	studying	cellular	proliferation	
in	the	subventricular	zone,	as	the	number	of	proliferating	cells	is	high	and	
generally	evenly	distributed,	especially	in	the	dorsolateral	SVZ.	However,	the	
optical	fractionator	is	less	useful	for	studies	of	neural	precursor	proliferation	in	
the	dentate	gyrus,	where	proliferating	cells	are	often	found	in	discrete	clusters	
with	large	spaces	in	between	(Noori	&	Fornal	2011).	For	this	reason,	and	because	
of	the	lower	level	of	cellular	proliferation	in	the	DG	versus	the	SVZ,	absolute	
counting	has	been	advised	(Noori	&	Fornal	2011).		
Type	of	Measurement	 Probe	Used	
Cell	Size	 Nucleator	
Cell	Shape	 Isotrophic	Fakir	
Cell	Number	 Optical	Fractionator	
Table	6:	Different	types	of	probes	commonly	used	in	unbiased	stereology.	
	
84	
	
	
Figure	7:	Stereology	method	for	counting	cells	in	the	SVZ.	A.	Schematic	of	a	
theoretical	structure	demonstrating	random	unbiased	sampling.	The	sampled	
volumes	are	the	four	solid	cubes	within	the	structure.	The	lower	figure	
demonstrate	the	2-D	cross	section	of	the	above	theoretical	structure	with	
example	cell	number	represented	by	the	purple	colored	dots.	The	total	number	of	
cells	in	the	theoretical	structure	is	a	function	of	mean	cell	density	and	volume	of	
the	structure	(described	by	the	stereology	equation).	B.	Our	approach	to	
quantifying	SVZ	cells	by	stereology.	Sections	were	collected	from	anterior	to	
posterior	SVZ	and	the	outline	tracings	of	the	representative	SVZ	are	shown	
bellow.	C.	High	magnification	view	of	the	SVZ	with	DAB	staining	for	BrdU.	The	
colored	box	is	called	the	optical	dissector	window.	D.	Schematic	representation	of	
the	optical	dissector	window	illustrating	the	stereology	counting	rules.	All	cell	
counting	was	performed	on	MBF	Bioscience	Leica	DM400B	with	Stereo	
Investigator	version	9.0.	
Anterior Posterior 
1 2 3 4 
A. 
B. 
C. 
D. 
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Lesion	analysis		
	 Brains	were	coronally	cryosectioned	at	40	μm	and	alternating	sections	were	
mounted	on	gelatin-coated	slides	and	stained	for	Nissl	substance	(excluding	
olfactory	bulbs	and	cerebellum).	The	TBI	lesion	volume	was	quantified	from	
1.4mm	to	2.5mm	relative	to	bregma	using	the	method	outlined	in	(Kawamata	et	
al	1997),	(the	total	area	of	the	uninjured	contralateral	hemisphere-total	area	of	
the	injured	(ipsilesional)	hemisphere,	divided	by	the	intact	hemisphere).	The	
lesion	size	was	thus	expressed	as	a	percentage	of	the	unlesioned	contralateral	
hemisphere.	Nissl	stained	slides	were	then	scanned	at	high	resolution	using	a	
flatbed	scanner	and	imported	into	Adobe	Photoshop	CS5,	where	the	number	of	
pixels	in	the	intact	and	lesioned	hemispheres	were	measured.		
Statistics	
	 All	data	analysis	was	performed	using	either	Minitab	version	17	(Minitab,	
Inc.	State	College,	Pennsylvania,	USA)	or	Graphpad	Prism	version	5.0	(GraphPad	
Software,	San	Diego	California,	USA).	Daily	animal	weights	were	fitted	using	a	
nonlinear,	third	order	polynomial	(cubic)	regression.	Lesion	volume	comparisons	
were	done	using	Student’s	t-test	with	α=0.05	as	the	cutoff	for	statistical	
significance.	BrdU	stereological	counting	results	was	analyzed	by	using	general	
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linear	model	two-way	ANOVA	to	detect	interactions	between	alcohol	treatment	
and	TBI	injury;	to	compare	if	means	of	treatment	groups	were	significantly	
different,	WITH-IN	group	analysis	was	performed	using	regression	analysis	with	
α=0.05	as	the	cutoff	for	statistical	significance.	For	7	days	post	TBI	groups,	cell	
count	data	was	transformed	on	the	natural	log	scale	to	stabilize	variance	and	
achieve	normality.		For	6	weeks	post	TBI	groups,	the	cell	count	data	was	
transformed	using	the	optimal	(Box-Cox)	transformation	to	stabilize	variance	and	
achieve	normality.		
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CHAPTER	FOUR	
	RESULTS	
AIM	1:	THE	SHORT-TERM	EFFECTS	OF	BINGE	ALCOHOL	AND	TRAUMATIC	
BRAIN	INJURY	ON	STEM	CELL	RESPONSES	
Gavage	results	in	intoxicating	BAL	and	decreased	animal	weight	
Blood	Alcohol	Level	(BAL)	
	 Rat	blood	alcohol	levels	were	determined	by	taking	500ul	of	blood	via	tail	
veinipuncture	one	hour	after	the	last	dose	of	3g/kg;	this	was	the	same	time	that	
the	animals	received	an	experimental	TBI	by	the	CCI	method.	The	mean	BAL	level	
of	this	cohort	of	animals	was	156.1mg/dL	with	a	standard	error	of	8.3mg/dL	
(figure	8A).		
Rat	Weights	
	 Rats	in	the	TBI	groups	were	weighed	during	a	14	day	period	during	which	
they	underwent	acclimatization,	binge	alcohol	administration,	and	experimental	
TBI	(Figure	8B).	During	the	acclimatization	period	(day	1	to	day	4),	there	were	no	
significant	differences	between	treatment	groups	(p>0.05).		During	the	three	days	
of	binge	alcohol	administration	(day	5	to	day	7),	there	were	also	no	significant	
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differences	between	treatment	groups	(p>0.05).	During	the	recovery	period	after	
TBI	(day	8	to	day	14),	the	weights	of	the	alcohol	binge	group	were	significantly	
lower	compared	to	the	vehicle	administration	group	at	two	time	points,	day	
11(means	306	grams	versus	318	grams	respectively)	and	day	13	(310	grams	
versus	319	grams	respectively),	(p<0.05).		
Lesion	Analysis	
	 The	lesion	was	confined	to	the	right	unilateral	cortical	region	of	the	
sensorimotor	cortex,	with	the	center	of	the	lesion	approximately	at	1.5mm	
anterior,	2.5mm	lateral	from	bregma.	Lesion	size	was	quantified	for	both	vehicle	
and	binge	alcohol	groups	at	24	hours	after	TBI	and	7	days	after	TBI.	At	24	hours	
post	TBI,	lesion	size	was	not	significantly	different	between	vehicle	TBI	and	
alcohol	TBI	groups	(mean	lesion	size	was	7.2%	and	5.5%	respectively)	(Figure	9A).	
At	7	days	post	TBI,	lesion	size	was	also	not	significantly	different	between	vehicle	
TBI	and	alcohol	TBI	groups	(mean	lesion	size	was	6.4%	and	9.4%	respectively)	
(Figure	9B).	
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Acute	Repeated	Binge	Alcohol	Causes	Intoxicating	BAL	and	Transient	
Weight	Loss	After	TBI	
	
	
	
Figure	8	A.	Alcohol	administration	by	gastric	gavage	produces	a	mean	BAL	of	
156.1mg/dL,+/-	8.3	SEM	(n=13)	B.	Weight	of	animals	before,	during	and	after	
alcohol	administration	and	experimental	TBI	by	controlled	cortical	impact	(CCI).	
The	average	weight	of	the	alcohol	group	was	significantly	less	compared	to	the	
vehicle	group	on	day	11	(306	vs.	318	respectively)	and	day	13	(310	vs.	319	
respectively)	(student	t	test,	n=6,	error	bars=SEM).	
	
	
	
	
A. B. 
* * 
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Acute	Repeated	Binge	Alcohol	Had	No	Effect	on	Lesion	Size	
	
	
	
Figure	9:	Alcohol	had	no	effect	on	lesion	size	at	early	time	points.	Lesion	size	is	
expressed	as	the	percentage	of	intact	contralesional	brain	hemisphere.	A.	At	24	
hours	after	TBI,	the	mean	lesion	size	was	7.2+/-	1.4%,	n=6	and	5.5+/-1.5,	n=7	for	
Vehicle	and	Alcohol	groups	respectively.	B.	At	7	days	after	TBI,	the	mean	lesion	
size	was	6.4+/-1.5,n=5	and	9.4+/-1.1,n=10	for	Vehicle	and	Alcohol	groups	
respectively.	Statistical	analysis	was	performed	by	Student’s	t-test	with	p	≤0.05	as	
significance	criteria,	error	bars=SEM.	
	
	
	
	
A. B. 
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Binge	Alcohol	Affects	Proliferation	within	the	SVZ	at	24	hours	Post	TBI	
	
Figure	10:	At	24	hours	after	injury,	binge	alcohol	significantly	increased	SVZ	
proliferation	in	sham	groups	(A,C)	and	decreased	proliferation	in	TBI	groups	(B,D).	
The	ipsilesional	SVZ	is	shown.	LV=lateral	ventricle,	CC=corpus	callosum,	ST=	
striatum,	SVZ=subventricular	zone.	C’	is	magnified	view	of	the	red	boxed	area	in	
C.	Yellow	arrows	point	to	BrdU+	nuclei	of	SVZ	cells.	Scale	bar=50μm. 
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Binge	Alcohol	Affects	Proliferation	within	the	SVZ	at	24	hours	Post	TBI	
	
Figure	11:	A.	At	24	hours	after	injury,	binge	alcohol	significantly	increased	SVZ	
proliferation	in	sham	groups	and	decreased	proliferation	in	TBI	groups	bilaterally.	
Statistical	analysis	was	performed	by	two-way	ANOVA,	post-hoc	within-group	
analysis	performed,	*	denotes	p≤0.05,	**	denotes	p≤0.01,	error	bars=SEM.	
	
	
	
** 
* 
** 
* * * 
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SVZ	Proliferation	Cell	Counting	by	Stereology	
	 24	hours:	The	ipsilesional	(injured	side)	and	contralesional	(uninjured	side)	
were	examined	separately	due	to	the	unique	proximity	of	these	two	SVZ	
environments	to	the	lesion	(Figure	10).	First,	we	looked	at	the	number	of	BrdU+	
cells	in	the	SVZ	of	the	ipsilesional	side	to	detect	if	there	was	main	effect	of	Injury	
(TBI,	Sham),	Treatment	(alcohol,	vehicle)	or	if	there	was	interaction	between	
them	(Figure	11).	We	found	that	there	was	statistically	significant	effect	of	Injury	x	
Treatment	interaction	(table	7)	(p=	0.005).	Next	we	performed	within	group	
analysis	to	determine	if	the	means	of	certain	groups	were	statistically	different.	
First,	the	mean	of	Vehicle	TBI	was	significantly	higher	than	that	of	Vehicle	Sham	
(table	8,	p=0.03);	TBI	induced	approximately	a	4	fold	increase	in	cell	proliferation.	
Next,	when	comparing	Alcohol	TBI	against	Vehicle	TBI	group,	there	was	a	
significant	effect	of	alcohol	reducing	proliferation	by	approximately	2	fold	(table	
8,	p=0.039).	Interestingly,	when	comparing	Vehicle	Sham	against	Alcohol	sham	
groups,	there	was	a	significant	effect	of	alcohol	increasing	proliferation	by	3	fold	
(table	8,	p=0.038).		
	 Then,	we	looked	at	the	number	of	BrdU+	cells	in	the	SVZ	of	the	
contralesional	side	to	detect	whether	there	was	a	main	effect	of	Injury	(TBI,	
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Sham),	Treatment	(alcohol,	vehicle)	or	if	there	was	an	interaction	between	them	
(Figure	11).	Similar	to	the	ipsilesional	SVZ,	there	was	a	statistically	significant	
effect	of	Injury	x	Treatment	interaction	(table	7)	(p	=	0.001).	Next	we	performed	
within	group	analysis	to	determine	if	the	means	of	certain	groups	were	
statistically	different.	Again,	the	mean	of	Vehicle	TBI	was	significantly	higher	than	
that	of	Vehicle	Sham	(table	8,	p=0.006);	TBI	induced	approximately	a	4	fold	
increase	in	the	number	of	proliferating	cells.	Next,	when	comparing	Alcohol	TBI	
against	Vehicle	TBI	group,	there	was	a	significant	effect	of	alcohol	reducing	
proliferation	by	almost	3	fold	(table	8,	p=0.016).	Again,	when	comparing	Vehicle	
Sham	against	Alcohol	sham	groups,	there	was	a	significant	effect	of	alcohol	
increasing	proliferation	by	almost	4	fold	(table	8,	p=0.012).	
Effect	 Treatment	 Injury	 Treatment*Injury	
Ipsilesional	BrdU+	
SVZ	cell	number	
F(1,23)	=	0.00,	
p	=0.996	
F(1,23)	=	1.90,	
p	=0.183	
F(1,23)	=	10.14,	p	
=0.005	
Contralesional	
BrdU+	SVZ	cell	
number	
F(1,23)	=	0.01,	
p	=0.931	
F(1,23)	=	0.28,	
p	=0.601	
F(1,23)	=	13.77,	p	
=0.001	
Table	7.	BrdU+	Cell	Number	in	The	SVZ	at	24	hours	two-way	ANOVA	Results	
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Effect	 Within	TBI	 Within	Sham	 Within	
Vehicle	
Within	
Alcohol	
Ipsilesional	
BrdU+	cell	#	
F(1,23)	=	
4.85,	p	
=0.039	
F(1,23)	=	
4.88,	p	
=0.038	
F(1,23)	=	
10.94,	p	
=0.003	
F(1,23)	=	
1.71,	p	
=0.205	
Contralesional	
BrdU+	cell	#	
F(1,23)	=	
6.79,	p	
=0.016	
F(1,23)	=	
7.47,	p	
=0.012	
F(1,23)	=	
9.44,	p	
=0.006	
F(1,23)	=	
5.30,	p	
=0.032	
Table	8.	BrdU+	Cell	Number	in	The	SVZ	at	24	hours	two-way	ANOVA	within	
Analysis	
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	Binge	Alcohol	Affects	Proliferation	within	the	SVZ	at	7	Days	Post	TBI	
	
Figure	12:	At	7	days	after	injury,	binge	alcohol	significantly	decreased	
proliferation	in	the	TBI	group	bilaterally.	Statistical	analysis	was	performed	by	
two-way	ANOVA,	post-hoc	within-group	analysis	performed,*	denotes	p≤0.05,	
error	bars=SEM.	
	
	
	
* 
* 
* 
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7	Days:	The	ipsilesional	(injured	side)	and	contralesional	(uninjured	side)	were	
analyzed	separately	(Figure	12).	For	the	Ipsilesional	SVZ,	there	was	no	statistically	
significant	main	effect	of	either	Injury	(TBI,	Sham)	or	Treatment	(Alcohol,	Vehicle).	
Also,	there	was	no	significant	Injury	x	Treatment	interaction	(table	9)	(p=	0.052).	
Within	group	analysis	showed	that	when	comparing	Alcohol	TBI	against	the	
Vehicle	TBI	group,	a	significant	effect	in	alcohol	reducing	proliferation	by	
approximately	1.6	fold	was	seen	(table	10,	p=0.024).		
	 Then,	we	looked	at	the	number	of	BrdU+	cells	in	the	SVZ	of	the	
contralesional	side.	Similar	to	the	ipsilesional	SVZ,	we	found	that	there	was	no	
statistically	significant	main	effect	of	either	Injury	(TBI,	Sham)	or	Treatment	
(Alcohol,	Vehicle).	Also,	there	was	no	significant	Injury	x	Treatment	interaction	
(table	9).	Within	group	analysis	showed	that	Alcohol	TBI	and	Vehicle	TBI	groups	
were	significantly	different;	alcohol	reduced	proliferation	by	approximately	2	fold	
(table	10,	p=0.028).		
Effect	 Treatment	 Injury	 Treatment*Injury	
Ipsilesional	BrdU+	
SVZ	cell	number	
F(1,25)	=	1.36,	
p	=0.256	
F(1,25)	=	0.03,	
p	=0.855	
F(1,25)	=	4.21,	p	
=0.052	
Contralesional	
BrdU+	SVZ	cell	
number	
F(1,25)	=	2.58,	
p	=0.122	
F(1,25)	=	3.37,	
p	=0.080	
F(1,25)	=	3.07,	p	
=0.094	
Table	9.	BrdU+	Cell	Number	in	The	SVZ	at	7	days	two-way	ANOVA	Results	
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Effect	 Within	TBI	 Within	Sham	 Within	
Vehicle	
Within	
Alcohol	
Ipsilesional	
BrdU+	SVZ	
cell	number	
F(1,25)	=	
5.85,	p	
=0.024	
F(1,25)	=	
0.38,	p	
=0.543	
F(1,25)	=	
2.67,	p	
=0.116	
F(1,25)	=	
1.89,	p	
=0.182	
Contralesional	
BrdU+	SVZ	
cell	number	
F(1,25)	=	
5.54,	p	
=0.028	
F(1,25)	=	
0.01,	p	
=0.926	
F(1,25)	=	
0.00,	p	
=0.978	
F(1,25)	=	
6.46,	p	
=0.018	
Table	10.	BrdU+	Cell	Number	in	The	SVZ	at	7	days	two-way	ANOVA	within	
Analysis	
	
In	summary,	the	results	from	Aim	#1	are:	
1) Binge	alcohol	had	no	effect	on	lesion	size.	
2) Binge	alcohol	alone	significantly	increased	proliferation	bilaterally	in	the	
SVZ	at	24	hours	only.	
3) TBI	alone	significantly	increased	proliferation	bilaterally	in	the	SVZ	at	24	
hours	after	injury.	
4) However,	when	binge	alcohol	was	combined	with	TBI,	binge	alcohol	
significantly	decreased	proliferation	bilaterally	in	the	SVZ	of	TBI	injured	
animals	at	24	hours	and	7	days	after	injury.		
	
99	
	
AIM	2:	THE	LONG-TERM	EFFECTS	OF	BINGE	ALCOHOL	AND	TRAUMATIC	
BRAIN	INJURY	ON	STEM	CELL	RESPONSES	
Lesion	Analysis	
As	in	Aim	1,	the	lesion	was	confined	to	the	right	unilateral	cortical	region	of	the	
sensorimotor	cortex,	with	the	center	of	the	lesion	approximately	at	1.5mm	
anterior,	2.5mm	lateral	from	bregma	(Figure	13A,B).	Lesion	size	was	quantified	for	
both	vehicle	and	binge	alcohol	groups	at	6	weeks	after	TBI.	Lesion	size	was	not	
significantly	different	between	vehicle	TBI	and	alcohol	TBI	groups	(mean	lesion	
size	was	9.7%	and	8.3%	respectively).		
SVZ	Proliferation	Cell	Counting	by	Stereology	
6	weeks	Total	BrdU+	Cell	in	SVZ:	We	examined	the	ipsilesional	(injured	side)	and	
contralesional	(uninjured	side)	separately	due	to	the	unique	proximity	of	these	
two	SVZ	environments	to	the	lesion	(Figure	14).	First,	we	looked	at	the	number	of	
BrdU+	cells	in	the	SVZ	of	the	ipsilesional	side	to	detect	if	there	was	a	main	effect	of	
Injury	(TBI,	Sham),	Treatment	(alcohol,	vehicle)	or	if	there	was	interaction	
between	them	(Figure	15).	We	found	that	there	was	a	statistically	significant	main	
effect	of	Injury	(TBI,	Sham)	(p=0.000),	but	no	statistically	significant	effects	of	
Treatment	or	Injury	x	Treatment	interaction	(table	11).	Next	we	performed	within	
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group	analysis	to	determine	if	the	means	of	certain	groups	were	statistically	
different.	First,	we	saw	that	the	mean	of	Vehicle	TBI	was	significantly	higher	than	
that	of	Vehicle	Sham	(table	12,	p=0.000);	TBI	induced	more	than	a	4	fold	increase	
in	the	number	of	proliferated	cell	in	the	SVZ.	The	mean	SVZ	BrdU+	cell	number	of	
Alcohol	TBI	group	was	significantly	higher	than	Alcohol	Sham	group	(more	than	a	
4	fold	increase)	(table	12,	p=0.000).		
In	contrast	to	the	ipsilesional	SVZ,	no	statistically	significant	effects	of	Injury,	
Treatment	or	Injury	x	Treatment	interaction	in	the	contralesional	SVZ	was	found	
(table	11).	
Effect	 Treatment	 Injury	 Treatment*Injury	
Ipsilesional	BrdU+	
SVZ	cell	number	
F(1,25)	=	1.40,	
p	=0.249	
F(1,25)	=	
137.54,	p	
=0.000	
F(1,25)	=	0.02,	p	
=0.904	
Contralesional	BrdU+	
SVZ	cell	number	
F(1,25)	=	0.38,	
p	=0.542	
F(1,25)	=	0.34,	
p	=0.566	
F(1,25)	=	0.03,	p	
=0.854	
Table	11.	BrdU+	Cell	Number	in	The	SVZ	at	6	weeks	two-way	ANOVA	Results	
Effect	 Within	TBI	 Within	Sham	 Within	
Vehicle	
Within	
Alcohol	
Ipsilesional	
BrdU+	SVZ	cell	
number	
F(1,25)	=	
0.61,	p	
=0.443	
F(1,25)	=	
0.79,	p	
=0.383	
F(1,25)	=	
67.34,	p	
=0.000	
F(1,25)	=	
70.22,	p	
=0.000	
Contralesional	
BrdU+	SVZ	cell	
number	
N/A	 N/A	 N/A	 N/A	
Table	12.	BrdU+	Cell	Number	in	The	SVZ	at	6	weeks	two-way	ANOVA	within	
Analysis	
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Repeated	Binge	Alcohol	Had	No	Effect	on	Long-term	Lesion	Size	
	
	
	
Figure	13:	Alcohol	had	no	effect	on	lesion	size	at	the	6	weeks	time	point.	A.	Gross	
rat	brain	with	a	TBI	in	the	right	sensorimotor	cortex	at	6	weeks	post	TBI.	B.	
Coronal	brain	sections	of	a	rat	with	TBI	stained	for	Nissl.	Red	arrows	point	to	the	
location	of	the	TBI	lesion.	C.	At	6	weeks	after	TBI,	the	mean	lesion	size	was	9.7+/-	
1.8%,	n=9	and	8.3+/-1.7,	n=9	for	Vehicle	and	Alcohol	groups	respectively.	
Statistical	analysis	was	performed	by	Student’s	t-test	with	p	≥0.05	as	significance	
criteria.	
	
	
	
	
	
A. B. 
C
C. 
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At	6	Weeks	Post-TBI,	TBI	Increased	Proliferation	within	the	Ipsilesional	
SVZ;	Binge	Alcohol	Had	No	Effect	on	SVZ	Proliferation	
	
Figure	14:	BrdU	immunofluorescence	showing	at	6	weeks	after	injury,	TBI	
significantly	increased	proliferation	in	the	ipsilateral	SVZ.	A-D.	Enlargements	of	
the	dorsolateral	SVZs	on	the	ipsilesional	side	of	the	brain.	Binge	alcohol	had	no	
effect	on	SVZ	proliferation	after	TBI.	LV=	lateral	ventricle,	ST=	striatum,	SVZ=	
subventricular	zone.	Yellow	arrows	point	to	BrdU+	nuclei	of	SVZ	cells.	Scale	bar	=	
50μm.		
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At	6	Weeks	Post-TBI,	TBI	Increased	Proliferation	within	the	Ipsilesional	
SVZ;	Binge	Alcohol	Had	No	Effect	on	SVZ	Proliferation	
	
	Figure	15:	Statistical	analysis	was	performed	by	two-way	ANOVA,	post-hoc	
within-group	analysis	performed,	***	denotes	p≤0.001,	error	bars=SEM.	
	
	
	
	
	
	
*** 
*** 
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6	weeks	(BrdU+/	DCX+)	Double-labeled	Cell	in	SVZ	(Figure	16,	17):	For	the	
ipsilesional	SVZ,	there	was	a	statistically	significant	main	effect	of	Injury	(TBI,	
Sham)	but	not	Treatment	(Alcohol,	Vehicle);	additionally,	there	was	a	significant	
Injury	x	Treatment	interaction	(table	13,	p=	0.029).	Within	group	analysis	showed	
that	when	comparing	Vehicle	Sham	against	Vehicle	TBI,	there	was	a	significant	
effect	in	TBI	increasing	the	number	of	double-labeled	(BrdU+	/DCX+)	cells	by	more	
than	11	fold	(table	14,	p=0.000).	When	comparing	Alcohol	Sham	against	Alcohol	
TBI,	a	significant	effect	in	TBI	increasing	the	number	of	double-labeled	cells	by	
about	7	fold	was	detected	(table	14,	p=0.000).	When	comparing	Vehicle	TBI	
against	Alcohol	TBI,	there	was	a	significant	effect	of	alcohol	decreasing	the	
number	of	double-labeled	cells	by	about	38%	(table	14,	p=0.006).	
Then,	the	number	of	double-labeled	(BrdU+/	DCX+)	cells	in	the	SVZ	of	the	
contralesional	side	was	examined	(Figure	17).	There	was	a	statistically	significant	
main	effect	of	Injury	(table	13,	p=0.000)	but	not	Treatment.	Furthermore,	there	
was	a	significant	Injury	x	Treatment	interaction	(table	13,	p=0.021).	Within	group	
analysis	showed	that	Vehicle	TBI	and	Vehicle	Sham	groups	were	significantly	
different;	TBI	increased	the	number	of	double-labeled	(BrdU+/	DCX+)	cells	by	more	
than	7	fold	(table	14,	p=0.000).	Alcohol	Sham	and	Vehicle	Sham	groups	were	also	
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significantly	different,	with	alcohol	increasing	the	number	of	double-labeled	
(BrdU+/	DCX+)	cells	by	more	than	2	fold	(table	14,	p=0.019).		
Effect	 Treatment	 Injury	 Treatment*Injury	
Ipsilesional	double	
labeled	cell	number	
F(1,25)	=	3.18,	
p	=0.088	
F(1,25)	=	
117.12,	p	
=0.000	
F(1,25)	=	5.43,	p	
=0.029	
Contralesional	
double	labeled	cell	
number	
F(1,25)	=	1.50,	
p	=0.234	
F(1,25)	=	
18.50,	p	=0.000	
F(1,25)	=	6.16,	p	
=0.021	
Table	13.	(BrdU+/	DCX+)	Double	Labeled	Cell	Number	in	The	SVZ	at	6	weeks	two-
way	ANOVA	Results	
	
Effect	 Within	TBI	 Within	Sham	 Within	
Vehicle	
Within	
Alcohol	
Ipsilesional	
double	
labeled	cell	
number	
F(1,25)	=	
9.17,	p	
=0.006	
F(1,25)	=	
0.14,	p	
=0.713	
F(1,25)	=	
86.49,	p	
=0.000	
F(1,25)	=	
36.06,	p	
=0.000	
Contralesional	
double	
labeled	cell	
number	
F(1,25)	=	
0.86,	p	
=0.365	
F(1,25)	=	
6.38,	p	
=0.019	
F(1,25)	=	
23.00,	p	
=0.000	
F(1,25)	=	
1.65,	p	
=0.212	
Table	14.	(BrdU+	&	DCX+)	Double	Labeled	Cell	Number	in	The	SVZ	at	6	weeks	
two-way	ANOVA	within	Analysis	
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Repeated	Binge	Alcohol	Decreased	Neuronal	Differentiation	within	the	
SVZ	at	6	Weeks	Post-TBI	
	
Figure	16:	At	6	weeks	after	injury,	binge	alcohol	significantly	decreased	neuronal	
differentiation	in	the	ipsilesional	SVZ.	Several	sections	were	chosen	for	
immunofluorescence	to	demonstrate	labeling.	First	column	imaged	at	400x	
magnification,	scale	bar	=	75	μm.	Second	column	imaged	at	1000x,	scale	
bar=10μm.		
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Repeated	Binge	Alcohol	Decreased	Neuronal	Differentiation	within	the	
SVZ	at	6	Weeks	Post-TBI	
	
Figure	17:	At	6	weeks	after	injury,	binge	alcohol	significantly	decreased	neuronal	
differentiation.	Statistical	analysis	was	performed	by	two-way	ANOVA,	post-hoc	
within-group	analysis	performed,*	denotes	p≤0.05,	**	p≤0.01,and	***	p≤0.001,	
error	bars=SEM.	
	
	
	
	
*** *** ** 
*** 
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6	weeks	(BrdU+/	DCX-)	Single-labeled	Cell	in	SVZ	(Figure	19):	For	the	ipsilesional	
SVZ,	we	found	that	there	was	a	statistically	significant	main	effect	of	Injury	(TBI,	
Sham),	(table	15,	p=0.000),	but	not	Treatment	(Alcohol,	Vehicle);	we	did	not	
detect	a	significant	Injury	x	Treatment	interaction.	Within	group	analysis	showed	
that	when	comparing	Vehicle	Sham	against	Vehicle	TBI,	there	was	a	significant	
effect	of	TBI	increasing	the	number	of	single-labeled	(BrdU+/	DCX-)	cells	by	more	
than	3	fold	(table	16,	p=0.000).	When	comparing	Alcohol	Sham	against	Alcohol	
TBI,	there	was	a	significant	effect	of	TBI	increasing	the	number	of	single-labeled	
cells	by	about	4	fold	(table	16,	p=0.000).	
On	the	contralesional	side,	we	did	not	detect	any	statistically	significant	main	
effect	of	Injury	or	Treatment	(Figure	19).	Furthermore,	there	was	no	significant	
Injury	x	Treatment	interaction.		
Effect	 Treatment	 Injury	 Treatment*Injury	
Ipsilesional	single	
labeled	cell	number	
F(1,25)	=	0.71,	
p	=0.408	
F(1,25)	=	
83.19,	p	=0.000	
F(1,25)	=	0.11,	p	
=0.740	
Contralesional	single	
labeled	cell	number	
F(1,25)	=	0.16,	
p	=0.692	
F(1,25)	=	0.06,	
p	=0.811	
F(1,25)	=	0.09,	p	
=0.765	
Table	15.	(BrdU+	&	DCX-)	Single	Labeled	Cell	Number	in	The	SVZ	at	6	weeks	two-
way	ANOVA	Results	
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Effect	 Within	TBI	 Within	Sham	 Within	
Vehicle	
Within	
Alcohol	
Ipsilesional	
single	labeled	
cell	number	
F(1,25)	=	
0.14,	p	
=0.712	
F(1,25)	=	
0.65,	p	
=0.430	
F(1,25)	=	
38.59,	p	
=0.000	
F(1,25)	
=44.72,	p	
=0.000	
Contralesional	
single	labeled	
cell	number	
N/A	 N/A	 N/A	 N/A	
Table	16.	(BrdU+	&	DCX-)	Single	Labeled	Cell	Number	in	The	SVZ	at	6	weeks	two-
way	ANOVA	within	Analysis	
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Repeated	Binge	Alcohol	Does	Not	Affect	Non-Neuronal	Differentiation	
within	the	SVZ	at	6	Weeks	Post-TBI		
	
	
Figure	18.	Immunofluorescence	of	BrdU	and	the	astrocyte	marker	GFAP.	A-D.	
Enlargements	of	the	dorsolateral	SVZs	of	the	ipsilesional	side	of	the	brain.	There	
appears	to	be	little	co-localization	of	BrdU	signal	and	GFAP	signal	in	the	sham	
groups.	In	TBI	groups,	more	BrdU	co-localize	with	GFAP	signal;	however,	there	
was	no	noticeable	difference	between	vehicle	and	alcohol	groups.	LV=	lateral	
ventricle,	ST=	striatum,	SVZ=	subventricular	zone.	Scale	bar=150μm.		
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Repeated	Binge	Alcohol	Did	Not	Affect	Non-Neuronal	Differentiation	
within	the	SVZ	at	6	Weeks	Post-TBI	
	
	
Figure	19:	Repeated	binge	alcohol	did	not	affect	glial	proliferation	as	measured	at	
6	weeks	after	injury.	Statistical	analysis	was	performed	by	two-way	ANOVA,	post-
hoc	within-group	analysis	was	performed,***	denotes	p≤0.001,	error	bars=SEM.	
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Repeated	Binge	Alcohol	Does	Not	Appear	to	Affect	the	Number	of	
Neurons	with	Mature	Phenotypes	Within	the	SVZ	and	Perilesional	Area	
at	6	Weeks	Post-TBI	
  
Figure	20:	Immunofluorescence	of	BrdU	and	the	mature	neuronal	marker	NeuN.	
Images	in	the	left	column	are	from	the	perilesional	cortical	area	(blue	box).	
Images	in	the	right	column	are	from	the	dorsolateral	SVZ	area		(red	box).	There	
appeared	to	be	little	co-localization	of	BrdU	and	NeuN	signal	in	either	the	SVZ	or	
the	cortical	area.	No	noticeable	differences	between	vehicle	and	alcohol	groups	
were	observed.	Scale	bar=10μm.		
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6	weeks	(BrdU+/	DCX+)	Double-labeled	Cells	in	the	Perilesional	Area	(figure	21):	
There	was	no	statistically	significant	difference	between	Vehicle	TBI	and	Alcohol	
TBI	groups.	
6	weeks	(BrdU+/	DCX+)	Double-labeled	Cell	in	RMS	(figures	22	and	23):	We	found	
that	there	was	a	statistically	significant	main	effect	of	Injury	(TBI,	Sham),	(table	17,	
p=0.000),	but	not	Treatment	(Alcohol,	Vehicle);	we	did	not	detect	a	significant	
Injury	x	Treatment	interaction.	Within	group	analysis	showed	that	when	
comparing	Vehicle	Sham	against	Vehicle	TBI,	there	was	a	significant	effect	of	TBI	
increasing	the	number	of	double-labeled	(BrdU+/	DCX+)	cells	by	about	2	fold	(table	
18,	p=0.001).	When	comparing	Alcohol	Sham	against	Alcohol	TBI,	we	also	saw	a	
significant	effect	of	TBI	increasing	the	number	of	double-labeled	cells	(table	18,	
p=0.037).	
Effect	 Treatment	 Injury	 Treatment*Injury	
RMS	double	labeled	
cell	number	
F(1,26)	=	1.12,	
p	=0.302	
F(1,26)	=	
19.48,	p	=0.000	
F(1,26)	=	1.87,	p	
=0.185	
Table	17.	Neuronal	Migration	in	the	RMS	at	6	weeks	two-way	ANOVA	Results	
Effect	 Within	TBI	 Within	Sham	 Within	
Vehicle	
Within	
Alcohol	
RMS	double	
labeled	cell	
number	
F(1,26)	=	
3.62,	p	
=0.070	
F(1,26)	=	
0.04,	p	
=0.843	
F(1,26)	=	
15.85,	p	
=0.001	
F(1,26)	=	
4.91,	p	
=0.037	
Table	18.	Neuronal	Migration	in	The	RMS	at	6	weeks	two-way	ANOVA	within	
Analysis	
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Repeated	Binge	Alcohol	Did	not	Affect	Peri-lesional	Migration	of	
Immature	Neurons	
	
	
Figure	21:	At	6	weeks	after	injury,	binge	alcohol	did	not	affect	the	migration	of	
neuroblasts	toward	the	peri-lesional	area.	Statistical	analysis	was	performed	by	
Student’s	t-test	with	significant	criteria	of	p≤0.05,	error	bars=SEM.	OB:	Olfactory	
bulb,	RMS:	Rostral	migratory	stream,	Str:	striatum,	SVZ:	subventricular	zone,	LV:	
lateral	ventricle,	HPC:	hippocampus,	DG:	dentate	gyrus,	SGZ:	subgranular	zone,	
4V:	4th	ventricle,	CCSC:	central	canal	of	the	spinal	cord,	CTX:	cortex.	Diagram	
adapted	from	(Emsley	et	al	2005).	
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TBI	increased	RMS	Migration		
	
Figure	22:	At	6	weeks	after	injury,	TBI	significantly	increased	migration	of	SVZ	
derived	neuroblasts	toward	the	olfactory	bulb.	A.	Diagram	of	the	rostral	migratory	
stream	(RMS)	the	pathway	that	neuroblasts	take	toward	the	olfactory	bulbs,	
shown	in	green.		B.	Coronal	section	of	rat	brain	immunolabeled	for	Doublecortin	
(DCX)	and	BrdU.	Area	in	the	blue	box	is	the	olfactory	bulb	nucleus	(OBN),	which	is	
a	part	of	the	RMS.		C-F.	Enlargements	of	the	ipsilateral	OBN,	with	BrdU+	cells	as	
black	and	DCX+	cells	as	dark	red.	Diagram	in	A	was	adapted	from	(Emsley	et	al	
2005).	Scale	bar=50μm.	
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TBI	increased	RMS	Migration	and	Binge	Alcohol	Did	Not	Affect	This	
Process	
	
Figure	23:	At	6	weeks	after	injury,	binge	alcohol	did	not	affect	migration	of	SVZ	
derived	neuroblasts	toward	the	olfactory	bulb.	Statistical	analysis	was	performed	
by	two-way	ANOVA,	post-hoc	within-group	analysis	performed,	***	denotes	
p≤0.001,	error	bars=SEM.	OB:	Olfactory	bulb,	RMS:	Rostral	migratory	stream,	Str:	
striatum,	SVZ:	subventricular	zone,	LV:	lateral	ventricle,	HPC:	hippocampus,	DG:	
dentate	gyrus,	SGZ:	subgranular	zone,	4V:	4th	ventricle,	CCSC:	central	canal	of	the	
spinal	cord,	CTX:	cortex.	Diagram	adapted	from	(Emsley	et	al	2005).	
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In	Summary,	the	results	from	Aim	#2	are:		
1) Binge	alcohol	had	no	effect	on	lesion	size	as	measured	at	6	weeks	after	TBI.	
2) Binge	alcohol	decreased	neuronal	differentiation	of	SVZ	derived	cells	at	6	
weeks	after	TBI.	
3) TBI	alone	increased	RMS	migration	to	the	olfactory	bulb.	
4) Binge	alcohol	did	not	affect	migration	of	immature	neurons	to	the	
perilesional	area	or	to	the	olfactory	bulb.	
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CHAPTER	FIVE	
DISCUSSION	
	 TBI	is	a	significant	health	crisis	as	many	survivors	of	TBI	face	disabilities	and	
a	difficult	path	to	recovery.	Alcohol	consumption	and	intoxication	is	a	lifestyle	
factor	that	strongly	contributes	to	suffering	a	TBI.	In	fact,	a	large	fraction	of	TBI	
patients	are	positive	for	blood	alcohol	levels	higher	than	the	0.08	legal	limit	at	the	
time	of	injury	(Parry-Jones	et	al	2006).	Binge	drinking	is	the	most	common	way	in	
which	alcohol	is	consumed	and	it	has	been	shown	to	be	extremely	widespread	in	
the	adolescence	and	adult	populations	in	our	society	(CDC	Vitalsigns,	2012).	
Despite	the	strong	association	of	alcohol	consumption	to	TBI	injuries,	the	
biological	effect	of	alcohol	consumption	and	intoxication	on	the	TBI	recovery	
process	is	not	well	understood.	An	earlier	behavioral	study	using	a	rat	model	for	
binge	alcohol	consumption	and	TBI	indicated	that	a	three	day	binge	alcohol	
administration	prior	to	cortical	injury	by	CCI	significantly	decreased	fine	motor	
skill	recovery	when	measured	8	weeks	after	TBI	(Vaagenes	et	al	2015).	However,	
the	mechanism	behind	this	alcohol-induced	impairment	is	not	known.	Therefore,	
in	this	dissertation,	we	used	the	same	binge	alcohol	and	TBI	model	previously	
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developed	in	our	lab	to	explore	the	combined	effect	of	binge	alcohol	and	TBI	on	
the	neural	stem	cell	response.		
	 Our	results	showed	that	alcohol	given	for	three	consecutive	days	(a	binge	
pattern	of	alcohol	consumption)	before	a	moderate	TBI	to	the	right	forelimb	
motor	cortex	leads	to	a	significant	reduction	in	short	term	SVZ	proliferation	as	
measured	at	24	hours	and	7	days	post	injury.	Binge	alcohol	did	not	affect	the	
retention	of	proliferated	cell	in	the	SVZ	as	measured	at	6	weeks	post	injury.	
However,	binge	alcohol	significantly	reduced	the	number	of	proliferated	cells	that	
differentiated	into	neurons	in	the	SVZ.	Binge	alcohol	did	not	have	significant	
effects	on	lesion	size,	or	migration	of	new	neurons	to	the	perilesional	area	and	
the	olfactory	bulb.	Additionally,	we	confirmed	earlier	literature	that	our	model	of	
TBI	using	the	controlled	cortical	impact	method	produced	a	significant	increase	in	
the	number	of	proliferating	cells	bilaterally	in	the	SVZ	when	measured	at	24	hours	
and	7	days	post	injury	and	ipsilateral	at	the	6	week	time	point.	TBI	also	induced	a	
significant	increase	in	migration	of	new	neurons	toward	the	perilesional	area	and	
the	olfactory	bulb	via	the	RMS	pathway.	An	interesting	effect	of	binge	alcohol	
alone	was	its	effect	on	increasing	SVZ	proliferation	when	measured	24	hours	after	
the	last	binge	episode.	Overall,	we	found	that	binge	alcohol	potently	affected	
neurogenesis	after	TBI,	and	this	might	be	the	reason	behind	the	reduced	
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functional	recovery	as	observed	in	the	same	animal	model	as	we	reported	
previously	(Vaagenes	et	al	2015).	
	 Alcohol	had	been	found	by	various	groups	to	have	detrimental	effects	on	
the	lesion	size	of	animals	(Kelly	et	al	1997).	Additionally,	there	is	evidence	to	
suggest	that	alcohol	affects	aquaporin	expression,	which	could	lead	to	elevated	
edema	in	animals	intoxicated	with	alcohol,	thus	leading	to	an	increase	in	lesion	
size	(Sripathirathan	et	al	2009).	However,	we	found	that	lesion	size	was	not	
affected	in	our	rat	model	of	binge	alcohol	and	TBI	at	the	acute	time	point	of	24	
hours,	sub-acute	time	point	of	7	days	or	the	chronic	time	point	of	6	weeks.	This	
suggests	that	alcohol	intoxication	at	the	level	experienced	in	our	model	does	not	
affect	the	edema	process	after	TBI.	Furthermore,	our	results	suggest	that	binge	
alcohol	consumption	did	not	have	detrimental	effects	on	perilesional	cell	death	
(apoptotic	or	necrotic)	or	lesion	site	degeneration.	However,	to	further	
investigate	this	process,	we	would	need	to	perform	staining	using	specific	markers	
for	apoptosis,	necrosis	or	degeneration.	
	 Additionally,	we	also	confirmed	observations	from	past	studies	regarding	
the	general	increase	in	SVZ	proliferation	post-TBI.	However,	we	observed	some	
differences	regarding	the	time-course	of	this	proliferative	response.	One	recent	
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study	noted	that	there	were	significant	variations	in	the	SVZ	proliferative	
response	following	a	TBI	(Chang	et	al	2016).	For	instance,	species	differences	(rats	
versus	mice)	and	different	TBI	methods	(CCI	versus	MFP	versus	weight	drop…etc)	
can	account	for	the	variation	in	the	SVZ	proliferative	response	as	observed	in	
these	studies	(Tzeng	&	Wu	1999),	(Szele	&	Chesselet	1996),(Goings	et	al	2002).	
However,	the	consensus	is	that	in	rats,	during	the	first	five	days	after	injury,	SVZ	
proliferation	is	unchanged.	However,	we	saw	that	TBI	alone	induced	up	to	a	4	fold	
increase	in	SVZ	proliferation	at	the	24	hour	time	point	(Figure	10	and	11).	The	
difference	in	this	result	might	be	due	to	the	difference	in	the	TBI	model	used,	for	
instance,	(Tzeng	&	Wu	1999)	used	the	stab	wound	model	to	inflict	TBI	while	
(Goodus	et	al	2014)	used	a	pediatric	rat	TBI	model.	While	another	group	used	a	
thermal	coagulation	model	to	produce	a	cortical	lesion	that	was	distal	to	the	SVZ	
to	show	that	within	the	first	5	days	after	injury,	there	was	no	change	in	
proliferation	(Gotts	&	Chesselet	2005).	The	model	used	in	this	dissertation,	i.e.,	
CCI,	is	thought	by	others	to	be	a	more	appropriate	model	for	closed-head	TBI	with	
contusion	(Dixon	et	al	1991),	produces	a	focal	TBI	lesion	that	is	proximal	to	the	
SVZ,	and	thus	might	explain	the	marked	and	almost	immediate	elevation	in	SVZ	
proliferation.	
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	 Furthermore,	according	to	two	groups	which	used	aspiration	lesion	and	
diffuse	TBI	models,	SVZ	proliferation	reached	a	maximum	of	around	2	fold	above	
baseline	at	5-7	days	post-TBI	(Szele	&	Chesselet	1996),	(Bye	et	al	2011).	In	our	
model,	at	7	days	post	injury	there	was	no	significant	difference	in	SVZ	
proliferation	in	TBI	versus	the	sham	group	(Figure	12).	This	result	indicates	that	
the	proliferative	maximum	had	been	reached	between	days	1	and	before	day	7,	
and	that	the	rate	of	new	cell	incorporation	into	the	SVZ	equals	the	rate	of	
migration	of	cells	away	from	the	SVZ.		Again,	as	in	the	24	hours	post-TBI	result,	we	
feel	that	the	difference	in	our	TBI	model	is	able	to	explain	why	we	observed	SVZ	
proliferation	reaching	a	maximum	before	7	days.	
	 At	7	days	after	TBI,	the	total	number	of	BrdU	labeled	cells	in	the	SVZ	of	
animals	in	all	the	groups	was	dramatically	higher	compared	to	the	24	hour	time	
point	because	of	the	accumulation	of	these	cells	during	the	7	days	of	BrdU	
injection/labeling.	The	distribution	of	proliferated	cells	was	dramatically	different	
when	we	observed	the	7	day	survival	animals	compared	to	the	24	hour	animals.	
At	24	hours,	we	only	observed	BrdU+	cells	in	the	SVZ	and	perilesional	area;	at	7	
days,	we	observed	BrdU+	cells	in	a	number	of	other	brain	structures	such	as	the	
striatum	and	RMS.	This	indicated	that	newborn	cells	from	the	SVZ	were	migrating	
toward	other	brain	structures.	It	is	possible	that	alcohol	could	increase	SVZ	cell	
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death	and	that	is	why	we	observed	less	BrdU+	cells	in	the	SVZ	of	TBI	animals	
exposed	to	alcohol	compared	to	vehicle.	This	is	unlikely,	however,	due	to	the	
relatively	low	dose	of	alcohol	that	we	used	and	thus	less	likely	to	induce	
neurodegeneration/cell	death.	Furthermore,	alcohol/sham	animals	in	our	study	
had	significantly	more	proliferation	compared	to	vehicle/sham	animals	and	thus	
we	do	not	believe	that	alcohol	caused	an	increase	in	cell	death.	
	 A	novel	result	from	this	study	was	that	binge	alcohol	alone	elicited	a	
proliferative	response	from	the	SVZ.	Alcohol	treated	sham	animals	exhibited	up	to	
a	4	fold	increase	in	BrdU+	cells	compared	to	vehicle	treated	sham	animals.	This	
increase	is	in	the	same	magnitude	as	an	increase	after	TBI	alone	(Figure	10	and	
11).	This	is	in	particular	contrast	with	previous	studies	using	different	alcohol	
intoxication	models	in	rodents	(either	acute	or	chronic)	indicating	that	alcohol	
caused	significant	depression	in	SVZ	and	SGZ	proliferation	(Anderson	et	al	2012)	
and	(Nixon	&	Crews	2002).	One	report	found	that	after	discontinuing	chronic	
alcohol	administration,	there	was	an	increase	in	SGZ	cell	number	at	day	2	and	7	
after	cessation	(Anderson	et	al	2012).	Similar	studies	have	found	similar	
proliferation	bursts	in	the	SVZ	(Hansson	et	al	2010);	however,	these	studies	used	
chronic	doses	of	alcohol	for	extended	periods	of	time	(up	to	7	weeks).	We	believe	
that	we	are	the	first	to	observe	this	SVZ	burst	of	proliferation	at	24	hours	after	the	
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last	dose	of	alcohol	following	three	days	of	moderate	binge.	It	is	possible	that	the	
three	days	moderate	binge	paradigm	that	we	used	was	enough	to	cause	
neurodegeneration	in	the	CNS,	which	in	turn	acts	as	an	injury	to	stimulate	an	
increase	in	neurogenesis.	Additionally,	reactive	oxygen	species	(ROS)	are	elevated	
in	the	enzymatic	degradation	of	alcohol.	There	is	strong	evidence	that	moderate	
ROS	increase	can	stimulate	neurogenesis	(Le	Belle	et	al	2011).	Therefore,	it	will	be	
important	to	further	characterize	this	unique	SVZ	response	by	employing	different	
markers	to	detect	neurodegeneration,	ROS	and	cell	death	in	different	brain	
regions	in	future	studies.	
	 Important	to	the	goal	of	this	dissertation,	we	found	that	at	the	24	hour	
time	point,	in	animals	that	received	binge	alcohol	and	TBI,	there	was	a	3	fold	
decrease	in	proliferating	cells	in	the	SVZ.	To	our	knowledge,	we	are	the	first	group	
to	show	that	alcohol	in	the	context	of	TBI	resulted	in	decreased	overall	SVZ	
proliferation.	This	is	what	we	predicted	in	our	hypothesis	based	on	our	previous	
observation	that	alcohol/TBI	rats	performed	worse	in	the	skilled	forelimb-
reaching	task	compared	to	vehicle/TBI	rats.	It	remains	to	be	determined	whether	
SVZ	proliferation	contributed	significantly	to	the	performance	on	the	skilled	
forelimb-reaching	task.	Although	not	examined	explicitly	in	this	dissertation,	this	
may	occur	through	the	production	of	new	interneurons	in	the	olfactory	bulb	
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(granular	cells	and	perigranular	cells,	Figure	2).	New	OB	granular	and	perigranular	
cells	are	inhibitory	interneurons	that	have	modulatory	functions	in	the	olfaction	
neural	circuitry	that	is	important	in	a	process	called	pattern	separation	(Sahay	et	
al	2011b).Furthermore,	one	important	study	showed	that	the	skilled	forelimb	
reaching	task	relies	heavily	on	olfaction	(Whishaw	&	Tomie	1989).This	group	used	
rats	that	were	trained	to	reach	food	through	a	small	opening;	when	these	animals	
had	their	vision	blocked	by	the	mean	of	eye	patches,	their	reaching	performance	
was	not	affected.	However,	when	the	olfactory	bulb	was	removed,	they	
experienced	profound	impairments	in	the	reaching	task.	These	findings	point	to	
the	possibility	that	reduced	SVZ-OB	neurogenesis	due	to	alcohol	could	lead	to	
impaired	olfaction	pattern	separation	and	in	turn	cause	deficits	in	the	skilled	
forelimb	reaching	task.	
	 Binge	alcohol	and	TBI	alone	increased	proliferation,	but	the	combination	of	
the	two	factors	led	to	decreased	proliferation	in	the	SVZ.	There	are	several	
mechanisms	that	might	explain	this	observation:	
	 	 Inflammatory	response:	TBI	has	an	important	inflammation	
component	in	the	primary	injury	phase.	Alcohol	is	known	to	increase	CNS	
inflammation	via	its	effect	on	microglia	(Marshall	et	al	2013).	It	is	possible	that	the	
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combined	magnitude	of	inflammation	in	TBI/binge	alcohol	animals	is	higher	than	
in	TBI	or	binge	alcohol	animals	alone.	A	certain	amount	of	inflammation	can	
stimulate	neurogenesis,	however,	if	inflammation	reaches	a	high	threshold,	it	may	
cause	the	SVZ	microenvironment	to	be	non-supportive	for	neurogenesis.	For	
instance,	there	is	strong	evidence	for	pro-inflammatory	cytokines	such	as	IL-1b	
suppressing	hippocampal	neurogenesis	(Goshen	et	al	2008).		
	 	 Reactive	oxygen	species	(ROS):	Alcohol	metabolism	produces	ROS	
and	primary	events	following	TBI	also	lead	to	high	ROS	levels.	Therefore,	in	TBI	
and	alcohol	administered	animals,	ROS	levels	could	become	additive	from	the	two	
conditions.	This	combined	elevated	ROS	from	TBI	and	alcohol	could	be	inhibitory	
to	proliferation.	As	previously	noted,	low	concentration	of	ROS	can	stimulate	
neurogenesis,	likely	through	a	mechanism	involving	elevated	NF-kB	(Ruiz-Ramos	
et	al	2009).	However,	extremely	high	levels	of	ROS	could	inhibit	NSC	proliferation	
(Limoli	et	al	2006).	Furthermore,	extreme	levels	of	ROS	could	lead	to	an	increased	
rate	of	cell	death	of	recently	proliferated	cells	due	to	an	increased	rate	of	DNA	
damage	(Figure	4).		
	 	 BDNF	availability:	Growth	factors	are	crucial	to	the	neurogenesis	
process.	For	instance,	BDNF	enhances	survival	and	in	certain	cases	serves	as	a	
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chemokine	to	attract	new	neurons	toward	lesion	areas	(Rostami	et	al	2014).	TBI	
increases	BDNF	expression	through	several	cellular	mechanisms:	astrocytes,	
microglia	and	vascular	cells	all	secrete	BDNF.	Alcohol	however,	decreases	BDNF	
expression	and	thus	lowers	the	potential	neurogenesis	that	is	possible	if	there	is	
only	TBI	alone.		
Technical	Issues:		 	
	 BrdU	injection	allows	us	to	label	and	birth-date	the	proliferating	cells;	
however,	there	are	some	drawbacks	of	this	technique	that	deserve	some	thought	
when	interpreting	the	data.	For	instance,	while	BrdU	readily	crosses	the	BBB	and	
becomes	available	to	CNS	cells	for	incorporation	into	their	DNA,	the	bioavailability	
of	BrdU	is	short.	It	is	rapidly	degraded	and	only	available	to	cells	for	about	2	hours	
after	injection.	This	likely	means	that	we	were	only	seeing	a	fraction	of	
proliferation	that	actually	happened	during	the	observed	time	interval.	Although	
we	did	use	daily	injections	of	BrdU	for	the	7	day	group	of	animals,	we	would	still	
not	be	able	to	label	all	proliferating	events.	An	alternative	approach	would	be	to	
inject	BrdU	more	frequently,	multiple	times	per	day;	however,	the	drawback	of	
such	an	approach	would	be	increased	animal	stress	and	exposure	to	anesthesia.	
Additionally,	there	are	some	concerns	that	after	TBI,	there	is	an	increase	in	BBB	
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leakiness,	which	might	lead	to	higher	BrdU	permeability	into	the	brain	
parenchyma.	However,	we	did	used	a	relatively	high	BrdU	dose	of	100mg/kg	
which	means	the	available	concentration	in	the	brain	reached	the	saturation	
point,	so	any	further	increase	in	BrdU	permeability	after	TBI	should	not	affect	the	
number	of	BrdU+	cells.	Due	to	the	short	bioavailability	of	BrdU,	in	future	studies,	it	
would	be	interesting	to	include	a	group	of	animals	that	would	be	sacrificed	at	the	
2-3	hour	post-TBI	and	BrdU	injection.	This	approach	would	enable	us	to	rule	out	
the	possibility	that	cell	death	or	migration	of	recently	proliferated	cells	might	
impact	the	number	of	BrdU+	cell	in	the	SVZ.	
	 An	important	consideration	when	looking	at	our	results	showing	alcohol	
decreased	the	SVZ	proliferative	response	after	TBI	is	how	this	translates	to	human	
patients.	While	production	of	new	brain	cells	by	neurogenesis	was	observed	in	
the	human	brain,	no	conclusive	evidence	exists	for	their	roles	(Chang	et	al	2016).	
Additionally,	neurogenesis	in	the	human	brain	happens	at	a	much	lower	level	
compared	to	the	rodent	brain	(Curtis	et	al	2007),	thus	limiting	the	translatability	
of	rodent	neurogenesis	findings.	Also,	newly	proliferated	cells	must	become	
functionally	relevant	in	the	adult	brain	post	TBI	for	them	to	have	any	role	in	the	
recovery	process.	These	newly	generated	cells	from	the	SVZ	would	need	to	
undergo	the	differentiation	process	to	become	either	neurons	or	glia	and	they	
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must	also	migrate	to	different	brain	regions.	Therefore,	we	sought	to	explore	
these	aspects	of	neurogenesis	in	our	second	aim.	
	 One	of	the	most	interesting	aspects	of	neurogenesis	is	whether	the	
newborn	cells	become	functionally	relevant	in	the	CNS.	In	the	rodent	system,	the	
roles	of	newborn	SVZ	and	DG	cells	are	perhaps	the	best	studied	and	understood.	
Yet	their	roles	after	CNS	injury	are	less	well	known	and	this	area	of	research	is	still	
very	active	as	the	roles	of	NSC	are	hotly	debated	(Garthe	&	Kempermann	2013).	
The	goal	for	this	part	of	the	dissertation	was	to	determine	the	NSC	responses	
after	TBI	in	the	chronic	TBI	phase.	These	long-term	responses	include	the	survival	
of	proliferated	cells,	their	differentiation	into	neuronal	and	glial	lineages	and	the	
migration	of	neuronal	differentiated	cells	to	various	areas	of	the	CNS.	To	this	end,	
we	performed	BrdU	injections	for	the	first	7	days	following	TBI	to	label	all	
proliferating	cells	within	this	period	of	time.	The	animals	were	allowed	to	survive	
for	6	weeks.	According	to	previous	behavioral	studies	in	our	lab,	this	is	sufficient	
time	for	animals	to	reach	a	functional	plateau,	which	in	human	corresponds	to	
the	chronic	phase	of	TBI.		
	 We	quantified	the	total	number	of	BrdU+	cells	in	the	SVZ	of	the	prolonged	
survival	time	point;	BrdU+	cells	are	those	that	had	been	labeled	during	the	first	7	
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days	after	injury.	We	found	at	the	acute	time	point	of	24	hours	and	sub-acute	7	
days	after	TBI,	the	contralesional	SVZ	robustly	responded	to	the	TBI	by	increasing	
proliferation	by	up	to	5	fold;	however,	at	6	weeks	after	TBI,	the	number	of	BrdU+	
cells	retained	in	the	contralesional	SVZ	decreased	to	baseline	levels,	essentially	
indistinguishable	from	sham	groups	(irrespective	of	alcohol	or	vehicle	treatment).	
It	is	possible	that	these	BrdU+	cells	seen	at	the	earlier	time	points	had	migrated	
out	from	the	SVZ	to	other	parts	of	the	CNS	such	as	the	striatum,	corpus	callosum,	
the	cortex	or	toward	the	olfactory	bulb.	
	 Interestingly,	we	found	significant	retention	of	BrdU+	cells	in	the	ipsilesional	
SVZ	in	TBI	animals	and	this	level	of	retention	was	virtually	the	same	across	alcohol	
and	vehicle	treated	groups.	There	were	around	60,000	cells	in	the	ipsilesional	SVZ	
of	TBI	animals,	which	is	around	4	fold	higher	than	baseline	levels	(sham	groups).	
This	is	not	surprising	considering	the	strong	evidence	in	the	literature	suggesting	
that	newly	proliferated	cells	could	survive	better	in	the	SVZ	after	TBI.	For	instance,	
one	group	found	that	there	was	a	decrease	of	TUNEL	positive	cells	in	the	SVZ	of	
animals	after	CCI	(Theus	et	al	2010).	TBI	might	have	altered	the	ipsilesional	SVZ	
microenvironment	to	support	more	proliferating	cells.	By	contrast,	another	group	
reached	different	conclusions	in	their	model	of	TBI	and	neurogenesis	(Acosta	et	al	
2013).	This	group	examined	the	long-term	effect	of	TBI	on	SVZ	neurogenesis.	They	
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found	that	at	8	weeks	post	TBI,	there	was	significant	reduction	in	Ki67+	cells	in	the	
SVZ	of	TBI	animals.	This	is	in	stark	contrast	to	our	finding	of	elevated	BrdU+	in	TBI	
animals	at	6	weeks.		It	is	possible	that	the	use	of	different	cell	proliferation	
markers	could	partially	explain	the	discrepancy.	Ki67	is	expressed	during	all	
phases	of	mitosis	and	is	necessary	for	cell	cycle	processes	(Mandyam	et	al	2007).		
Ki67	has	been	shown	to	correlate	with	BrdU	staining;	however,	Ki67	has	a	half-life	
of	17	hours,	which	make	it	difficult	to	ascertain	when	the	cell	proliferation	event	
happens.		
	 Binge	alcohol	did	not	affect	the	long-term	survival	of	proliferated	cells	in	
the	SVZ	in	our	model.	This	result	is	somewhat	unexpected	and	is	in	contrast	with	
previous	studies	on	alcohol	binge.	For	instance,	in	a	prominent	study,	alcohol	was	
given	to	rats	4	days	in	a	row;	they	detected	significant	reduction	in	the	survival	of	
new	hippocampal	cells	4	weeks	after	the	binge	episodes	(Nixon	&	Crews	2002).	It	
is	possible	there	are	regional	differences	in	response	to	binge	alcohol,	i.e.,	
hippocampus	being	more	sensitive	to	binge	alcohol	than	the	SVZ.	Additionally,	the	
binge	alcohol	given	to	the	animals	in	that	study	was	a	very	high	dose	of	5g/kg	for	
4	days	(versus	our	model	of	3g/kg	for	3	days)	which	could	contribute	to	the	
differences	observed.	
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	 Neuronal	differentiation	was	measured	as	the	number	of	cells	that	
expressed	both	BrdU	and	DCX	(doublecortin).	DCX	is	expressed	by	developing	
neurons	and	is	thus	a	reliable	marker	for	neuronal	differentiation	(Francis	et	al	
1999).	We	found	that	TBI	alone	significantly	induced	an	increase	in	neuronal	
differentiation	bilaterally	in	the	SVZ.	This	observation	is	in	agreement	with	the	
literature	on	neuronal	differentiation	after	TBI.	For	instance,	one	group	used	
transgenic	mice	that	had	YFP	tagged	to	new	neurons	to	show	that	new	neurons	
were	populated	in	the	dorsal	SVZ	and	expressed	DCX;	they	used	the	same	CCI	
model	and	detected	these	cells	at	6	week	post	TBI	similar	to	our	approach	
(Mierzwa	et	al	2014).	It	is	possible	that	the	microenvironment	of	the	SVZ	is	
changed	after	TBI	and	thus	more	permissive	to	the	neuronal	differentiation	of	
new	proliferating	cells;	for	instance,	one	study	found	BDNF	expression	to	be	
increased	in	the	hippocampus	after	TBI	(Hicks	et	al	1997).		
	 Intriguingly,	we	found	that	binge	alcohol	decreased	the	number	of	early	
SVZ	proliferating	cells	differentiated	into	the	neuronal	lineage	6	weeks	after	TBI.	
Stereological	quantification	of	the	SVZ	area	showed	that	alcohol	significantly	
reduced	the	number	of	BrdU+/DCX+	double-labeled	cell	by	38%	on	the	ipsilesional	
side	(Figure	17).	Immunofluorescence	imaging	confirmed	our	counting	data	
showing	reduced	co-localization	of	BrdU	and	DCX	signaling	in	TBI	animals	that	
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were	alcohol	treated	versus	vehicle	(Figure	16).	We	suspect	that	binge	alcohol	
might	have	affected	neuronal	differentiation	by	changing	expression	levels	of	
trophic	factors	in	the	brain,	for	instance,	BDNF,	insulin,	GDNF	and	EGF	(Janak	et	al	
2006).	One	group	found	that	high	dose	alcohol	administration	lead	to	depressive	
like	behavior	and	reduction	in	hippocampal	BDNF	(Hauser	et	al	2011).		One	
clinical	study	looking	at	serum	levels	of	several	trophic	factors	found	that	alcohol	
dependent	patients	had	reduced	GDNF	and	BDNF	(Heberlein	et	al	2010).		
	 We	did	not	expect	our	binge	alcohol	administration	paradigm	to	have	such	
long-term	effect	on	neuronal	differentiation	post	TBI.	It	is	possible	that	alcohol	is	
acting	on	neuronal	differentiation	via	epigenetic	mechanisms.	One	study	found	
that	there	was	reduced	methylation	of	the	CpG	(Cytosin-phosphatidyl-Guanin)	of	
the	promoter	of	NGF	(nerve	growth	factor)	in	the	serum	of	alcohol	dependent	
patients	(Heberlein	et	al	2013).	Furthermore,	BDNF,	a	trophic	factor	important	in	
the	neuronal	differentiation	process	is	found	to	be	affected	by	alcohol	by	
epigenetic	regulation	in	mice	(Stragier	et	al	2015).		
	 Another	finding	from	this	dissertation	was	that	binge	alcohol	affects	
neuronal	differentiation.	New	SVZ	derived	cells	can	differentiate	into	the	three	
main	cells	of	the	CNS,	i.e.,	neurons,	astrocytes	and	oligodendrocytes.	We	
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quantified	the	number	of	cells	in	the	SVZ	at	6	weeks	that	were	positive	for	BrdU	
and	negative	for	DCX.	BrdU+/DCX-	cells	are	early-proliferated	cells	that	
differentiated	into	the	non-neuronal	lineage,	either	astrocytes	or	
oligodendrocytes.	Alcohol	did	not	change	the	number	of	BrdU+/DCX-	cells	in	the	
SVZ	of	TBI	animals	(Figure	19).	It	appears	that	the	vast	majority	of	BrdU+/DCX-	
cells	were	astrocytes	according	to	qualitative	microscopic	observation	of	GFAP	
and	BrdU	staining	(Figure	18).	However,	it	is	also	possible	that	BrdU+/DCX-	cells	
might	be	microglia	or	infiltrating	blood-borne	macrophages.	These	types	of	
immune	cells	have	been	found	to	proliferate	after	TBI	(Lalancette-Hébert	et	al	
2007).	While	alcohol	did	not	have	an	effect	on	total	glial	differentiation,	it	could	
have	effects	on	specific	types	of	glia;	for	instance,	there	was	qualitatively	more	
BrdU+/GFAP+	cells	in	our	microscopic	observation	of	the	Alcohol	TBI	compared	to	
Vehicle	TBI	groups	(Figure	18).		
	 Migration	is	an	important	aspect	of	SVZ	neurogenesis.	For	instance,	in	the	
SVZ-OB	system,	new	putative	neurons	travel	through	a	network	of	astrocytes	and	
vascular	cells	to	reach	their	destination	in	the	OB.	The	molecular	and	cellular	
interactions	that	these	migratory	cells	experienced	during	their	excursion	play	an	
important	role	in	their	eventual	differentiation	into	functional	neurons.	Alcohol	
exposure	had	been	found	to	profoundly	affect	neuronal	migration.	For	instance,	
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in	a	model	of	prenatal	alcohol	exposure,	alcohol	was	found	to	decrease	migration	
of	serotonin	neurons	(Zhou	et	al	2001).	Furthermore,	after	TBI,	neuronal	
migration	toward	the	perilesional	area	was	increased;	for	instance,	more	DCX+	
cells	were	detected	in	the	TBI	lesion	area	in	a	model	of	TBI	(Chang	et	al	2016)	
	 First,	we	determined	whether	binge	alcohol	differentially	affected	TBI	
induced	perilesional	migration	of	new	neurons.	TBI	itself	induced	robust	
migration	of	new	cells	toward	the	perilesional	area	(defined	as	100um	from	the	
edge	of	the	lesion).	The	total	number	of	BrdU+/DCX+	cells	in	the	perilesional	area	
was	around	12,000	cells	which	is	the	same	magnitude	as	the	number	of	
BrdU+/DCX+	in	the	SVZ.	However,	the	total	volume	of	the	perilesional	area	is	much	
larger	than	that	of	the	SVZ	so	the	effective	density	of	new	neurons	in	the	
perilesional	area	is	much	less.	Furthermore,	qualitative	microscopic	observation	
of	sham	animals	showed	there	were	little	to	no	BrdU+/DCX+	cells	in	the	
neocortical	area	dorsal	to	the	SVZ.	However,	there	was	no	evidence	for	binge	
alcohol	having	any	effect	on	perilesional	area	migration	of	new	neurons	in	TBI	
animals	(Figure	21).	In	addition	to	the	presence	of	new	migratory	neurons	in	the	
perilesional	area,	there	was	a	large	population	of	proliferating	cells	in	this	area.	
However,	these	BrdU+	cells	did	not	express	markers	for	mature	neurons	
(BrdU+/NeuN+,	Figure	20).	Our	observation	is	in	line	with	the	literature	on	post-TBI	
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migration	to	the	cortical	area	in	that	there	are	rarely	any	new	cells	expressing	
markers	of	mature	cortical	neurons	(Chang	et	al	2016).	 	
	 Migration	from	the	SVZ	to	the	cortex	has	important	implications	in	the	
recovery	post-TBI.	The	presence	of	new	neurons	in	the	perilesional	area	raises	the	
possibility	that	these	new	cells	can	become	functionally	integrated	and	can	take	
over	the	role	of	previously	dead	neurons.	This	event	however	has	not	been	well	
documented.	There	is	also	the	possibility	that	newborn	neurons	contribute	to	
functional	recovery	in	structures	other	than	the	perilesional	area.	There	is	strong	
evidence	that	olfactory	function	contributes	greatly	to	the	skilled	forelimb	
reaching	task	performance	(Whishaw	&	Tomie	1989).	We	quantified	the	migration	
of	new	neurons	in	the	SVZ-OB	pathway	by	counting	the	number	of	cells	
expressing	both	BrdU	and	DCX	(Figure	22).	This	pathway	is	the	well-characterized	
rostral	migratory	stream.	We	found	TBI	significantly	elevated	SVZ-OB	migration	
(Figure	23).	However,	alcohol	did	not	have	a	significant	effect	on	SVZ-OB	
migration.		
Future	Directions	
	 Although	we	did	not	examine	neurogenesis	in	the	hippocampus,	it	is	
possible	that	binge	alcohol	might	also	affect	hippocampal	neurogenesis.	In	future	
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studies,	we	could	first	use	a	hippocampal	sensitive	functional	task	to	assess	binge	
alcohol	impact	on	the	hippocampal	dependent	task	post	TBI.	However,	we	know	
that	in	the	hippocampus,	reduced	NSC	proliferation	or	ablation	was	shown	to	lead	
to	inhibition	of	LTP	in	the	perforant	pathway	(Kempermann	2011).	Other	evidence	
suggests	that	reduced	NSC	responses	can	lead	to	worse	performance	on	
hippocampal	dependent	tasks	such	as	the	MWM,	contextual	fear	conditioning,	
and	trace	conditioning.	Additionally,	we	could	extend	our	work	by	using	the	BrdU	
injection	paradigm	to	study	different	temporal	responses	of	neurogenesis	to	TBI	
and	alcohol	in	the	hippocampus.	
	 BDNF	is	responsible	for	the	survival	of	new	neurons.	A	large	number	of	
newly	generated	cells	die	due	to	insufficient	trophic	support.	Alcohol	potently	
affects	BDNF	expression	and	could	affect	how	many	newly	generated	cells	in	the	
SVZ	survive.	Our	future	study	could	explore	how	alcohol	affects	BDNF	expression	
in	TBI	animals	and	in	turn	how	that	affects	the	survival	of	those	new	neurons.	We	
would	need	to	utilize	markers	of	neurogenesis	(such	as	BrdU)	along	with	markers	
of	cell	death	(such	as	Caspase3).	Furthermore,	our	lab	is	in	the	process	of	refining	
the	method	to	alter	the	BDNF	level	in	the	SVZ.	This	would	allow	us	to	modulate	
the	endogenous	BDNF	and	to	assess	its	contribution	to	neurogenesis	after	TBI.		
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	 While	BrdU	has	been	a	useful	tool	in	the	study	of	neurogenesis,	there	are	
important	limitations	to	this	technique.	One	new	technology	that	has	been	shown	
to	be	useful	in	the	study	of	neurogenesis	is	conditional	lentivirus	expressing	Cre-
Flex,	a	bioluminescence	marker	in	addition	to	green	fluorescence	protein	(GFP).	
This	technique	utilizes	lentivirus	and	can	be	used	to	label	neural	stem	cells	in	the	
SVZ	as	has	been	demonstrated	recently	in	a	stroke	model	(Vandeputte	et	al	
2014).	The	lentivirus	vector	is	introduced	into	the	SVZ	by	stereotactic	injection,	
and	becomes	incorporated	into	the	stem	cells	of	the	SVZ.	The	markers	carried	by	
the	lentivirus	become	stably	expressed	in	the	stem	cells	which	allow	us	to	track	
the	migration	pattern	as	well	as	determine	the	eventual	phenotype	of	these	cells.		
	 Inflammation	is	a	large	component	of	TBI	pathology,	and	alcohol	has	a	
pronounced	inflammatory	modulating	effect.	One	question	is	how	binge	alcohol	
affects	inflammatory	cells	such	as	infiltrating	macrophage,	and	microglia	
activation.	In	this	regard,	large	amounts	of	adenosine	triphosphate	(ATP)	is	
produced	in	the	cells	of	TBI	lesion	sites	after	CNS	injury	and	released	to	the	
extracellular	space	and	serves	as	an	inflammatory	signaling	molecule.	ATP	has	
been	found	to	be	a	potent	chemo-attractant	to	microglia,	the	resident	
inflammatory	cell	of	the	CNS	(Ohsawa	&	Kohsaka	2011).	Additionally,	in	the	
hematopoietic	system,	ATP	has	a	chemo-attraction	role	for	stem	cells	(Rossi	et	al	
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2012).	It	is	likely	that	ATP	also	is	a	homing	signal	for	migrating	neuroblasts	(i.e.	
DCX+	cells).	Extracellular	ATP	is	recognized	by	cells	via	the	purinergic	cell	surface	
receptors	such	as	P2X4	and	P2X7.	Interestingly,	P2X7	receptors	are	also	affected	
by	alcohol.	For	instance,	alcohol	is	an	antagonist	for	purinergic	receptors	P2X4	
and	P2X7	(Ostrovskaya	et	al	2011).		
	 Finally,	we	could	expand	our	binge	alcohol	model	to	more	closely	mimic	
human	alcohol	consumption.	Typically,	TBI	patients	do	not	get	a	TBI	during	their	
first	binge	episode.	It	is	likely	that	they	would	have	a	more	prolonged	history	of	
alcohol	consumption.	Since	laboratory	animals	such	as	rats	can	experience	
tolerant	effects	to	alcohol	when	given	repeatedly	over	time,	this	may	affect	the	
outcome	of	repeated	binge	alcohol	studies.	Alcohol	is	an	antagonist	for	NMDA	
receptors	and	repeated	alcohol	administration	can	lead	to	an	increase	in	
expression	of	NMDA	receptors.	We	know	that	NMDA	receptors	are	the	main	
perpetrator	for	excitotoxicity	via	high	levels	of	extracellular	glutamate	after	TBI.	
Therefore,	it	is	possible	that	a	more	prolonged	binge	alcohol	administration	
paradigm	could	lead	to	different	SVZ	response	outcomes	as	compared	to	what	we	
observed	in	our	current	model.	As	there	is	evidence	in	human	TBI	patients	of	a	
strong	likelihood	of	increase	in	intake	of	alcohol	post-TBI	(Bombardier	et	al	2003),	
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examining	how	alcohol	given	after	TBI	affects	neurogenesis	is	an	interesting	
avenue	of	research.	 	
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